Home
  >  
Section 55

EurekaMag PDF full texts Chapter 54,352



References:

Padhy, D.; Madhuri, V.; Pulimood, S.A.; Danda, S.; Walter, N.M.; Wang, L.L. 2010: Metatarsal osteosarcoma in Rothmund-Thomson syndrome: a case report. Journal of Bone and Joint Surgery. American Volume 92(3): 726-730
Simon, D.M. 1947: Metatarsal pain of systemic origin. Journal of the National Association of Chiropodists 37(6): 28
Domínguez, G.; Munuera, P.V.; Lomas, M. 2009: Metatarsal protrusion angle: values of normality. Journal of the American Podiatric Medical Association 99(1): 49-53
Toma, C.D.; Dominkus, M.; Pfeiffer, M.; Giovanoli, P.; Assadian, O.; Kotz, R. 2007: Metatarsal reconstruction with use of free vascularized osteomyocutaneous fibular grafts following resection of malignant tumors of the midfoot. A series of six cases. Journal of Bone and Joint Surgery. American Volume 89(7): 1553-1564
Drakonaki, E.E.; Garbi, A. 2010: Metatarsal stress fracture diagnosed with high-resolution sonography. Journal of Ultrasound in Medicine: Official Journal of the American Institute of Ultrasound in Medicine 29(3): 473-476
Waterman, G.N.; Yellin, O.; Jamshidinia, K.; Swift, R.A.; Tamkin, J.A.; Audell, R.A.; Berenson, J.R. 2011: Metatarsal stress fractures in patients with multiple myeloma treated with long-term bisphosphonates: a report of six cases. Journal of Bone and Joint Surgery. American Volume 93(18): E106
Malhotra, K.; Nunn, T.; Chandramohan, M.; Shanker, J. 2011: Metatarsal stress fractures secondary to soft-tissue osteochondroma in the foot: case report and literature review. Foot and Ankle Surgery: Official Journal of the European Society of Foot and Ankle Surgeons 17(4): E51-E54
Pardal-Fernández, J.é M.; Rodríguez-Vázquez, M.ía. 2011: Metatarsalgia and neuropathies of the foot. Differential diagnosis. Revista de Neurologia 52(1): 37-44
DiPreta, J.A. 2014: Metatarsalgia, lesser toe deformities, and associated disorders of the forefoot. Medical Clinics of North America 98(2): 233-251
Gregg, J.; Marks, P. 2007: Metatarsalgia: an ultrasound perspective. Australasian Radiology 51(6): 493-499
Schuh, R.; Trnka, H.J. 2011: Metatarsalgia: distal metatarsal osteotomies. Foot and Ankle Clinics 16(4): 583-595
Pearce, C.J.; Calder, J.D. 2011: Metatarsalgia: proximal metatarsal osteotomies. Foot and Ankle Clinics 16(4): 597-608
Lerner, H.H. 1945: Metatarsalgia; painful foot, Morton's syndrome, march fracture; a physiologic entity. Proceedings. American Federation for Clinical Research 2: 105
Bidmos, M.A. 2008: Metatarsals in the estimation of stature in South Africans. Journal of Forensic and Legal Medicine 15(8): 505-509
Tan, J.; Lau, J.T.C. 2011: Metatarso-sesamoid osteoarthritis as a cause of pain after first metatarsophalangeal joint fusion: case report. Foot and Ankle International 32(8): 822-825
Gilheany, M.F.; Amir, O.T. 2013: Metatarsocuneiform joint resection arthroplasty for atraumatic osteoarthrosis: an alternative to arthrodesis. Journal of Foot and Ankle Surgery: Official Publication of the American College of Foot and Ankle Surgeons 52(1): 122-124
Haleem, A.M.; Mintz, D.N.; Rozbruch, S.Robert. 2014: Metatarsophalangeal arthritis following fourth metatarsal lengthening treated with distraction arthroplasty: case report. Foot and Ankle International 35(10): 1075-1081
Parra-Téllez, P.; López-Gavito, E.; Vázquez-Escamilla, J. 2013: Metatarsophalangeal arthrodesis of the hallux and arthroplastic resection of the second to fifth metatarsal heads in the rheumatic foot. Acta Ortopedica Mexicana 27(2): 78-86
Sperati, G. 2014: Metatarsophalangeal joint arthroplasty with implantation of Osteomed Interflex IPG system: our experience. Acta Bio-Medica: Atenei Parmensis 85(Suppl 2): 118-120
Smith, G.; Lake, M.; Lees, A. 2014: Metatarsophalangeal joint function during sprinting: a comparison of barefoot and sprint spike shod foot conditions. Journal of Applied Biomechanics 30(2): 206-212
Gimple, K.; Amspacher, J.C.; Kopta, J.A. 1978: Metatarsophalangeal joint fusion of the great toe. Orthopedics 1(6): 462-467
Doty, J.F.; Coughlin, M.J. 2014: Metatarsophalangeal joint instability of the lesser toes and plantar plate deficiency. Journal of the American Academy of Orthopaedic Surgeons 22(4): 235-245
Turner, D.E.; Hyslop, E.; Barn, R.; McInnes, I.B.; Steultjens, M.P.M.; Woodburn, J. 2014: Metatarsophalangeal joint pain in psoriatic arthritis: a cross-sectional study. Rheumatology 53(4): 737-740
Coughlin, M.J.; Schutt, S.A.; Hirose, C.B.; Kennedy, M.J.; Grebing, B.R.; Smith, B.W.; Cooper, M.T.; Golano, P.; Viladot, R.ón.; Alvarez, F. 2012: Metatarsophalangeal joint pathology in crossover second toe deformity: a cadaveric study. Foot and Ankle International 33(2): 133-140
Lambrinudi, C. 1938: Metatarsus Primus Elevatus. Proceedings of the Royal Society of Medicine 31(11): 1273
Charvát, J. 1996: Metatarsus Varus among Forefoot Adduction Deformities in Children. Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca 63(4): 221-225
McCORMICK, D.W.; Blount, W.P. 1949: Metatarsus adductovarus: skewfoot. Journal of the American Medical Association 141(7): 449-453
Domínguez, G.; Munuera, P.V. 2008: Metatarsus adductus angle in male and female feet: normal values with two measurement techniques. Journal of the American Podiatric Medical Association 98(5): 364-369
Sorensen, M.D.; Hyer, C.F. 2009: Metatarsus primus varus correction: the osteotomies. Clinics in Podiatric Medicine and Surgery 26(3): 409
Davies, H. 1949: Metatarsus quintus valgus. British Medical Journal 1(4606): 664
Baker, F. 1948: Metatarsus virus. California Medicine 69(5): 346-348
Jiménez, D.J.; Dini-Andreote, F.; van Elsas, J.D. 2014: Metataxonomic profiling and prediction of functional behaviour of wheat straw degrading microbial consortia. Biotechnology for Biofuels 7: 92
Tanaka, Y.; Kita, K.; Takao, R.; Amano, H.; Uchida, R.; Shiozaki, Y.; Yonetani, Y.; Kinugasa, K.; Mae, T.; Horibe, S. 2018: Chronicity of Anterior Cruciate Ligament Deficiency, Part 1: Effects on the Tibiofemoral Relationship Before and Immediately After Anatomic ACL Reconstruction with Autologous Hamstring Grafts. Orthopaedic Journal of Sports Medicine 6(1): 2325967117750813
Jeon, K.O.; Rayabarapu, D.; Rolfe, A.; Volp, K.; Omar, I.; Hanson, P.R. 2009: Metathesis Cascade Strategies (ROM-RCM-CM): a DOS approach to Skeletally Diverse Sultams. Tetrahedron 65(26): 4992-5000
Dragutan, I.; Dragutan, V.; Mitan, C.; Vosloo, H.C.; Delaude, L.; Demonceau, A. 2011: Metathesis access to monocyclic iminocyclitol-based therapeutic agents. Beilstein Journal of Organic Chemistry 7: 699-716
Illesinghe, J.; Guo, C.X.; Garland, R.; Ahmed, A.; van Lierop, B.; Elaridi, J.; Jackson, W.R.; Robinson, A.J. 2009: Metathesis assisted synthesis of cyclic peptides. Chemical Communications 3: 295-297
Polarz, S.; Völker, B.; Jeremias, F. 2010: Metathesis catalysts in confining reaction fields--confinement effects vs. surface effects. Dalton Transactions 2: 577-584
Das, S.; Kim, H.; Kim, K. 2009: Metathesis in single crystal: complete and reversible exchange of metal ions constituting the frameworks of metal-organic frameworks. Journal of the American Chemical Society 131(11): 3814-3815
Van Otterlo, W.A.L.; de Koning, C.B. 2009: Metathesis in the synthesis of aromatic compounds. Chemical Reviews 109(8): 3743-3782
Fürstner, A. 2011: Metathesis in total synthesis. Chemical Communications 47(23): 6505-6511
Basset, J.-M.; Copéret, C.; Soulivong, D.; Taoufik, M.; Cazat, J.T. 2010: Metathesis of alkanes and related reactions. Accounts of Chemical Research 43(2): 323-334
Thomas, P.A.; Marvey, B.B.; Ebenso, E.E. 2011: Metathesis of fatty acid ester derivatives in 1,1-dialkyl and 1,2,3-trialkyl imidazolium type ionic liquids. International Journal of Molecular Sciences 12(6): 3989-3997
Burroughs, B.A.; Bursten, B.E.; Chen, S.; Chisholm, M.H.; Kidwell, A.R. 2008: Metathesis of nitrogen atoms within triple bonds involving carbon, tungsten, and molybdenum. Inorganic Chemistry 47(12): 5377-5385
Tahara, A.; Kajigaya, M.; Moriya, M.; Takao, T.; Suzuki, H. 2010: Metathesis reaction of hydrocarbyl ligands across the triruthenium plane. Angewandte Chemie 49(34): 5898-5901
Bauer, J.ür.; Braunschweig, H.; Damme, A.; Jimenez-Halla, J.O.C.; Kramer, T.; Radacki, K.; Shang, R.; Siedler, E.; Ye, Q. 2013: Metathesis reactions of a manganese borylene complex with polar heteroatom-carbon double bonds: a pathway to previously inaccessible carbene complexes. Journal of the American Chemical Society 135(23): 8726-8734
Martínez, A.; Gutiérrez, S.; Tlenkopatchev, M.A. 2012: Metathesis transformations of natural products: cross-metathesis of natural rubber and mandarin oil by Ru-alkylidene catalysts. Molecules 17(5): 6001-6010
Moffat, J.R.; Coates, I.A.; Leng, F.J.; Smith, D.K. 2009: Metathesis within self-assembled gels: transcribing nanostructured soft materials into a more robust form. Langmuir: the Acs Journal of Surfaces and Colloids 25(15): 8786-8793
Tanaka, Y.; Shinokubo, H.; Yoshimura, Y.; Osuka, A. 2009: Metathesis-like splitting reactions of metallated [36]octaphyrins(1.1.1.1.1.1.1.1): experimental and computational investigations. Chemistry 15(23): 5674-5685
Shikichi, Y.; Mori, K. 2012: Metathesis-mediated synthesis of (R)-10-methyl-2-tridecanone, the southern corn rootworm pheromone. Bioscience Biotechnology and Biochemistry 76(2): 407-409
Hirsh, J.B.; Deyoung, C.G.; Peterson, J.B. 2009: Metatraits of the Big Five differentially predict engagement and restraint of behavior. Journal of Personality 77(4): 1085-1102
Weckx, S.; Allemeersch, J.; Van der Meulen, R.; Vrancken, G.; Huys, G.; Vandamme, P.; Van Hummelen, P.; De Vuyst, L. 2011: Metatranscriptome analysis for insight into whole-ecosystem gene expression during spontaneous wheat and spelt sourdough fermentations. Applied and Environmental Microbiology 77(2): 618-626
Lessard, M-Hélène.; Viel, C.; Boyle, B.; St-Gelais, D.; Labrie, S. 2014: Metatranscriptome analysis of fungal strains Penicillium camemberti and Geotrichum candidum reveal cheese matrix breakdown and potential development of sensory properties of ripened Camembert-type cheese. Bmc Genomics 15: 235
Booijink, C.C.G.M.; Boekhorst, J.; Zoetendal, E.G.; Smidt, H.; Kleerebezem, M.; de Vos, W.M. 2010: Metatranscriptome analysis of the human fecal microbiota reveals subject-specific expression profiles, with genes encoding proteins involved in carbohydrate metabolism being dominantly expressed. Applied and Environmental Microbiology 76(16): 5533-5540
Luo, F.; Gitiafroz, R.; Devine, C.E.; Gong, Y.; Hug, L.A.; Raskin, L.; Edwards, E.A. 2014: Metatranscriptome of an anaerobic benzene-degrading, nitrate-reducing enrichment culture reveals involvement of carboxylation in benzene ring activation. Applied and Environmental Microbiology 80(14): 4095-4107
Toseland, A.; Moxon, S.; Mock, T.; Moulton, V. 2014: Metatranscriptomes from diverse microbial communities: assessment of data reduction techniques for rigorous annotation. Bmc Genomics 15: 901
Hewson, I.; Eggleston, E.M.; Doherty, M.; Lee, D.Y.; Owens, M.; Shapleigh, J.P.; Cornwell, J.C.; Crump, B.C. 2014: Metatranscriptomic analyses of plankton communities inhabiting surface and subpycnocline waters of the Chesapeake Bay during oxic-anoxic-oxic transitions. Applied and Environmental Microbiology 80(1): 328-338
Tveit, A.T.; Urich, T.; Svenning, M.M. 2014: Metatranscriptomic analysis of arctic peat soil microbiota. Applied and Environmental Microbiology 80(18): 5761-5772
Liao, H.-L.; Chen, Y.; Bruns, T.D.; Peay, K.G.; Taylor, J.W.; Branco, S.; Talbot, J.M.; Vilgalys, R. 2014: Metatranscriptomic analysis of ectomycorrhizal roots reveals genes associated with Piloderma-Pinus symbiosis: improved methodologies for assessing gene expression in situ. Environmental Microbiology 16(12): 3730-3742
Molina, L.G.; da Fonseca, G.C.; de Morais, G.L.; de Oliveira, L.F.V.; de Carvalho, J.B.; Kulcheski, F.R.; Margis, R. 2012: Metatranscriptomic analysis of small RNAs present in soybean deep sequencing libraries. Genetics and Molecular Biology 35(1): 292-303
Stewart, F.J.; Dmytrenko, O.; Delong, E.F.; Cavanaugh, C.M. 2011: Metatranscriptomic analysis of sulfur oxidation genes in the endosymbiont of solemya velum. Frontiers in Microbiology 2: 134
Yergeau, E.; Lawrence, J.R.; Waiser, M.J.; Korber, D.R.; Greer, C.W. 2010: Metatranscriptomic analysis of the response of river biofilms to pharmaceutical products, using anonymous DNA microarrays. Applied and Environmental Microbiology 76(16): 5432-5439
Martínez, A.ón.; Ventouras, L.-A.; Wilson, S.T.; Karl, D.M.; Delong, E.F. 2013: Metatranscriptomic and functional metagenomic analysis of methylphosphonate utilization by marine bacteria. Frontiers in Microbiology 4: 340
Gosalbes, M.ía.J.é; Durbán, A.; Pignatelli, M.; Abellan, J.J.é; Jiménez-Hernández, N.; Pérez-Cobas, A.E.; Latorre, A.; Moya, A.és. 2011: Metatranscriptomic approach to analyze the functional human gut microbiota. Plos one 6(3): E17447
He, S.; Kunin, V.; Haynes, M.; Martin, H.G.; Ivanova, N.; Rohwer, F.; Hugenholtz, P.; McMahon, K.D. 2010: Metatranscriptomic array analysis of 'Candidatus Accumulibacter phosphatis'-enriched enhanced biological phosphorus removal sludge. Environmental Microbiology 12(5): 1205-1217
Jorth, P.; Turner, K.H.; Gumus, P.; Nizam, N.; Buduneli, N.; Whiteley, M. 2014: Metatranscriptomics of the human oral microbiome during health and disease. Mbio 5(2): E01012-E01014
Damon, C.; Lehembre, F.éd.ér.; Oger-Desfeux, C.; Luis, P.; Ranger, J.; Fraissinet-Tachet, L.; Marmeisse, R. 2012: Metatranscriptomics reveals the diversity of genes expressed by eukaryotes in forest soils. Plos one 7(1): E28967
Barna, M.; Stulík, J.; Fencl, F. 2012: Metatropic dysplasia as the cause of atlantoaxial instability, spinal stenosis and myelopathy: case report and literature review. Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca 79(2): 169-174
Akhter, S.; Rahman, S.; Momen, M.; Karim, M.; Kawser, C. 2008: Metatropic dysplasia in children. Mymensingh Medical Journal: Mmj 17(1): 93-97
Kleszczyński, J.; Błoch, Mł.; Hofbauer, K.; Dominiak, P. 2012: Metatropic dysplasia in four-year-old boy--physiotherapy and orthopaedic care problems--case report. Ortopedia Traumatologia Rehabilitacja 14(3): 289-302
Tarallo, M.; Cigna, E.; Frati, R.; Delfino, S.; Innocenzi, D.; Fama, U.; Corbianco, A.; Scuderi, N.ò 2008: Metatypical basal cell carcinoma: a clinical review. Journal of Experimental and Clinical Cancer Research: Cr 27: 65
Tarallo, M.; Cigna, E.; Fino, P.; Sorvillo, V.; Scuderi, N.ò 2011: Metatypical basal-cell carcinoma (MTC) or basosquamos carcinoma (BSC): surgical therapy. Annali Italiani di Chirurgia 82(5): 389-394
Cigna, E.; Tarallo, M.; Sorvillo, V.; Piperno, A.; Scuderi, N. 2012: Metatypical carcinoma of the head: a review of 312 cases. European Review for Medical and Pharmacological Sciences 16(14): 1915-1918
Tarallo, M.; Cigna, E.; Sorvillo, V.; Stefanizzi, G.; Scuderi, N.ò 2011: Metatypical carcinoma. a review of 327 cases. Annali Italiani di Chirurgia 82(2): 131-135
Dima, F.; Ghimicescu, G. 1977: Metavanadate as a reagent for the colorimetric determination of acids. Talanta 24(5): 333-334
Kuznetsov, V.I.; Alexandrova, A.N.; Hengge, A.C. 2012: Metavanadate at the active site of the phosphatase VHZ. Journal of the American Chemical Society 134(35): 14298-14301
Athwal, G.S.; MacDermid, J.C.; Goel, D.P. 2010: Metaversion can reliably predict humeral head version: a computed tomography-based validation study. Journal of Shoulder and Elbow Surgery 19(8): 1145-1149
Roux, S.; Tournayre, J.; Mahul, A.; Debroas, D.; Enault, F.ço. 2014: Metavir 2: new tools for viral metagenome comparison and assembled virome analysis. Bmc Bioinformatics 15: 76
Roux, S.; Faubladier, M.ël.; Mahul, A.; Paulhe, N.; Bernard, A.él.; Debroas, D.; Enault, F.ço. 2011: Metavir: a web server dedicated to virome analysis. Bioinformatics 27(21): 3074-3075
Mazor, Y.; Steinberg, B.Z. 2014: Metaweaves: sector-way nonreciprocal metasurfaces. Physical Review Letters 112(15): 153901
Goswami, D.; Saha, A.; Gurule, S.; Khuroo, A.; Monif, T.; Vats, P. 2012: Metaxalone estimation in biological matrix using high-throughput LC-MS/MS bioanalytical method. Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 902: 132-136
Ono, K.; Wang, X.; Kim, S.O.; Armstrong, L.C.; Bornstein, P.; Han, J. 2010: Metaxin deficiency alters mitochondrial membrane permeability and leads to resistance to TNF-induced cell killing. Protein and Cell 1(2): 161-173
Cartron, P.-F.ço.; Petit, E.; Bellot, G.ég.; Oliver, L.; Vallette, F.ço.M. 2014: Metaxins 1 and 2, two proteins of the mitochondrial protein sorting and assembly machinery, are essential for Bak activation during TNF alpha triggered apoptosis. Cellular Signalling 26(9): 1928-1934
Peña-Santiago, R.; Niknam, G.; Alvarez-Ortega, S.; Jabbari, H. 2014: Metaxonchium persicum sp. n. from Iran (Nematoda, Dorylaimida, Belondiridae), with an updated taxonomy of the genus. Zootaxa 3785: 501-517
Du Pasquier, L. 2009: Metazoa immune receptors diversification during evolution. Medecine Sciences: M/S 25(3): 273-280
Fairley, N.H. 1938: Metazoal Immunity: (Section of Comparative Medicine). Proceedings of the Royal Society of Medicine 31(11): 1291-1298
Zlatic, S.A.; Tornieri, K.; L'hernault, S.W.; Faundez, V. 2011: Metazoan cell biology of the HOPS tethering complex. Cellular Logistics 1(3): 111-117
Ribeiro, T.S.; Lizama, M.A.P.; Takemoto, R.M. 2014: Metazoan endoparasites diversity of Pseudoplatystoma corruscans (Siluriformes: Pimelodidae) as an indicator of environmental alterations on a tropical aquatic system. Acta Parasitologica 59(3): 398-404
Vicentin, W.; Vieira, K.R.I.; Tavares, L.E.R.; Costa, F.áb.E.d.S.; Takemoto, R.M.; Paiva, F. 2013: Metazoan endoparasites of Pygocentrus nattereri (Characiformes: Serrasalminae) in the Negro River, Pantanal, Brazil. Revista Brasileira de Parasitologia Veterinaria 22(3): 331-338
Vicentin, W.; Vieira, K.R.I.; Costa, F.áb.E.D.S.; Takemoto, R.M.; Tavares, L.E.R.; Paiva, F. 2011: Metazoan endoparasites of Serrasalmus marginatus (Characiformes: Serrasalminae) in the Negro River, Pantanal, Brazil. Revista Brasileira de Parasitologia Veterinaria 20(1): 61-63
Culurgioni, J.; Mele, S.; Merella, P.; Addis, P.; Figus, V.; Cau, A.; Karakulak, F.S.; Garippa, G. 2014: Metazoan gill parasites of the Atlantic bluefin tuna Thunnus thynnus (Linnaeus) (Osteichthyes: Scombridae) from the Mediterranean and their possible use as biological tags. Folia Parasitologica 61(2): 148-156
Tossavi, N.D.; Gbankoto, A.; Adité, A.; Ibikounlé, M.; Grunau, C.; Sakiti, G.N. 2014: Metazoan parasite communities of catfishes (Teleostei: Siluridae) in Benin (West Africa). Parasitology Research 113(11): 3973-3983
Violante-González, J.; Aguirre-Macedo, M.L.; Rojas-Herrera, A.ín.; Guerrero, S.G. 2009: Metazoan parasite community of blue sea catfish, Sciades guatemalensis (Ariidae), from Tres Palos Lagoon, Guerrero, Mexico. Parasitology Research 105(4): 997-1005
Mattiucci, S.; Garcia, A.; Cipriani, P.; Santos, M.N.; Nascetti, G.; Cimmaruta, R. 2014: Metazoan parasite infection in the swordfish, Xiphias gladius, from the Mediterranean Sea and comparison with Atlantic populations: implications for its stock characterization. Parasite 21: 35
Unger, P.; Klimpel, S.; Lang, T.; Palm, H.W. 2014: Metazoan parasites from herring (Clupea harengus L.) as biological indicators in the Baltic Sea. Acta Parasitologica 59(3): 518-528
Mele, S.; Saber, S.; Gómez-Vives, M.J.; Garippa, G.; Alemany, F.; Macías, D.; Merella, P. 2015: Metazoan parasites in the head region of the bullet tuna Auxis rochei (Osteichthyes: Scombridae) from the western Mediterranean Sea. Journal of Helminthology 89(6): 734-739
Venancio, A.C.P.; de Aguiar, G.R.; Lopes, P.íc.d.S.; Alves, D.R. 2010: Metazoan parasites of Mandi-amarelo Pimelodus maculatus and of Jundiá Rhamdia quelen (Osteichthyes: Siluriformes) of Paraíba do Sul River, Volta Redonda, Rio de Janeiro. Revista Brasileira de Parasitologia Veterinaria 19(3): 157-163
Vankara, A.P.; Vijayalakshmi, C. 2009: Metazoan parasites of Mystus vittatus (Bloch) of River Godavari with description of a new species of Acanthocephala, Raosentis godavarensis sp. nov. Journal of Parasitic Diseases: Official Organ of the Indian Society for Parasitology 33(1-2): 77-83
Kuształa, M. 2010: Metazoan parasites of roach Rutilus rutilus (L., 1758), bream Abramis brama (L., 1758) and perch Perca fluviatilis L., 1758 from lakes of river Łyna watershed. Wiadomosci Parazytologiczne 56(1): 81-82
Madhavi, R.; Triveni Lakshmi, T. 2011: Metazoan parasites of the Indian mackerel, Rastrelliger kanagurta (Scombridae) of Visakhapatnam coast, Bay of Bengal. Journal of Parasitic Diseases: Official Organ of the Indian Society for Parasitology 35(1): 66-74
Karakişi, H.; Demir, S. 2012: Metazoan parasites of the common carp (Cyprinus carpio L., 1758) from Tahtalı Dam Lake (İzmir). Turkiye Parazitolojii Dergisi 36(3): 174-177
Mele, S.; Macías, D.; Gómez-Vives, M.ía.J.; Garippa, G.; Alemany, F.; Merella, P. 2012: Metazoan parasites on the gills of the skipjack tuna Katsuwonus pelamis (Osteichthyes: Scombridae) from the Alboran Sea (western Mediterranean Sea). Diseases of Aquatic Organisms 97(3): 219-225
Farny, N.G.; Kedersha, N.L.; Silver, P.A. 2009: Metazoan stress granule assembly is mediated by P-eIF2alpha-dependent and -independent mechanisms. Rna 15(10): 1814-1821
López, Z.; Cárdenas, L.; González, M.T. 2014: Metazoan symbionts of the yellow clam, Mesodesma donacium (Bivalvia), in southern Chile: geographical variations. Journal of Parasitology 100(6): 797-804
Lauder, G.V. 1995: Metazoan transitions. Science 268(5214): 1208
Sebastiani, P.; Bae, H.; Sun, F.X.; Andersen, S.L.; Daw, E.W.; Malovini, A.; Kojima, T.; Hirose, N.; Schupf, N.; Puca, A.; Perls, T.T. 2013: Meta‐analysis of genetic variants associated with human exceptional longevity. Aging 5(9): 653-661
Caramia, G.; Metchnikoff, E. 2008: Metchnikoff and a century of probiotics. from intuition to science. La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics 30(4): 215-219
Podolsky, S.H.; Metchnikoff, E. 2012: Metchnikoff and the microbiome. Lancet 380(9856): 1810-1811
Bailly, V.; Le Ray, I.; Bardonnaud, N.; Pillot, P.; Martin, L.; Pastori, J.; Balssa, L.; Guichard, G.; Bittard, H.; Kleinclauss, F. 2014: Meteo-U-rology: climate impact on urological emergencies. Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 24(9): 535-539
Traversi, D.; Alessandria, L.; Schilirò, T.; Chiadò Piat, S.; Gilli, G. 2010: Meteo-climatic conditions influence the contribution of endotoxins to PM10 in an urban polluted environment. Journal of Environmental Monitoring: Jem 12(2): 484-490
Poncino, S.; Bande, S.; Muraro, M. 2009: Meteo-diffusive analysis: a case-study of Turin. Epidemiologia e Prevenzione 33(6 Suppl 1: 27-33
Ganapol'skiĭ, V.P.; Shabanov, P.D. 2009: Meteoadaptogenic properties of antihypoxic drugs. Eksperimental'naia i Klinicheskaia Farmakologiia 72(6): 36-41
Shabanov, P.D.; Ganapol'skiĭ, V.P.; Aleksandrov, P.V. 2007: Meteoadaptogenic properties of peptide drugs in healthy volunteers. Eksperimental'naia i Klinicheskaia Farmakologiia 70(6): 41-47
Blackwelder, E. 1946: Meteor Crater, Arizona. Science 104(2689): 38-39
Tabrah, F.L. 1946: Meteor Trails on the Moon. Science 104(2709): 514
Jenniskens, P. 2012: Meteor hunt. Scientific American 307(3): 23
Kunz, G.F. 1887: Meteor-Fall. Science 10(253): 288
Wadsworth, M.E. 1883: Meteoric and Terrestrial Rocks. Science 1(5): 127-130
Fisher, W.J. 1932: Meteoric Dust. Science 75(1938): 216
Larkin, E.L. 1892: Meteoric Shower. Science 20(515): 346
Myers, D. 1885: Meteoric activity, Aug. 10. Science 6(133): 142
Whalley, C.L.; Plane, J.M.C. 2010: Meteoric ion layers in the Martian atmosphere. Faraday Discussions 147: 349-368; Discussion: 379-403
Revelle, D.O. 1985: Meteoric processes: physics of meteoric phenomena. Science 227(4691): 1219-1220
Lee, H.S.; Han, J.; Lee, S.-H.; Park, J.A.; Kim, K.-W. 2010: Meteorin promotes the formation of GFAP-positive glia via activation of the Jak-STAT3 pathway. Journal of Cell Science 123(Part 11): 1959-1968
Kim, Y.-Y.; Moon, J.-S.; Kwon, M.-c.; Shin, J.; Im, S.-K.; Kim, H.-A.; Han, J.-K.; Kong, Y.-Y. 2014: Meteorin regulates mesendoderm development by enhancing nodal expression. Plos one 9(2): E88811
Rao, R.R.; Long, J.Z.; White, J.P.; Svensson, K.J.; Lou, J.; Lokurkar, I.; Jedrychowski, M.P.; Ruas, J.L.; Wrann, C.D.; Lo, J.C.; Camera, D.M.; Lachey, J.; Gygi, S.; Seehra, J.; Hawley, J.A.; Spiegelman, B.M. 2014: Meteorin-like is a hormone that regulates immune-adipose interactions to increase beige fat thermogenesis. Cell 157(6): 1279-1291
King, E.A.; Schonfeld, E.; Richardson, K.A.; Eldridge, J.S. 1969: Meteorite fail at pueblito de allende, chihuahua, Mexico: preliminary information. Science 163(3870): 928-929
Cannon, P.J. 1978: Meteorite impact crater in central alaska. Science 201(4352): 279-280
Mardon, A. 1996: Meteorite recovery. Science 274(5286): 329a
Moore, C.B. 1965: Meteorites. Science 147(3661): 1061-1062
Cassidy, W.A.; Villar, L.M.; Bunch, T.E.; Kohman, T.P.; Milton, D.J. 1965: Meteorites and Craters Campo del Cielo, Argentina. Science 149(3688): 1055-1064
Urey, H.C. 1965: Meteorites and the Moon: Cosmic-ray ages and contaminants provide evidence that meteorites may come from the moon. Science 147(3663): 1262-1265
Saladino, R.; Botta, G.; Delfino, M.; Di Mauro, E. 2013: Meteorites as catalysts for prebiotic chemistry. Chemistry 19(50): 16916-16922
Hofmann, B.A. 2010: Meteorites: messengers from the early solar system. Chimia 64(10): 736-740
Carter, N.L. 1968: Meteoritic impact and deformation of quartz. Science 160(3827): 526-528
Stone, R. 2013: Meteoritics. Siberian meteor spurs dash for data, calls for safeguards. Science 339(6124): 1135
Underwood, E. 2012: Meteoritics. Sutter's Mill meteorite produces mother lode of research. Science 338(6114): 1521
Anders, J.M. 1904: Meteorologic Conditions in the Causation of Lobar Pneumonia. Transactions of the American Climatological Association for the year . American Climatological Association 20: 204-231
Hervás, D.; Reina, J.; Hervás, J.A. 2012: Meteorologic conditions and respiratory syncytial virus activity. Pediatric Infectious Disease Journal 31(10): E176-E181
Yalta, K.; Geyık, B.; Sıvrı, N.; Yetkın, E. 2013: Meteorologic factors may trigger arrhythmogenesis through induction of systemic inflammation and coagulation response: potential antiarrhythmic benefits of mitigating this response in arrhythmia-prone subjects under poor meteorologic conditions?. International Journal of Cardiology 168(5): 4937-4938
Ward, R.D. 1903: Meteorological Bibliographies. Science 18(468): 795
Davis, W.M. 1884: Meteorological Charts of the North Atlantic. Science 3(69): 654-657
Phillips, W.F. 1897: Meteorological Conditions of Sunstroke. Transactions of the American Climatological Association for the year . American Climatological Association 13: 223-237
Lhermitte, R. 1973: Meteorological Doppler radar. Science 182(4109): 258-262
Anonymous 1881: Meteorological Electricity. Science 2(52): 288
Cullen, W.H. 1843: Meteorological Journal: Kept at Sidmouth. Provincial Medical Journal and Retrospect of the Medical Sciences 6(151): 437
Anonymous 1885: Meteorological Notes. Science 6(151): 556-557
Anonymous 1885: Meteorological Notes. Science 5(104): 97-98
Smith, T.B. 1891: Meteorological Notes. Science 18(456): 244
Reed, W.G. 1913: Meteorological Observations at the University of California. Science 37(960): 800-802
Ward, R.d.C. 1897: Meteorological Observations during an Atlantic Voyage. Science 6(139): 324-325
Abbe, C. 1915: Meteorological Observations in Germany. Science 41(1045): 65
Anonymous 1890: Meteorological Observations on Pike's Peak. Science 15(368): 122-124
Rotch, A.L. 1903: Meteorological Observations with Kites at Sea. Science 18(447): 113-114
Payne, W.W. 1888: Meteorological Observations as respects Disease Prevalence. Public Health Papers and Reports 14: 179-182
Anonymous 1942: Meteorological Officers in the Army Air Forces. Science 96(2500): 489
Fergusson, S.P. 1906: Meteorological Phenomena on Mountain Summits. Science 23(591): 672-674
Draper, D. 1881: Meteorological Report for new York City for the Week Ending Aug. 20, 1881. Science 2(62): 412
Ward, R.D. 1905: Meteorological Results of the Blue Hill Kite Work. Science 21(533): 433-435
Erickson, C.O. 1964: Meteorological Satellites. Science 143(3606): 612-613
Anonymous 1943: Meteorological Training for the Army Air Forces. Science 97(2512): 179
Reyes, E.ía.S.án.; de la Cruz, D.R.íg.; Merino, M.E.S.ís.; Sánchez, J.é S.án. 2009: Meteorological and agricultural effects on airborne Alternaria and Cladosporium spores and clinical aspects in Valladolid (Spain). Annals of Agricultural and Environmental Medicine: Aaem 16(1): 53-61
Tuite, J.J.; Haley, R.W. 2013: Meteorological and intelligence evidence of long-distance transit of chemical weapons fallout from bombing early in the 1991 Persian Gulf War. Neuroepidemiology 40(3): 160-177
Guazzoni, N.ò; Comolli, R.; Mariani, L.; Cola, G.; Parolini, M.; Binelli, A.; Tremolada, P. 2011: Meteorological and pedological influence on the PCBs distribution in mountain soils. Chemosphere 83(2): 186-192
Rasmusson, E.M.; Wallace, J.M. 1983: Meteorological aspects of the el nino/southern oscillation. Science 222(4629): 1195-1202
Wang, D.; Yu, Z-Wen.; Zhang, Y-Li. 2007: Meteorological conditions affecting the quality of strong gluten- and medium gluten- wheat and climate division in Shandong Province. Ying Yong Sheng Tai Xue Bao 18(10): 2269-2276
Baikoussis, N.G.; Apostolakis, E.E.; Koniari, I.; Dougenis, D. 2010: Meteorological conditions and acute cardiovascular events; is there any correlation?. Interactive Cardiovascular and Thoracic Surgery 10(3): 406-407
Dunn, C.E.; Rowlingson, B.; Bhopal, R.S.; Diggle, P. 2013: Meteorological conditions and incidence of Legionnaires' disease in Glasgow, Scotland: application of statistical modelling. Epidemiology and Infection 141(4): 687-696
Hegewald, J.; Uter, W.; Kränke, B.; Schnuch, A.; Pfahlberg, A.; Gefeller, O. 2008: Meteorological conditions and the diagnosis of occupationally related contact sensitizations. Scandinavian Journal of Work Environment and Health 34(4): 316-321
Seo, J.-H.; Jeon, E.-J.; Park, Y.-S.; Kim, J.; Chang, K.-H.; Yeo, S.-W. 2014: Meteorological conditions related to the onset of idiopathic sudden sensorineural hearing loss. Yonsei Medical Journal 55(6): 1678-1682
Ozpolat, B.; Gözübüyük, A.; Koçer, B.ül.; Yazkan, R.; Dural, K.; Genç, O. 2009: Meteorological conditions related to the onset of spontaneous pneumothorax. Tohoku Journal of Experimental Medicine 217(4): 329-334
Shakhbazyan, G.K. 1949: Meteorological conditions, research. Higiene y Salubridad 14(2): 8-12
Fang, W.; Sheng, V.S.; Wen, X.; Pan, W. 2014: Meteorological data analysis using MapReduce. Thescientificworldjournal 2014: 646497
Van Hennekeler, K.; Jones, R.E.; Skerratt, L.F.; Muzari, M.O.; Fitzpatrick, L.A. 2011: Meteorological effects on the daily activity patterns of tabanid biting flies in northern Queensland, Australia. Medical and Veterinary Entomology 25(1): 17-24
Westbury, B. 1983: Meteorological factors affecting behaviour. Journal of the Royal Society of Medicine 76(1): 84-85
Chan, J.Y.C.; Lin, H.L.; Tian, L.W. 2014: Meteorological factors and El Nino Southern Oscillation are associated with paediatric varicella infections in Hong Kong, 2004-2010. Epidemiology and infection 142(7): 1384-1392
Earnest, A.; Tan, S.B.; Wilder-Smith, A. 2012: Meteorological factors and El Niño Southern Oscillation are independently associated with dengue infections. Epidemiology and Infection 140(7): 1244-1251
Law, H.Y.; Wong, G.K.C.; Chan, D.T.M.; Wong, L.; Poon, W.S. 2009: Meteorological factors and aneurysmal subarachnoid haemorrhage in Hong Kong. Hong Kong Medical Journal 15(2): 85-89
García, F.M.ó; Boada, S.S.ó i.; Collsamata, A.X.ó; Joaquim, I.G.; Pérez, Y.A.; Tricio, O.G.óm.; Ibiza, C.M. 2009: Meteorological factors and psychiatric emergencies. Actas Espanolas de Psiquiatria 37(1): 34-41
Conza, L.; Casati, S.; Limoni, C.; Gaia, V. 2013: Meteorological factors and risk of community-acquired Legionnaires' disease in Switzerland: an epidemiological study. Bmj Open 3(3)
Li, T.; Yang, Z.; Dong, Z.; Wang, M. 2014: Meteorological factors and risk of scrub typhus in Guangzhou, southern China, 2006-2012. BMC infectious diseases 14: 139
Hirsch, E.; Lim, C.; Dobrez, D.; Adams, M.G.; Noble, W. 2011: Meteorological factors and timing of the initiating event of human parturition. International Journal of Biometeorology 55(2): 265-272
Lin, H.; Zhang, Z.; Lu, L.; Li, X.; Liu, Q. 2014: Meteorological factors are associated with hemorrhagic fever with renal syndrome in Jiaonan County, China, 2006-2011. International journal of biometeorology 58(6): 1031-1037
Viveiros, F.át.; Ferreira, T.; Silva, C.; Gaspar, J.ão.L. 2009: Meteorological factors controlling soil gases and indoor CO2 concentration: a permanent risk in degassing areas. Science of the Total Environment 407(4): 1362-1372
Qasem, J.A.; Nasrallah, H.; Al-Khalaf, B.N.; Al-Sharifi, F.; Al-Sherayfee, A.; Almathkouri, S.A.; Al-Saraf, H. 2008: Meteorological factors, aeroallergens and asthma-related visits in Kuwait: a 12-month retrospective study. Annals of Saudi Medicine 28(6): 435-441
Huang, F.; Zhou, S.; Zhang, S.; Zhang, H.; Li, W. 2011: Meteorological factors-based spatio-temporal mapping and predicting malaria in central China. American Journal of Tropical Medicine and Hygiene 85(3): 560-567
Nilsson, B. 1979: Meteorological influence on aerosol extinction in the 0.2-40-microm wavelength range. Applied Optics 18(20): 3457-3473
Xue, D.; Yin, J. 2014: Meteorological influence on predicting surface SO2 concentration from satellite remote sensing in Shanghai, China. Environmental Monitoring and Assessment 186(5): 2895-2906
Van Renterghem, T.; Botteldooren, D. 2010: Meteorological influence on sound propagation between adjacent city canyons: a real-life experiment. Journal of the Acoustical Society of America 127(6): 3335-3346
Van Stan, J.T.; Van Stan, J.H.; Levia, D.F. 2014: Meteorological influences on stemflow generation across diameter size classes of two morphologically distinct deciduous species. International Journal of Biometeorology 58(10): 2059-2069
Neidert, M.C.; Sprenger, M.; Wernli, H.; Burkhardt, J.-K.; Krayenbühl, N.; Bozinov, O.; Regli, L.; Woernle, C.M. 2013: Meteorological influences on the incidence of aneurysmal subarachnoid hemorrhage - a single center study of 511 patients. Plos one 8(12): E81621
Prakash S Mohan, R.; Ghanta, S.; Verma, S.; Agarwal, N.; Gupta, N.; Singh, U. 2013: Meteorological influences on the incidence of lichen planus in a north Indian population. Journal of Oral Science 55(4): 311-318
Moore, S.M.; Eisen, R.J.; Monaghan, A.; Mead, P. 2014: Meteorological influences on the seasonality of Lyme disease in the United States. American Journal of Tropical Medicine and Hygiene 90(3): 486-496
Lipsius, K.; Wilhelm, R.; Richter, O.; Schmalstieg, K.J.ür.; Schiemann, J. 2006: Meteorological input data requirements to predict cross-pollination of GMO maize with Lagrangian approaches. Environmental Biosafety Research 5(3): 151-168
Oztuna, F.; Ozsu, S.ş; Topbaş, M.; Bülbül, Y.; Koşucu, P.; Ozlü, T. 2008: Meteorological parameters and seasonal variations in pulmonary thromboembolism. American Journal of Emergency Medicine 26(9): 1035-1041
Staśkiewicz, G.; Czekajska-Chehab, E.żb.; Przegaliński, J.; Maciejewski, M.; Pachowicz, M.; Drop, A. 2011: Meteorological parameters and severity of acute pulmonary embolism episodes. Annals of Agricultural and Environmental Medicine: Aaem 18(1): 127-130
Jia, E.-Z.; Liu, Z.; Chen, A.-J.; Gu, Y.; Li, Z.-Y.; Zhu, T.-B.; Li, C.-J.; Wang, L.-S.; Ma, W.-Z.; Yang, Z.-J. 2014: Meteorological parameters and the onset of chest pain in subjects with acute ST-elevation myocardial infarction: an eight-year, single-center study in China. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology Biochemistry and Pharmacology 34(5): 1589-1596
Lebedev, I.A.; Gilvanov, V.A.; Akinina, S.A.; Anishchenko, L.I. 2013: Meteorological risk factors of stroke. Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 113(9 Part 2): 28-32
Palacios, C.; Abecia, J.A. 2015: Meteorological variables affect fertility rate after intrauterine artificial insemination in sheep in a seasonal-dependent manner: a 7-year study. International Journal of Biometeorology 59(5): 585-592
Gao, L.; Zhang, Y.; Ding, G.; Liu, Q.; Zhou, M.; Li, X.; Jiang, B. 2014: Meteorological variables and bacillary dysentery cases in Changsha City, China. American Journal of Tropical Medicine and Hygiene 90(4): 697-704
Zhang, Y.; Bi, P.; Hiller, J.E. 2010: Meteorological variables and malaria in a Chinese temperate city: a twenty-year time-series data analysis. Environment International 36(5): 439-445
Guerrero-Alonso, P.; Prieto-Salceda, D.; Llorca, J. 2007: Meteorological variables do not explain the North-South gradient in mortality from multiple sclerosis in Spain. Gaceta Sanitaria 21(4): 329-333
Egan, W.G.; Hogan, A.W. 1986: Meteorological variation of atmospheric optical properties in an antarctic storm. Applied Optics 25(7): 1155
Akyüz, M.; Cabuk, H. 2009: Meteorological variations of PM2.5/PM10 concentrations and particle-associated polycyclic aromatic hydrocarbons in the atmospheric environment of Zonguldak, Turkey. Journal of Hazardous Materials 170(1): 13-21
Kiang, R.; Adimi, F.; Soika, V.; Nigro, J.; Singhasivanon, P.; Sirichaisinthop, J.; Leemingsawat, S.; Apiwathnasorn, C.; Looareesuwan, S. 2006: Meteorological, environmental remote sensing and neural network analysis of the epidemiology of malaria transmission in Thailand. Geospatial Health 1(1): 71-84
White, N.; teWaterNaude, J.; van der Walt, A.; Ravenscroft, G.; Roberts, W.; Ehrlich, R. 2009: Meteorologically estimated exposure but not distance predicts asthma symptoms in schoolchildren in the environs of a petrochemical refinery: a cross-sectional study. Environmental Health: a Global Access Science Source 8: 45
Sánchez-Garrido, J.é C.; Lafuente, J.ús.G.ía.; Sammartino, S.; Naranjo, C.; de los Santos, F.J.; Álvarez Fanjul, E. 2014: Meteorologically-driven circulation and flushing times of the Bay of Algeciras, Strait of Gibraltar. Marine Pollution Bulletin 80(1-2): 97-106
Klotz, O. 1921: Meteorologische Zeitschrift. Science 54(1409): 663-664
Tai, A.M.; Aleksoff, C.C. 1984: Grating-based interferometric processor for real-time optical Fourier transformation. Applied Optics 23(14): 2282
Abbe, C. 1899: Meteorology. Science 9(234): 871-872
Rubin, M.J. 1963: Meteorology. Science 142(3590): 416
Ward, R.D. 1919: Meteorology and the Trans-Atlantic Flight. Science 50(1283): 114-115
Rotch, A.L. 1903: Meteorology at the British Association. Science 18(464): 657-661
Anonymous 1902: Meteorology in Argentina. Science 15(387): 875-876
D, W.M. 1886: Meteorology in California. Science 8(204s): 634-636
Ward, R.D. 1897: Meteorology in South America. Science 6(144): 523-525
Abbe, C. 1895: Meteorology in the University. Science 2(48): 709-714
Merrifield, J. 1871: Meteorology and Climate of Plymouth. British Medical Journal 2(560): 347-349
Velschow, F.A. 1891: Meteorology and Mathematics. Science 17(416): 51
Yuan, C.; Wang, X.-M.; Galzote, C.; Tan, Y.-M.; Bhagat, K.V.; Yuan, Z.-K.; Du, J.-F.; Tan, Y. 2013: Meteorology and ethnicity as critical factors in HRIPT: Comparing responses between Chinese and Indian ethnicities. Regulatory Toxicology and Pharmacology: Rtp 66(1): 59-65
Forrai, J. 2010: Meteorology and the human body: two hundred years of history. Orvosi hetilap 151(27): 1099-1105
Finger, F.G.; McInturff, R.M. 1970: Meteorology and the supersonic transport. Science 167(3914): 16-25
Decker, F.W. 1960: Meteorology as a Field of Study. Science 131(3404): 944
Day, J.A. 1959: Meteorology for Non-Science Majors. Science 130(3388): 1600-1604
Moore, J.W. 1873: Meteorology in its Bearing on Health and Disease. British Medical Journal 1(641): 400-402
Takagi, H.; Watanabe, T.; Mizuno, Y.; Kawai, N.; Umemoto, T. 2014: Meteorology in ruptured abdominal aortic aneurysm: an institutional study and a meta-analysis of published studies reporting atmospheric pressure. International Angiology: a Journal of the International Union of Angiology 33(6): 553-559
Pack, D.H. 1964: Meteorology of Air Pollution: the need to preserve our air resources challenges our understanding of the atmosphere's capacities. Science 146(3648): 1119-1128
Davis, T. 1843: Alleged Neglect on the Part of the Bedminster Union Guardians. Provincial Medical Journal and Retrospect of the Medical Sciences 6(135): 97-98
Dobson, G.M.B.; Brewer, A.W.; Cwilong, B.M. 1946: Meteorology of the lower stratosphere. Proceedings of the Royal Society of Medicine 185(Ser A): 144-175
Humphreys, W.J. 1929: Meteorology's Frozen Assets. Science 69(1784): 255-259
Lewis, D. 2014: Meteorology. Heat wave forecasts debut in scorching Australia. Science 343(6171): 587
Kerr, R.A. 2012: Meteorology. one Sandy forecast a bigger winner than others. Science 338(6108): 736-737
Kerr, R.A. 2007: Meteorology. Order from chaos, power from dissipation in planetary flows. Science 317(5837): 449-499
Kerr, R.A. 2014: Meteorology. Southern Hemisphere storms pulsate to a 25-day beat, new papers show. Science 343(6171): 588
Kerr, R.A. 2012: Meteorology. Weather forecasts slowly clearing up. Science 338(6108): 734-737
Lovell, A.C.B. 1947: Meteors, comets and meteoric ionization. Nature 159(4055): 76-78
Ellyett, C.D.; Keay, C.S. 1964: Meteors: An Unexpected Increase in 1963. Science 146(3650): 1458
Agafonova, N.A.; Iakovenko, E.P.; Ivanov, A.N.; Prianishnikova, A.S.; Iakovenko, A.V. 2009: Meteospazmil for correction of motor disorders in functional colon diseases. Eksperimental'naia i Klinicheskaia Gastroenterologiia 2009(4): 101-106
Lay, G.W. 1932: Meter in Composition. Science 75(1951): 536-537
Henkel, D. 1954: Meter Versus Yard. Science 119(3095): 567-568
Kiriya, D.; Ikeda, M.; Onoe, H.; Takinoue, M.; Komatsu, H.; Shimoyama, Y.; Hamachi, I.; Takeuchi, S. 2012: Meter-long and robust supramolecular strands encapsulated in hydrogel jackets. Angewandte Chemie 51(7): 1553-1557
Voswinckel, R.; Reichenberger, F.; Gall, H.; Schmehl, T.; Gessler, T.; Schermuly, R.T.; Grimminger, F.; Rubin, L.J.; Seeger, W.; Ghofrani, H.A.; Olschewski, H. 2009: Metered dose inhaler delivery of treprostinil for the treatment of pulmonary hypertension. Pulmonary Pharmacology and Therapeutics 22(1): 50-56
Lurslurchachai, L.; Krauskopf, K.; Roy, A.; Halm, E.A.; Leventhal, H.; Wisnivesky, J.P. 2014: Metered dose inhaler technique among inner-city asthmatics and its association with asthma medication adherence. Clinical Respiratory Journal 8(4): 397-403
Mathew, J.L.; Singh, M. 2008: Metered dose inhaler with spacer in children with acute asthma. Indian Pediatrics 45(4): 295-297
Holland, A.; Smith, F.; Penny, K.; McCrossan, G.; Veitch, L.; Nicholson, C. 2013: Metered dose inhalers versus nebulizers for aerosol bronchodilator delivery for adult patients receiving mechanical ventilation in critical care units. Cochrane Database of Systematic Reviews 6: Cd008863
Fadl, A.; Wang, J.; Zhang, Z. 2010: Metered-dose inhaler efficiency enhancement: a case study and novel design. Inhalation Toxicology 22(7): 601-609
Wyatt, E.L.; Borland, M.L.; Doyle, S.K.; Geelhoed, G.C. 2015: Metered-dose inhaler ipratropium bromide in moderate acute asthma in children: a single-blinded randomised controlled trial. Journal of Paediatrics and Child Health 51(2): 192-198
Bosnic-Anticevich, S.Z.; Sinha, H.; So, S.; Reddel, H.K. 2010: Metered-dose inhaler technique: the effect of two educational interventions delivered in community pharmacy over time. Journal of Asthma: Official Journal of the Association for the Care of Asthma 47(3): 251-256
Khoo, S.M.; Tan, L.K.; Said, N.; Lim, T.K. 2009: Metered-dose inhaler with spacer instead of nebulizer during the outbreak of severe acute respiratory syndrome in Singapore. Respiratory Care 54(7): 855-860
Lewis, D. 2007: Metered-dose inhalers: actuators old and new. Expert Opinion on Drug Delivery 4(3): 235-245
Nielsen, J.A. 1986: Metergoline, pirenperone and pizotifen alter dopamine and 5-hydroxytryptamine synthesis in discrete rat brain nuclei. Neurochemistry International 9(3): 423-429
Kang, K.; Wong, K.-S.; Fong, W.-P.; Tsang, P.W.-K. 2011: Metergoline-induced cell death in Candida krusei. Fungal Biology 115(3): 302-309
Noh, H.; Phillips, S.T. 2010: Metering the capillary-driven flow of fluids in paper-based microfluidic devices. Analytical Chemistry 82(10): 4181-4187
Kenyon, A.P.; Shennan, A.H. 2008: Metformin (alone or with insulin) was as effective as insulin for preventing perinatal complications in gestational diabetes. Acp Journal Club 149(2): 7
Amador, R.R.; Longo, J.ão.P.F.ó; Lacava, Z.G.; Dórea, J.é G.; Almeida Santos, M.d.F.át.M. 2012: Metformin (dimethyl-biguanide) induced DNA damage in mammalian cells. Genetics and Molecular Biology 35(1): 153-158
Scheen, A.é J. 2012: Metformin + saxagliptin for type 2 diabetes. Expert Opinion on PharmacoTherapy 13(1): 139-146
Grzybowska, M.; Bober, J.; Olszewska, M. 2011: Metformin - mechanisms of action and use for the treatment of type 2 diabetes mellitus. Postepy Higieny i Medycyny Doswiadczalnej 65: 277-285
Aghahosseini, M.; Aleyaseen, A.; Safdarian, L.; Moddaress-Hashemi, S.; Mofid, B.; Kashani, L. 2010: Metformin 2,500 mg/day in the treatment of obese women with polycystic ovary syndrome and its effect on weight, hormones, and lipid profile. Archives of Gynecology and Obstetrics 282(6): 691-694
Hyun, B.; Shin, S.; Lee, A.; Lee, S.; Song, Y.; Ha, N.-J.; Cho, K.-H.; Kim, K. 2013: Metformin Down-regulates TNF-α Secretion via Suppression of Scavenger Receptors in Macrophages. Immune Network 13(4): 123-132
Alzoubi, K.H.; Khabour, O.F.; Al-Azzam, S.I.; Tashtoush, M.H.; Mhaidat, N.M. 2014: Metformin Eased Cognitive Impairment Induced by Chronic L-methionine Administration: Potential Role of Oxidative Stress. Current Neuropharmacology 12(2): 186-192
Bikman, B.T.; Zheng, D.; Kane, D.A.; Anderson, E.J.; Woodlief, T.L.; Price, J.W.; Dohm, G.L.; Neufer, P.D.; Cortright, R.N. 2010: Metformin Improves Insulin Signaling in Obese Rats via Reduced IKKbeta Action in a Fiber-Type Specific Manner. Journal of Obesity 2010
Cha, H.-N.; Choi, J.H.; Kim, Y.-W.; Kim, J.-Y.; Ahn, M.-W.; Park, S.-Y. 2010: Metformin Inhibits Isoproterenol-induced Cardiac Hypertrophy in Mice. Korean Journal of Physiology and Pharmacology: Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology 14(6): 377-384
Anonymous 2014: Metformin OK in CKD?. Drug and therapeutics bulletin 52(4): 37
Zhao, L-Mei.; Wang, Y.; Yang, Y.; Guo, R.; Wang, N-Ping.; Deng, X-Ling. 2014: Metformin Restores Intermediate-Conductance Calcium-Activated K⁺ Channel- and Small-Conductance Calcium-Activated K⁺ Channel-Mediated Vasodilatation Impaired by Advanced Glycation End Products in Rat Mesenteric Artery. [Corrected. Molecular Pharmacology 86(5): 580-591
Shin, S.; Hyun, B.; Lee, A.; Kong, H.; Han, S.; Lee, C-Kil.; Ha, N-Joo.; Kim, K. 2013: Metformin Suppresses MHC-Restricted Antigen Presentation by Inhibiting Co-Stimulatory Factors and MHC Molecules in APCs. Biomolecules and Therapeutics 21(1): 35-41
Lundberg, G.D. 2008: Metformin Trumps insulin in the treatment of gestational diabetes. Medscape Journal of Medicine 10(7): 179
Mashhedi, H.; Blouin, M.-J.é; Zakikhani, M.; David, S.ép.; Zhao, Y.; Bazile, M.; Birman, E.; Algire, C.; Aliaga, A.; Bedell, B.J.; Pollak, M. 2011: Metformin abolishes increased tumor (18)F-2-fluoro-2-deoxy-D-glucose uptake associated with a high energy diet. Cell Cycle 10(16): 2770-2778
Martin, M.J.; Hayward, R.; Viros, A.; Marais, R. 2012: Metformin accelerates the growth of BRAF V600E-driven melanoma by upregulating VEGF-A. Cancer Discovery 2(4): 344-355
Lalau, J.D.; Azzoug, M.L.; Kajbaf, F.; Briet, C.; Desailloud, R. 2014: Metformin accumulation without hyperlactataemia and metformin-induced hyperlactataemia without metformin accumulation. Diabetes and Metabolism 40(3): 220-223
Vecchio, S.; Giampreti, A.; Petrolini, V.M.; Lonati, D.; Protti, A.; Papa, P.; Rognoni, C.; Valli, A.; Rocchi, L.; Rolandi, L.; Manzo, L.; Locatelli, C.A. 2014: Metformin accumulation: lactic acidosis and high plasmatic metformin levels in a retrospective case series of 66 patients on chronic therapy. Clinical Toxicology 52(2): 129-135
Sajan, M.P.; Ivey, R.A.; Farese, R.V. 2013: Metformin action in human hepatocytes: coactivation of atypical protein kinase C alters 5'-AMP-activated protein kinase effects on lipogenic and gluconeogenic enzyme expression. Diabetologia 56(11): 2507-2516
Boyle, J.G.; Salt, I.P.; McKay, G.A. 2010: Metformin action on AMP-activated protein kinase: a translational research approach to understanding a potential new therapeutic target. Diabetic Medicine: a Journal of the British Diabetic Association 27(10): 1097-1106
Ouyang, J.; Parakhia, R.A.; Ochs, R.S. 2011: Metformin activates AMP kinase through inhibition of AMP deaminase. Journal of Biological Chemistry 286(1): 1-11
Vazquez-Martin, A.; Oliveras-Ferraros, C.; Cufí, Sílvia.; Martin-Castillo, Bña.; Menendez, J.A. 2011: Metformin activates an ataxia telangiectasia mutated (ATM)/Chk2-regulated DNA damage-like response. Cell Cycle 10(9): 1499-1501
Abdelghaffar, S.; Attia, A.M. 2009: Metformin added to insulin therapy for type 1 diabetes mellitus in adolescents. Cochrane Database of Systematic Reviews 1: Cd006691
Burchardt, P.ł; Zawada, A.; Tabaczewski, P.; Naskręt, D.; Kaczmarek, J.; Marcinkaniec, J.; Wierusz-Wysocka, B.; Wysocki, H. 2013: Metformin added to intensive insulin therapy reduces plasma levels of glycated but not oxidized low‑density lipoprotein in young patients with type 1 diabetes and obesity in comparison with insulin alone: a pilot study. Polskie Archiwum Medycyny Wewnetrznej 123(10): 526-532
Palomba, S.; Falbo, A.; Russo, T.; Di Cello, A.; Morelli, M.; Orio, F.; Cappiello, F.; Tolino, A.; Zullo, F. 2012: Metformin administration in patients with polycystic ovary syndrome who receive gonadotropins for in vitro fertilization cycles: 10-year experience in a large infertile population. Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 28(2): 81-86
Genazzani, A.D.; Lanzoni, C.; Ricchieri, F.; Baraldi, E.; Casarosa, E.; Jasonni, V.M. 2007: Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia. Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 23(3): 146-152
Genazzani, A.D.; Chierchia, E.; Rattighieri, E.; Santagni, S.; Casarosa, E.; Luisi, M.; Genazzani, A.R. 2010: Metformin administration restores allopregnanolone response to adrenocorticotropic hormone (ACTH) stimulation in overweight hyperinsulinemic patients with PCOS. Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 26(9): 684-689
Billa, E.; Kapolla, N.; Nicopoulou, S.C.; Koukkou, E.; Venaki, E.; Milingos, S.; Antsaklis, A.; Adamopoulos, D.A. 2009: Metformin administration was associated with a modification of LH, prolactin and insulin secretion dynamics in women with polycystic ovarian syndrome. Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 25(7): 427-434
Bułdak, Łu.; Łabuzek, K.; Bułdak, R.ł J.; Kozłowski, M.ł; Machnik, G.; Liber, S.; Suchy, D.; Duława-Bułdak, A.; Okopień, B.ła. 2014: Metformin affects macrophages' phenotype and improves the activity of glutathione peroxidase, superoxide dismutase, catalase and decreases malondialdehyde concentration in a partially AMPK-independent manner in LPS-stimulated human monocytes/macrophages. Pharmacological Reports: Pr 66(3): 418-429
Barnea, M.; Haviv, L.; Gutman, R.; Chapnik, N.; Madar, Z.; Froy, O. 2012: Metformin affects the circadian clock and metabolic rhythms in a tissue-specific manner. Biochimica et Biophysica Acta 1822(11): 1796-1806
Aberle, J.; Reining, F.; Dannheim, V.; Flitsch, J.; Klinge, A.; Mann, O. 2012: Metformin after bariatric surgery--an acid problem. Experimental and Clinical Endocrinology and Diabetes: Official Journal German Society of Endocrinology and German Diabetes Association 120(3): 152-153
Cufí, S.; Vazquez-Martin, A.; Oliveras-Ferraros, C.; Martin-Castillo, B.ña.; Joven, J.; Menendez, J.A. 2010: Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT): from cancer stem cells to aging-associated fibrosis. Cell Cycle 9(22): 4461-4468
Kim, T.H.; Suh, D.H.; Kim, M.-K.; Song, Y.S. 2014: Metformin against cancer stem cells through the modulation of energy metabolism: special considerations on ovarian cancer. Biomed Research International 2014: 132702
Volarevic, V.; Misirkic, M.; Vucicevic, L.; Paunovic, V.; Simovic Markovic, B.; Stojanovic, M.; Milovanovic, M.; Jakovljevic, V.; Micic, D.; Arsenijevic, N.; Trajkovic, V.; Lukic, M.L. 2015: Metformin aggravates immune-mediated liver injury in mice. Archives of Toxicology 89(3): 437-450
Wiwanitkit, V. 2011: Metformin allergy. Indian Journal of Pharmacology 43(2): 216-217
Carracedo-Martínez, E.; Pia-Morandeira, A. 2009: Metformin also as first choice in patients with normal weight. Has its use increased?. Atencion Primaria 41(6): 324-328
Elmadhun, N.Y.; Lassaletta, A.D.; Chu, L.M.; Sellke, F.W. 2013: Metformin alters the insulin signaling pathway in ischemic cardiac tissue in a swine model of metabolic syndrome. Journal of Thoracic and Cardiovascular Surgery 145(1): 258-265; Discussion: 265-266
Woo, S.-L.; Xu, H.; Li, H.; Zhao, Y.; Hu, X.; Zhao, J.; Guo, X.; Guo, T.; Botchlett, R.; Qi, T.; Pei, Y.; Zheng, J.; Xu, Y.; An, X.; Chen, L.; Chen, L.; Li, Q.; Xiao, X.; Huo, Y.; Wu, C. 2014: Metformin ameliorates hepatic steatosis and inflammation without altering adipose phenotype in diet-induced obesity. Plos one 9(3): E91111
Song, Y.; Shi, J.; Wu, Y.; Han, C.; Zou, J.; Shi, Y.; Liu, Z. 2014: Metformin ameliorates insulin resistance in L6 rat skeletal muscle cells through upregulation of SIRT3. Chinese Medical Journal 127(8): 1523-1529
Hadi, N.R.; Al-Amran, F.G.; Swadi, A. 2012: Metformin ameliorates methotrexate-induced hepatotoxicity. Journal of Pharmacology and Pharmacotherapeutics 3(3): 248-253
Oliveira, P.W.C.; de Sousa, G.J.; Caliman, I.F.; Lamas, A.Z.; Santos de Medeiros, A.R.; de Andrade, T.U.; de Abreu, G.R.; de Figueiredo, S.G.; Bissoli, N.é S. 2014: Metformin ameliorates ovariectomy-induced vascular dysfunction in non-diabetic Wistar rats. Clinical Science 127(4): 265-275
Rocha, G.Z.; Dias, M.íl.M.; Ropelle, E.R.; Osório-Costa, F.; Rossato, F.A.; Vercesi, A.E.; Saad, M.J.A.; Carvalheira, J.é B.C. 2011: Metformin amplifies chemotherapy-induced AMPK activation and antitumoral growth. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 17(12): 3993-4005
Santomauro Júnior, A.C.éz.; Ugolini, M.R.ão.; Santomauro, A.T.; Souto, R.P.d. 2008: Metformin and AMPK: an old drug and a new enzyme in the context of metabolic syndrome. Arquivos Brasileiros de Endocrinologia e Metabologia 52(1): 120-125
Rosenfeld, J.E. 2014: Metformin and Alzheimer's disease risk. American Journal of Psychiatry 171(1): 119
Matafome, P.; Louro, T.; Rodrigues, L.; Crisóstomo, J.; Nunes, E.; Amaral, C.; Monteiro, P.; Cipriano, A.; Seiça, R. 2011: Metformin and atorvastatin combination further protect the liver in type 2 diabetes with hyperlipidaemia. Diabetes/Metabolism Research and Reviews 27(1): 54-62
Hu, Y.; Young, A.J.; Ehli, E.A.; Nowotny, D.; Davies, P.S.; Droke, E.A.; Soundy, T.J.; Davies, G.E. 2014: Metformin and berberine prevent olanzapine-induced weight gain in rats. Plos one 9(3): E93310
Gandini, S.; Guerrieri-Gonzaga, A.; Puntoni, M.; Decensi, A. 2013: Metformin and breast cancer risk. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 31(7): 973-974
Vallianou, N.G.; Evangelopoulos, A.; Kazazis, C. 2013: Metformin and cancer. Review of Diabetic Studies: Rds 10(4): 228-235
Park, H.K. 2013: Metformin and cancer in type 2 diabetes. Diabetes and Metabolism Journal 37(2): 113-116
Monami, M.; Colombi, C.; Balzi, D.; Dicembrini, I.; Giannini, S.; Melani, C.; Vitale, V.; Romano, D.; Barchielli, A.; Marchionni, N.ò; Rotella, C.M.; Mannucci, E. 2011: Metformin and cancer occurrence in insulin-treated type 2 diabetic patients. Diabetes Care 34(1): 129-131
Gandini, S.; Puntoni, M.; Heckman-Stoddard, B.M.; Dunn, B.K.; Ford, L.; DeCensi, A.; Szabo, E. 2014: Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders. Cancer Prevention Research 7(9): 867-885
Decensi, A.; Puntoni, M.; Goodwin, P.; Cazzaniga, M.; Gennari, A.; Bonanni, B.; Gandini, S. 2010: Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis. Cancer Prevention Research 3(11): 1451-1461
Bednar, F.; Simeone, D.M. 2012: Metformin and cancer stem cells: old drug, new targets. Cancer Prevention Research 5(3): 351-354
Bost, F.éd.ér.; Sahra, I.B.; Le Marchand-Brustel, Y.; Tanti, J.-F.ço. 2012: Metformin and cancer therapy. Current Opinion in Oncology 24(1): 103-108
Martin-Castillo, B.ña.; Vazquez-Martin, A.; Oliveras-Ferraros, C.; Menendez, J.A. 2010: Metformin and cancer: doses, mechanisms and the dandelion and hormetic phenomena. Cell Cycle 9(6): 1057-1064
Papanas, N.; Maltezos, E.; Mikhailidis, D.P. 2010: Metformin and cancer: licence to heal?. Expert Opinion on Investigational Drugs 19(8): 913-917
Suissa, S.; Azoulay, L. 2014: Metformin and cancer: mounting evidence against an association. Diabetes Care 37(7): 1786-1788
Kourelis, T.V.; Siegel, R.D. 2012: Metformin and cancer: new applications for an old drug. Medical Oncology 29(2): 1314-1327
Ioannou, G.N.; Boyko, E.J. 2011: Metformin and colorectal cancer risk in diabetic patients. Diabetes Care 34(10): 2336-2337
Thomsen, H.S.; Morcos, S.K.; Almén, T.; Aspelin, P.; Bellin, M.-F.; Clément, O.; Heinz-Peer, G.; Reimer, P.; Stacul, F.; van der Molen, A.J.; Webb, J.A.W.; Goergen, S.K. 2010: Metformin and contrast media. Radiology 256(2): 672
Bouchoucha, M.; Uzzan, B.; Cohen, R. 2011: Metformin and digestive disorders. Diabetes and Metabolism 37(2): 90-96
Lau, Y.-K.I.; Du, X.; Rayannavar, V.; Hopkins, B.; Shaw, J.; Bessler, E.; Thomas, T.; Pires, M.M.; Keniry, M.; Parsons, R.E.; Cremers, S.; Szabolcs, M.; Maurer, M.A. 2014: Metformin and erlotinib synergize to inhibit basal breast cancer. Oncotarget 5(21): 10503-10517
Pillai, A.; Bang, H.; Green, C. 2007: Metformin and glitazones: do they really help PCOS patients?. Journal of Family Practice 56(6): 444-453
Palomba, S.; Falbo, A.; La Sala, G.B. 2014: Metformin and gonadotropins for ovulation induction in patients with polycystic ovary syndrome: a systematic review with meta-analysis of randomized controlled trials. Reproductive Biology and Endocrinology: Rb&e 12: 3
Stine, J.E.; Bae-Jump, V. 2014: Metformin and gynecologic cancers. Obstetrical and Gynecological Survey 69(8): 477-489
Papanas, N.; Maltezos, E.; Mikhailidis, D.P. 2012: Metformin and heart failure: never say never again. Expert Opinion on PharmacoTherapy 13(1): 1-8
Hehir, M.P.; Morrison, J.J. 2012: Metformin and human uterine contractility. Endocrine 42(3): 761-763
Gómez-Sámano, M.Án.; Gulias-Herrero, A.; Cuevas-Ramos, D.; Brau-Figueroa, H.; Mehta, R.; Vargas-Gutiérrez, D.; Meza-Arana, C.E.; Nieves-Niebla, J.ín.M.ía.; Vázquez-Hernández, M.ía.O. 2012: Metformin and improvement of the hepatic insulin resistance index independent of anthropometric changes. Endocrine Practice: Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 18(1): 8-16
Bosco, J.L.F.; Antonsen, S.; Sørensen, H.T.; Pedersen, L.; Lash, T.L. 2011: Metformin and incident breast cancer among diabetic women: a population-based case-control study in Denmark. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 20(1): 101-111
Wiwanitkit, S.; Wiwanitkit, V. 2011: Metformin and insomnia: an interesting story. Diabetes and Metabolic Syndrome 5(3): 160
Cosmi, F.; Cosmi, D. 2011: Metformin and insulin in chronic heart failure: contraindications not contraindicated and indications not indicated. Giornale Italiano di Cardiologia 12(12): 796-803
White, M.F. 2009: Metformin and insulin meet in a most atypical way. Cell Metabolism 9(6): 485-487
He, L.; Sabet, A.; Djedjos, S.; Miller, R.; Sun, X.; Hussain, M.A.; Radovick, S.; Wondisford, F.E. 2009: Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein. Cell 137(4): 635-646
Cicero, A.F.G.; Tartagni, E.; Ertek, S. 2012: Metformin and its clinical use: new insights for an old drug in clinical practice. Archives of Medical Science: Ams 8(5): 907-917
Smahelová, A. 2008: Metformin and kidneys. Vnitrni Lekarstvi 54(5): 535-540
Ashall, V.; Dawes, T. 2008: Metformin and lactic acidosis. British Journal of Anaesthesia 101(6): 876-877
Scheen, A.J. 2011: Metformin and lactic acidosis. Acta Clinica Belgica 66(5): 329-331
Kamber, N.; Davis, W.A.; Bruce, D.G.; Davis, T.M.E. 2008: Metformin and lactic acidosis in an Australian community setting: the Fremantle Diabetes Study. Medical Journal of Australia 188(8): 446-449
Papanas, N.; Monastiriotis, C.; Christakidis, D.; Maltezos, E. 2009: Metformin and lactic acidosis in patients with type 2 diabetes--from pride and prejudice to sense and sensibility. Acta Clinica Belgica 64(1): 42-48
Preiss, D.J.; Sattar, N. 2009: Metformin and lactic acidosis. Metformin: framed again?. Bmj 339: B5570
James, A. 2009: Metformin and lactic acidosis. NSAIDs and renin-angiotensin-aldosterone system. Bmj 339: B5567
Weber, M. 2008: Metformin and lifestyle changes reduce antipsychotic-related weight gain in adults with schizophrenia. Evidence-Based Mental Health 11(3): 82
Batchuluun, B.; Inoguchi, T.; Sonoda, N.; Sasaki, S.; Inoue, T.; Fujimura, Y.; Miura, D.; Takayanagi, R. 2014: Metformin and liraglutide ameliorate high glucose-induced oxidative stress via inhibition of PKC-NAD(P)H oxidase pathway in human aortic endothelial cells. Atherosclerosis 232(1): 156-164
Fournier, J.-P.; Yin, H.; Yu, O.H.Y.; Azoulay, L. 2014: Metformin and low levels of thyroid-stimulating hormone in patients with type 2 diabetes mellitus. Cmaj: Canadian Medical Association Journal 186(15): 1138-1145
Alves, M.G.; Martins, A.D.; Vaz, C.V.; Correia, S.; Moreira, P.I.; Oliveira, P.F.; Socorro, S. 2014: Metformin and male reproduction: effects on Sertoli cell metabolism. British Journal of Pharmacology 171(4): 1033-1042
Lund, S.S. 2013: Metformin and mortality. Diabetologia 56(4): 937-938
Ozgurtas, T.; Oktenli, C.; Dede, M.; Tapan, S.; Kenar, L.; Sanisoglu, S.Y.; Yesilova, Z.; Yenen, M.C.; Erbil, M.K.; Baser, I. 2008: Metformin and oral contraceptive treatments reduced circulating asymmetric dimethylarginine (ADMA) levels in patients with polycystic ovary syndrome (PCOS). Atherosclerosis 200(2): 336-344
Pollak, M. 2010: Metformin and other biguanides in oncology: advancing the research agenda. Cancer Prevention Research 3(9): 1060-1065
Pollak, M. 2012: Metformin and pancreatic cancer: a clue requiring investigation. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 18(10): 2723-2725
Jiralerspong, S.; Palla, S.L.; Giordano, S.H.; Meric-Bernstam, F.; Liedtke, C.; Barnett, C.M.; Hsu, L.; Hung, M.-C.; Hortobagyi, G.N.; Gonzalez-Angulo, A.M. 2009: Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 27(20): 3297-3302
Chan, D.K.; Miskimins, W.Keith. 2012: Metformin and phenethyl isothiocyanate combined treatment in vitro is cytotoxic to ovarian cancer cultures. Journal of Ovarian Research 5(1): 19
Janzer, A.; German, N.J.; Gonzalez-Herrera, K.N.; Asara, J.M.; Haigis, M.C.; Struhl, K. 2014: Metformin and phenformin deplete tricarboxylic acid cycle and glycolytic intermediates during cell transformation and NTPs in cancer stem cells. Proceedings of the National Academy of Sciences of the United States of America 111(29): 10574-10579
Wiegand, S.; l'Allemand, D.; Hübel, H.; Krude, H.; Bürmann, M.; Martus, P.; Grüters, A.; Holl, R.W. 2010: Metformin and placebo therapy both improve weight management and fasting insulin in obese insulin-resistant adolescents: a prospective, placebo-controlled, randomized study. European Journal of Endocrinology 163(4): 585-592
Lebinger, T.G. 2007: Metformin and polycystic ovary syndrome. Current Opinion in Endocrinology Diabetes and Obesity 14(2): 132-140
Christiansen, C.F. 2013: Metformin and prognosis of critical illness: a question of timing?. Critical Care 17(6): 471
Anisimov, V.N. 2013: Metformin and rapamycin are master-keys for understanding the relationship between cell senescent, aging and cancer. Aging 5(5): 337-338
Zakikhani, M.; Blouin, M.-J.é; Piura, E.; Pollak, M.N. 2010: Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cells. Breast Cancer Research and Treatment 123(1): 271-279
Donadon, V.; Balbi, M.; Mas, M.D.; Casarin, P.; Zanette, G. 2010: Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease. Liver International: Official Journal of the International Association for the Study of the Liver 30(5): 750-758
Zhang, H.; Gao, C.; Fang, L.; Zhao, H.-C.; Yao, S.-K. 2013: Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis. Scandinavian Journal of Gastroenterology 48(1): 78-87
Rafieian-Kopaie, M. 2013: Metformin and renal injury protection. Journal of Renal Injury Prevention 2(3): 91-92
Serrano, M. 2012: Metformin and reprogramming into iPSCs. Cell Cycle 11(6): 1058-1059
Fontaine, E. 2014: Metformin and respiratory chain complex I: the last piece of the puzzle?. Biochemical Journal 463(3): E3-E5
Xiao, Z.; Sperl, B.; Ullrich, A.; Knyazev, P. 2014: Metformin and salinomycin as the best combination for the eradication of NSCLC monolayer cells and their alveospheres (cancer stem cells) irrespective of EGFR, KRAS, EML4/ALK and LKB1 status. Oncotarget 5(24): 12877-12890
Blagosklonny, M.V. 2010: Metformin and sex: Why suppression of aging may be harmful to young male mice. Aging 2(12): 897-899
Wiwanitkit, S.; Wiwanitkit, V. 2012: Metformin and sleep disorders. Indian Journal of Endocrinology and Metabolism 16(Suppl 1): S63-S64
Hwang, A.L.; Haynes, K.; Hwang, W-Ting.; Yang, Y-Xiao. 2013: Metformin and survival in pancreatic cancer: a retrospective cohort study. Pancreas 42(7): 1054-1059
Menendez, J.A.; Cufí, S.íl.; Oliveras-Ferraros, C.; Martin-Castillo, B.ña.; Joven, J.; Vellon, L.; Vazquez-Martin, A. 2011: Metformin and the ATM DNA damage response (DDR): accelerating the onset of stress-induced senescence to boost protection against cancer. Aging 3(11): 1063-1077
Wang, S.-Y.; Chuang, C.-S.; Muo, C.-H.; Tu, S.-T.; Lin, M.-C.; Sung, F.-C.; Kao, C.-H. 2013: Metformin and the incidence of cancer in patients with diabetes: a nested case-control study. Diabetes Care 36(9): E155-E156
Azoulay, L.; Dell'Aniello, S.; Gagnon, B.; Pollak, M.; Suissa, S. 2011: Metformin and the incidence of prostate cancer in patients with type 2 diabetes. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 20(2): 337-344
Bailey, C.J.; Wilcock, C.; Scarpello, J.H.B. 2008: Metformin and the intestine. Diabetologia 51(8): 1552-1553
Liu, H.; Scholz, C.; Zang, C.; Schefe, J.H.; Habbel, P.; Regierer, A.-C.; Schulz, C.-O.; Possinger, K.; Eucker, J. 2012: Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro. Anticancer Research 32(5): 1627-1637
Kalra, S.; Unnikrishnan, A.G.; Sahay, R. 2012: Metformin and the promise of geroprotection. Indian Journal of Endocrinology and Metabolism 16(4): 496-498
Yang, X.; Chan, J.C. 2014: Metformin and the risk of cancer in type 2 diabetes: methodological challenges and perspectives. Annals of Translational Medicine 2(6): 52
Suissa, S.; Azoulay, L. 2012: Metformin and the risk of cancer: time-related biases in observational studies. Diabetes Care 35(12): 2665-2673
Becker, C.; Jick, S.S.; Meier, C.R.; Bodmer, M. 2014: Metformin and the risk of head and neck cancer: a case-control analysis. Diabetes Obesity and Metabolism 16(11): 1148-1154
Pappa, T.; Alevizaki, M. 2013: Metformin and thyroid: an update. European Thyroid Journal 2(1): 22-28
Sangraula, H.; Paudel, K.R.; Sharma, M. 2009: Metformin and troglitazone in the treatment of female infertility associated with polycystic ovarian syndrome. Jnma; Journal of the Nepal Medical Association 48(176): 335-339
Leverve, X.M. 2007: Metformin and type 2 diabetes: the UKPDS experience. Journees Annuelles de Diabetologie de l'Hotel-Dieu 2007: 5-11
Mata Cases, M. 2008: Metformin and type-2 diabetes mellitus. Atencion Primaria 40(3): 147-153
Carlsen, S.M. 2007: Metformin and vitamin B 12 deficiency. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 127(6): 764; Author Reply 764
Hidalgo, S.F.; Prieto de Paula, J.é M.ía.; Salado Valdivieso, I.és. 2010: Metformin and vitamin B12 deficiency. Medicina Clinica 135(6): 286-287
Lev, I. 2007: Metformin and vitamin B12 deficiency: association and not causation may play a major role in cohort studies. Archives of Internal Medicine 167(7): 730; Author Reply 730-1
Demir, U.; Koehler, A.; Schneider, R.; Schweiger, S.; Klocker, H. 2014: Metformin anti-tumor effect via disruption of the MID1 translational regulator complex and AR downregulation in prostate cancer cells. Bmc Cancer 14: 52
Zheng, L. 2016: Metformin as a Rare Cause of Drug-Induced Liver Injury, a Case Report and Literature Review. American Journal of Therapeutics 23(1): E315-E317
Rao, V.S.R.; Sugunendran, S.; Issa, E.; Krishnan, A.; Pearson, H.J. 2012: Metformin as a cause of high stomal output. Colorectal Disease: the Official Journal of the Association of Coloproctology of Great Britain and Ireland 14(2): E77
Bulterijs, S. 2011: Metformin as a geroprotector. Rejuvenation Research 14(5): 469-482
Łabuzek, K.; Gabryel, B.że.; Okopień, B.ła. 2014: Metformin as a key to alternative activation of microglia?. Postepy Higieny i Medycyny Doswiadczalnej 68: 247-257
Smith, R.C. 2012: Metformin as a treatment for antipsychotic drug side effects: special focus on women with schizophrenia. American Journal of Psychiatry 169(8): 774-776
Kasa-Vubu, J.Z. 2008: Metformin as a weight-loss tool in "at-risk" obese adolescents: a magic bullet?. Journal of Pediatrics 152(6): 750-752
Singhal, A.; Jie, L.; Kumar, P.; Hong, G.S.; Leow, M.K.-S.; Paleja, B.; Tsenova, L.; Kurepina, N.; Chen, J.; Zolezzi, F.; Kreiswirth, B.; Poidinger, M.; Chee, C.; Kaplan, G.; Wang, Y.T.; De Libero, G. 2014: Metformin as adjunct antituberculosis therapy. Science Translational Medicine 6(263): 263ra159
Legro, R.S. 2011: Metformin as adjuvant therapy to IVF in women with PCOS: when is intention-to-treat unintentional?. Human Reproduction 26(8): 2043-2044
Grenader, T.; Goldberg, A.; Shavit, L. 2009: Metformin as an addition to conventional chemotherapy in breast cancer. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 27(35): e259; author reply e260
Baradari, A.G.; Emami Zeydi, A.; Aarabi, M.; Ghafari, R. 2011: Metformin as an adjunct to insulin for glycemic control in patients with type 2 diabetes after CABG surgery: a randomized double blind clinical trial. Pakistan Journal of Biological Sciences: Pjbs 14(23): 1047-1054
Garofalo, C.; Capristo, M.; Manara, M.C.; Mancarella, C.; Landuzzi, L.; Belfiore, A.; Lollini, P.-L.; Picci, P.; Scotlandi, K. 2013: Metformin as an adjuvant drug against pediatric sarcomas: hypoxia limits therapeutic effects of the drug. Plos one 8(12): E83832
Li, D. 2011: Metformin as an antitumor agent in cancer prevention and treatment. Journal of Diabetes 3(4): 320-327
Zhu, Z.; Jiang, W.; Thompson, M.D.; McGinley, J.N.; Thompson, H.J. 2011: Metformin as an energy restriction mimetic agent for breast cancer prevention. Journal of Carcinogenesis 10: 17
Svacina, S. 2010: Metformin as the first line antidiabetic agent. Vnitrni Lekarstvi 56(12): 1225-1227
Kumthekar, A.A.; Gidwani, H.V.; Kumthekar, A.B. 2012: Metformin associated B12 deficiency. Journal of the Association of Physicians of India 60: 58-60
Clare, S.; Paul, P.; Hulley, C.; Jones, S. 2006: Metformin associated lactic acidosis not as rare as we think:. Acute Medicine 5(3): 99-101
Van Berlo-van de Laar, I.R.F.; Vermeij, C.G.; Doorenbos, C.J. 2011: Metformin associated lactic acidosis: incidence and clinical correlation with metformin serum concentration measurements. Journal of Clinical Pharmacy and Therapeutics 36(3): 376-382
Bloomgarden, Z.T. 2014: Metformin associated with better cardiovascular outcomes than other glycaemic therapies. Evidence-Based Medicine 19(3): 103
Holst, H.; Eldrup, E.; Guldstad, N.H.; Bülow, H.H.; Christensen, H.R. 2012: Metformin associated with lactic acidosis in treatment of type 2 diabetes. Ugeskrift for Laeger 174(23): 1598-1602
Landman, G.W.D.; Kleefstra, N.; van Hateren, K.J.J.; Groenier, K.H.; Gans, R.O.B.; Bilo, H.J.G. 2010: Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16. Diabetes Care 33(2): 322-326
Chen, T.-M.; Lin, C.-C.; Huang, P.-T.; Wen, C.-F. 2011: Metformin associated with lower mortality in diabetic patients with early stage hepatocellular carcinoma after radiofrequency ablation. Journal of Gastroenterology and Hepatology 26(5): 858-865
Nenu, I.; Popescu, T.; Aldea, M.D.; Craciun, L.; Olteanu, D.; Tatomir, C.; Bolfa, P.; Ion, R.M.; Muresan, A.; Filip, A.G. 2014: Metformin associated with photodynamic therapy--a novel oncological direction. Journal of Photochemistry and Photobiology. B Biology 138: 80-91
Montini, F.; Rondeau, E.; Peltier, J.; Mesnard, L.; Jouzel, C.; Ridel, C. 2012: Metformin associates lactic acidosis. Presse Medicale 41(10): 907-916
Nath, N.; Khan, M.; Paintlia, M.K.; Singh, I.; Hoda, M.N.; Giri, S. 2009: Metformin attenuated the autoimmune disease of the central nervous system in animal models of multiple sclerosis. Journal of Immunology 182(12): 8005-8014
Li, J.; Deng, J.; Sheng, W.; Zuo, Z. 2012: Metformin attenuates Alzheimer's disease-like neuropathology in obese, leptin-resistant mice. Pharmacology Biochemistry and Behavior 101(4): 564-574
Liu, Y.; Tang, G.; Li, Y.; Wang, Y.; Chen, X.; Gu, X.; Zhang, Z.; Wang, Y.; Yang, G.-Y. 2014: Metformin attenuates blood-brain barrier disruption in mice following middle cerebral artery occlusion. Journal of Neuroinflammation 11: 177
Xiao, H.; Ma, X.; Feng, W.; Fu, Y.; Lu, Z.; Xu, M.; Shen, Q.; Zhu, Y.; Zhang, Y. 2010: Metformin attenuates cardiac fibrosis by inhibiting the TGFbeta1-Smad3 signalling pathway. Cardiovascular Research 87(3): 504-513
Son, H.-J.; Lee, J.; Lee, S.-Y.; Kim, E.-K.; Park, M.-J.; Kim, K.-W.; Park, S.-H.; Cho, M.-L. 2014: Metformin attenuates experimental autoimmune arthritis through reciprocal regulation of Th17/Treg balance and osteoclastogenesis. Mediators of Inflammation 2014: 973986
Rattan, R.; Giri, S.; Hartmann, L.C.; Shridhar, V. 2011: Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner. Journal of Cellular and Molecular Medicine 15(1): 166-178
Simon-Szabó, L.; Kokas, M.ár.; Mandl, J.óz.; Kéri, G.ör.; Csala, M.ós. 2014: Metformin attenuates palmitate-induced endoplasmic reticulum stress, serine phosphorylation of IRS-1 and apoptosis in rat insulinoma cells. Plos one 9(6): E97868
Alhaider, A.A.; Korashy, H.M.; Sayed-Ahmed, M.M.; Mobark, M.; Kfoury, H.; Mansour, M.A. 2011: Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression. Chemico-Biological Interactions 192(3): 233-242
Calixto, M.C.; Lintomen, L.íc.; André, D.M.; Leiria, L.O.ór.; Ferreira, D.; Lellis-Santos, C.; Anhê, G.F.; Bordin, S.; Landgraf, R.G.; Antunes, E. 2013: Metformin attenuates the exacerbation of the allergic eosinophilic inflammation in high fat-diet-induced obesity in mice. Plos one 8(10): E76786
Algire, C.; Zakikhani, M.; Blouin, M.-J.; Shuai, J.H.; Pollak, M. 2008: Metformin attenuates the stimulatory effect of a high-energy diet on in vivo LLC1 carcinoma growth. Endocrine-Related Cancer 15(3): 833-839
Zhang, C.-X.; Pan, S.-N.; Meng, R.-S.; Peng, C.-Q.; Xiong, Z.-J.; Chen, B.-L.; Chen, G.-Q.; Yao, F.-J.; Chen, Y.-L.; Ma, Y.-D.; Dong, Y.-G. 2011: Metformin attenuates ventricular hypertrophy by activating the AMP-activated protein kinase-endothelial nitric oxide synthase pathway in rats. Clinical and Experimental Pharmacology and Physiology 38(1): 55-62
Carvajal, R.; Rosas, C.; Kohan, K.; Gabler, F.; Vantman, D.; Romero, C.; Vega, M. 2013: Metformin augments the levels of molecules that regulate the expression of the insulin-dependent glucose transporter GLUT4 in the endometria of hyperinsulinemic PCOS patients. Human Reproduction 28(8): 2235-2244
Kim, D.-L. 2013: Metformin based dual-combination therapies in drug naïve type 2 diabetic patients. Diabetes and Metabolism Journal 37(6): 429-432
Glueck, C.J.; Wang, P. 2007: Metformin before and during pregnancy and lactation in polycystic ovary syndrome. Expert Opinion on Drug Safety 6(2): 191-198
Cerezo, M.ël.; Tichet, M.él.; Abbe, P.; Ohanna, M.ël.; Lehraiki, A.; Rouaud, F.; Allegra, M.; Giacchero, D.; Bahadoran, P.; Bertolotto, C.; Tartare-Deckert, S.; Ballotti, R.; Rocchi, S.ép. 2013: Metformin blocks melanoma invasion and metastasis development in AMPK/p53-dependent manner. Molecular Cancer Therapeutics 12(8): 1605-1615
Hwang, Y.P.; Jeong, H.G. 2010: Metformin blocks migration and invasion of tumour cells by inhibition of matrix metalloproteinase-9 activation through a calcium and protein kinase Calpha-dependent pathway: phorbol-12-myristate-13-acetate-induced/extracellular signal-regulated kinase/activator protein-1. British Journal of Pharmacology 160(5): 1195-1211
Algire, C.; Amrein, L.; Zakikhani, M.; Panasci, L.; Pollak, M. 2010: Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase. Endocrine-Related Cancer 17(2): 351-360
O'Hora, T.R.; Markos, F.; Wiernsperger, N.F.; Noble, M.I.M. 2012: Metformin causes nitric oxide-mediated dilatation in a shorter time than insulin in the iliac artery of the anesthetized pig. Journal of Cardiovascular Pharmacology 59(2): 182-187
Obeid, R. 2014: Metformin causing vitamin B12 deficiency: a guilty verdict without sufficient evidence. Diabetes Care 37(2): E22-E23
Xie, Y.; Peng, Z.; Shi, M.; Ji, M.; Guo, H.; Shi, H. 2014: Metformin combined with p38 MAPK inhibitor improves cisplatin sensitivity in cisplatin‑resistant ovarian cancer. Molecular Medicine Reports 10(5): 2346-2350
Silva, J.C.; Pacheco, C.; Bizato, J.; de Souza, B.ár.V.; Ribeiro, T.ís.E.; Bertini, A.M. 2010: Metformin compared with glyburide for the management of gestational diabetes. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 111(1): 37-40
Moore, L.E.; Clokey, D.; Rappaport, V.J.; Curet, L.B. 2010: Metformin compared with glyburide in gestational diabetes: a randomized controlled trial. Obstetrics and Gynecology 115(1): 55-59
Grisouard, J.; Timper, K.; Bouillet, E.; Radimerski, T.; Dembinski, K.; Frey, D.M.; Peterli, R.; Zulewski, H.; Keller, U.; Müller, B.; Christ-Crain, M. 2011: Metformin counters both lipolytic/inflammatory agents-decreased hormone sensitive lipase phosphorylation at Ser-554 and -induced lipolysis in human adipocytes. Archives of Physiology and Biochemistry 117(4): 209-214
Tosca, L.; Froment, P.; Rame, C.; McNeilly, J.R.; McNeilly, A.S.; Maillard, V.; Dupont, J. 2011: Metformin decreases GnRH- and activin-induced gonadotropin secretion in rat pituitary cells: potential involvement of adenosine 5' monophosphate-activated protein kinase (PRKA). Biology of Reproduction 84(2): 351-362
Tosca, L.; Ramé, C.; Chabrolle, C.; Tesseraud, S.; Dupont, J.ël. 2010: Metformin decreases IGF1-induced cell proliferation and protein synthesis through AMP-activated protein kinase in cultured bovine granulosa cells. Reproduction 139(2): 409-418
Zhao, D.; Long, X.-D.; Lu, T.-F.; Wang, T.; Zhang, W.-W.; Liu, Y.-X.; Cui, X.-L.; Dai, H.-J.; Xue, F.; Xia, Q. 2015: Metformin decreases IL-22 secretion to suppress tumor growth in an orthotopic mouse model of hepatocellular carcinoma. International Journal of Cancer 136(11): 2556-2565
Tan, B.K.; Adya, R.; Chen, J.; Farhatullah, S.; Heutling, D.; Mitchell, D.; Lehnert, H.; Randeva, H.S. 2009: Metformin decreases angiogenesis via NF-kappaB and Erk1/2/Erk5 pathways by increasing the antiangiogenic thrombospondin-1. Cardiovascular Research 83(3): 566-574
Oktenli, C.; Ozgurtas, T.; Dede, M.; Sanisoglu, Y.S.; Yenen, M.C.; Yesilova, Z.; Kenar, L.; Kurt, Y.G.; Baser, I.; Smith, J.; Cianflone, K. 2007: Metformin decreases circulating acylation-stimulating protein levels in polycystic ovary syndrome. Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 23(12): 710-715
Campagnoli, C.; Berrino, F.; Venturelli, E.; Abbà, C.; Biglia, N.; Brucato, T.; Cogliati, P.; Danese, S.; Donadio, M.; Zito, G.; Pasanisi, P. 2013: Metformin decreases circulating androgen and estrogen levels in nondiabetic women with breast cancer. Clinical Breast Cancer 13(6): 433-438
Fendt, S.-M.; Bell, E.L.; Keibler, M.A.; Davidson, S.M.; Wirth, G.J.; Fiske, B.; Mayers, J.R.; Schwab, M.; Bellinger, G.; Csibi, A.; Patnaik, A.; Blouin, M.J.; Cantley, L.C.; Guarente, L.; Blenis, J.; Pollak, M.N.; Olumi, A.F.; Vander Heiden, M.G.; Stephanopoulos, G. 2013: Metformin decreases glucose oxidation and increases the dependency of prostate cancer cells on reductive glutamine metabolism. Cancer Research 73(14): 4429-4438
Sumitani, S.; Morita, S.; Deguchi, R.; Hirai, K.; Mukai, K.; Utsu, Y.; Miki, S.; Sato, B.; Nakamura, H.; Kasayama, S.; Koga, M. 2015: Metformin decreases glycated albumin to glycated haemoglobin ratio in patients with newly diagnosed type 2 diabetes. Annals of Clinical Biochemistry 52(Part 1): 76-81
Kim, D.; Lee, J.E.; Jung, Y.J.; Lee, A.S.; Lee, S.; Park, S.K.; Kim, S.H.; Park, B.-H.; Kim, W.; Kang, K.P. 2013: Metformin decreases high-fat diet-induced renal injury by regulating the expression of adipokines and the renal AMP-activated protein kinase/acetyl-CoA carboxylase pathway in mice. International Journal of Molecular Medicine 32(6): 1293-1302
Tsai, M.-J.; Yang, C.-J.; Kung, Y.-T.; Sheu, C.-C.; Shen, Y.-T.; Chang, P.-Y.; Huang, M.-S.; Chiu, H.-C. 2014: Metformin decreases lung cancer risk in diabetic patients in a dose-dependent manner. Lung Cancer 86(2): 137-143
Gómez-Díaz, R.A.; Talavera, J.O.; Pool, E.Canché.; Ortiz-Navarrete, F.Vianney.; Solórzano-Santos, F.; Mondragón-González, R.; Valladares-Salgado, A.; Cruz, M.; Aguilar-Salinas, C.A.; Wacher, N.H. 2012: Metformin decreases plasma resistin concentrations in pediatric patients with impaired glucose tolerance: a placebo-controlled randomized clinical trial. Metabolism, Clinical and Experimental 61(9): 1247-1255
Elia, E.M.; Quintana, R.; Carrere, C.; Bazzano, M.ía.V.; Rey-Valzacchi, G.ón.; Paz, D.A.; Pustovrh, M.ía.C. 2013: Metformin decreases the incidence of ovarian hyperstimulation syndrome: an experimental study. Journal of Ovarian Research 6(1): 62
Morteza Taghavi, S.; Rokni, H.; Fatemi, S. 2011: Metformin decreases thyrotropin in overweight women with polycystic ovarian syndrome and hypothyroidism. Diabetes and Vascular Disease Research 8(1): 47-48
Quentin, T.; Steinmetz, M.; Poppe, A.; Thoms, S. 2012: Metformin differentially activates ER stress signaling pathways without inducing apoptosis. Disease Models and Mechanisms 5(2): 259-269
Andrzejewski, S.; Gravel, S.-P.; Pollak, M.; St-Pierre, J. 2014: Metformin directly acts on mitochondria to alter cellular bioenergetics. Cancer and Metabolism 2: 12
Mansour, A.A.; Habib, O.S. 2007: Metformin discontinuation rate among patients with type-2 diabetes mellitus in Basrah, Iraq. Saudi Medical Journal 28(12): 1919-1921
Anonymous 2008: Metformin dispersible tablets: line extension. A welcome formulation of an essential drug. Prescrire international 17(96): 138
Zi, F.-M.; He, J.-S.; Li, Y.; Wu, C.; Yang, L.; Yang, Y.; Wang, L.-J.; He, D.-H.; Zhao, Y.; Wu, W.-J.; Zheng, G.-F.; Han, X.-Y.; Huang, H.; Yi, Q.; Cai, Z. 2015: Metformin displays anti-myeloma activity and synergistic effect with dexamethasone in in vitro and in vivo xenograft models. Cancer Letters 356(2 Part B): 443-453
Kisfalvi, K.; Eibl, G.; Sinnett-Smith, J.; Rozengurt, E. 2009: Metformin disrupts crosstalk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth. Cancer Research 69(16): 6539-6545
Tsilidis, K.K.; Capothanassi, D.; Allen, N.E.; Rizos, E.C.; Lopez, D.S.; van Veldhoven, K.; Sacerdote, C.; Ashby, D.; Vineis, P.; Tzoulaki, I.; Ioannidis, J.P.A. 2014: Metformin does not affect cancer risk: a cohort study in the U.K. Clinical Practice Research Datalink analyzed like an intention-to-treat trial. Diabetes Care 37(9): 2522-2532
Ortega, J.F.; Hamouti, N.; Fernández-Elías, Vín.E.; de Prada, Mía.V.Guío.; Martínez-Vizcaíno, V.; Mora-Rodríguez, R. 2014: Metformin does not attenuate the acute insulin-sensitizing effect of a single bout of exercise in individuals with insulin resistance. Acta Diabetologica 51(5): 749-755
Anonymous 2007: Metformin does not harm diabetic patients with heart failure. Journal of Family Practice 56(12): 996
Bhat, M.; Chaiteerakij, R.; Harmsen, W.S.; Schleck, C.D.; Yang, J.D.; Giama, N.H.; Therneau, T.M.; Gores, G.J.; Roberts, L.R. 2014: Metformin does not improve survival in patients with hepatocellular carcinoma. World Journal of Gastroenterology 20(42): 15750-15755
Aubuchon, M.; Lieman, H.; Stein, D.; Cohen, H.W.; Isaac, B.; Adel, G.; Weitzman, V.; Tetrokalashvili, M.; Polotsky, A.J.; Santoro, N. 2009: Metformin does not improve the reproductive or metabolic profile in women with polycystic ovary syndrome (PCOS). Reproductive Sciences 16(10): 938-946
Chak, A.; Buttar, N.S.; Foster, N.R.; Seisler, D.K.; Marcon, N.E.; Schoen, R.; Cruz-Correa, M.R.; Falk, G.W.; Sharma, P.; Hur, C.; Katzka, D.A.; Rodriguez, L.M.; Richmond, E.; Sharma, A.N.; Smyrk, T.C.; Mandrekar, S.J.; Limburg, P.J. 2015: Metformin does not reduce markers of cell proliferation in esophageal tissues of patients with Barrett's esophagus. Clinical Gastroenterology and Hepatology: the Official Clinical Practice Journal of the American Gastroenterological Association 13(4): 665-72.E1-4
Bershteĭn, L.M.; Turkevich, E.A.; Boiarkina, M.P. 2012: Metformin does not suppress the aromatase expression in breast cancer tissue of patients with concurrent type 2 diabetes. Voprosy Onkologii 58(2): 194-198
Davidson, M.B.; Ramos, L. 2008: Metformin does not suppress thyrotropin. Endocrine Practice: Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 14(2): 252-253
Sarfstein, R.; Friedman, Y.; Attias-Geva, Z.; Fishman, A.; Bruchim, I.; Werner, H. 2013: Metformin downregulates the insulin/IGF-i signaling pathway and inhibits different uterine serous carcinoma (USC) cells proliferation and migration in p53-dependent or -independent manners. Plos one 8(4): E61537
Legro, R.S. 2010: Metformin during pregnancy in polycystic ovary syndrome: another vitamin bites the dust. Journal of Clinical Endocrinology and Metabolism 95(12): 5199-5202
Popovich, I.G.; Piskunova, T.S.; Tyndyk, M.L.; Anikin, I.V.; Zabezhinskiĭ, M.A.; Anisimov, V.N. 2012: Metformin effect on urethane-induced tumorigenesis in mice. Voprosy Onkologii 58(4): 549-553
Ben Ayed, B.; Dammak dit Mlik, S.; Ben Arab, H.; Trabelssi, H.; Chahtour, H.; Mathlouthi, N.; Dhuib, M.; Kassis, M.; Saiidane, D.; Trabelssi, K.; Guermazi, M. 2009: Metformin effects on clomifene-induced ovulation in the polycystic ovary syndrome. La Tunisie Medicale 87(1): 43-49
Damjanović, A.; Matić, I.Z.; Ðorđić, M.; Ðurović, M.N.ć; Nikolić, S.đa.; Roki, K.; Milovanović, Z.; Antić-Stanković, J.; Džodić, R.; Damjanović, S.; Kanjer, K.; Abu Rabi, Z.; Juranić, Z. 2015: Metformin effects on malignant cells and healthy PBMC; the influence of metformin on the phenotype of breast cancer cells. Pathology Oncology Research: Por 21(3): 605-612
Romualdi, D.; Giuliani, M.; Cristello, F.; Fulghesu, A.M.; Selvaggi, L.; Lanzone, A.; Guido, M. 2010: Metformin effects on ovarian ultrasound appearance and steroidogenic function in normal-weight normoinsulinemic women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial. Fertility and Sterility 93(7): 2303-2310
Andújar-Plata, P.; Pi-Sunyer, X.; Laferrère, B. 2012: Metformin effects revisited. Diabetes Research and Clinical Practice 95(1): 1-9
Ferreira, C.B.N.D.; Cesaretti, Mário.Luís.R.; Ginoza, M.; Kohlmann, O. 2009: Metformin effects upon blood pressure and glucose metabolism of monossodium glutamate induced-obese spontaneously hypertensive rats. Arquivos Brasileiros de Endocrinologia e Metabologia 53(4): 409-415
Kedikova, S.; Sirakov, M.; Boyadzhieva, M. 2012: Metformin efficiency for the adolescent PCOS treatment. Akusherstvo i Ginekologiia 51(6): 6-10
Lin, C.-C.; Yeh, H.-H.; Huang, W.-L.; Yan, J.-J.; Lai, W.-W.; Su, W.-P.; Chen, H.H.W.; Su, W.-C. 2013: Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway. American Journal of Respiratory Cell and Molecular Biology 49(2): 241-250
Kim, M.-H.; Jee, J.-H.; Park, S.; Lee, M.-S.; Kim, K.-W.; Lee, M.-K. 2014: Metformin enhances glucagon-like peptide 1 via cooperation between insulin and Wnt signaling. Journal of Endocrinology 220(2): 117-128
Liu, Y.; Huang, C.; Ceng, C.; Zhan, H.; Zheng, D.; Han, W. 2014: Metformin enhances nitric oxide production and diminishes Rho kinase activity in rats with hyperlipidemia. Lipids in Health and Disease 13: 115
Ma, J.; Guo, Y.; Chen, S.; Zhong, C.; Xue, Y.; Zhang, Y.; Lai, X.; Wei, Y.; Yu, S.; Zhang, J.; Liu, W. 2014: Metformin enhances tamoxifen-mediated tumor growth inhibition in ER-positive breast carcinoma. Bmc Cancer 14: 172
Kanazawa, I.; Yamaguchi, T.; Yano, S.; Yamauchi, M.; Sugimoto, T. 2008: Metformin enhances the differentiation and mineralization of osteoblastic MC3T3-E1 cells via AMP kinase activation as well as eNOS and BMP-2 expression. Biochemical and Biophysical Research Communications 375(3): 414-419
Pyla, R.; Osman, I.; Pichavaram, P.; Hansen, P.; Segar, L. 2014: Metformin exaggerates phenylephrine-induced AMPK phosphorylation independent of CaMKKβ and attenuates contractile response in endothelium-denuded rat aorta. Biochemical Pharmacology 92(2): 266-279
Miller, R.C.; Murley, J.S.; Grdina, D.J. 2014: Metformin exhibits radiation countermeasures efficacy when used alone or in combination with sulfhydryl containing drugs. Radiation Research 181(5): 464-470
Tartarin, P.; Moison, D.; Guibert, E.; Dupont, J.; Habert, R.; Rouiller-Fabre, V.; Frydman, N.; Pozzi, S.; Frydman, R.; Lecureuil, C.; Froment, P. 2012: Metformin exposure affects human and mouse fetal testicular cells. Human Reproduction 27(11): 3304-3314
Spillane, S.; Bennett, K.; Sharp, L.; Barron, T.I. 2014: Metformin exposure and disseminated disease in patients with colorectal cancer. Cancer Epidemiology 38(1): 79-84
Niemuth, N.J.; Jordan, R.; Crago, J.; Blanksma, C.; Johnson, R.; Klaper, R.D. 2015: Metformin exposure at environmentally relevant concentrations causes potential endocrine disruption in adult male fish. Environmental Toxicology and Chemistry 34(2): 291-296
Wilson, D.M.; Abrams, S.H.; Aye, T.; Lee, P.D.K.; Lenders, C.; Lustig, R.H.; Osganian, S.V.; Feldman, H.A.; Wilson, D.M.; Fechner, P.; Aye, T.; Robinson, T.; Buckingham, B.; Esrey, T.; McNeil, K.; Sorensen, B.; Wilson, K.; Davis, J.; Klish, W.; Abrams, S.; Holt, P.; Edwards, C.; Howard, L.; Gitelman, S.; Lustig, R.; Wertz, M.; Breland, J.; Lihatsh, T.; Lee, P.D.K.; Haddal, A.; Cohen, P.; Shupien, S.; Mooney, J.; Khanukhova, E.; Cohen, H.; Lenders, C.; Taylor, G.; Duggan, C.; Nurko, S.; Sweeney, C.; Zhang, K. 2010: Metformin extended release treatment of adolescent obesity: a 48-week randomized, double-blind, placebo-controlled trial with 48-week follow-up. Archives of Pediatrics and Adolescent Medicine 164(2): 116-123
Anisimov, V.N.; Egormin, P.A.; Piskunova, T.S.; Popovich, I.G.; Tyndyk, M.L.; Yurova, M.N.; Zabezhinski, M.A.; Anikin, I.V.; Karkach, A.S.; Romanyukha, A.A. 2010: Metformin extends life span of HER-2/neu transgenic mice and in combination with melatonin inhibits growth of transplantable tumors in vivo. Cell Cycle 9(1): 188-197
Anisimov, V.N. 2010: Metformin for aging and cancer prevention. Aging 2(11): 760-774
Correll, C.U.; Sikich, L.; Reeves, G.; Riddle, M. 2013: Metformin for antipsychotic-related weight gain and metabolic abnormalities: when, for whom, and for how long?. American Journal of Psychiatry 170(9): 947-952
Hasnain, M.; Vieweg, W.Victor.R.; Fredrickson, S.K. 2010: Metformin for atypical antipsychotic-induced weight gain and glucose metabolism dysregulation: review of the literature and clinical suggestions. Cns Drugs 24(3): 193-206
Yang, Y. 2011: Metformin for cancer prevention. Frontiers of Medicine 5(2): 115-117
Lexis, C.P.H.; van der Horst, I.C.C. 2014: Metformin for cardiovascular disease: promise still unproven. LANCET. Diabetes and Endocrinology 2(2): 94-95
Hamilton, R.J. 2014: Metformin for castrate-resistant prostate cancer: learning more about an old dog's new tricks. European Urology 66(3): 475-477; Discussion: 477-478
Preiss, D.; Lloyd, S.M.; Ford, I.; McMurray, J.J.; Holman, R.R.; Welsh, P.; Fisher, M.; Packard, C.J.; Sattar, N. 2014: Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial. LANCET. Diabetes and Endocrinology 2(2): 116-124
Park, M.H.; Kinra, S.; Ward, K.J.; White, B.; Viner, R.M. 2009: Metformin for obesity in children and adolescents: a systematic review. Diabetes Care 32(9): 1743-1745
Praharaj, S.K.; Jana, A.K.; Goyal, N.; Sinha, V.K. 2011: Metformin for olanzapine-induced weight gain: a systematic review and meta-analysis. British Journal of Clinical Pharmacology 71(3): 377-382
Worsley, R.; Jane, F.; Robinson, P.J.; Bell, R.J.; Davis, S.R. 2015: Metformin for overweight women at midlife: a double-blind, randomized, controlled trial. Climacteric: the Journal of the International Menopause Society 18(2): 270-277
Milewicz, A. 2013: Metformin for polycystic ovary syndrome. Endokrynologia Polska 64(5): 409-414
Sehdev, A.; Shih, Y-Chen.T.; Vekhter, B.; Bissonnette, M.B.; Olopade, O.I.; Polite, B.N. 2015: Metformin for primary colorectal cancer prevention in patients with diabetes: a case-control study in a US population. Cancer 121(7): 1071-1078
Tanaka, Y.; Kita, K.; Takao, R.; Amano, H.; Uchida, R.; Shiozaki, Y.; Yonetani, Y.; Kinugasa, K.; Mae, T.; Horibe, S. 2018: Chronicity of Anterior Cruciate Ligament Deficiency, Part 2: Radiographic Predictors of Early Graft Failure. Orthopaedic Journal of Sports Medicine 6(2): 2325967117751915
Cohen, P. 2009: Metformin for the prevention of androgen deprivation induced metabolic syndrome, obesity and type 2 diabetes. Medical Hypotheses 72(2): 227-228
Codner, E.; Iñíguez, G.án.; López, P.; Mujica, V.ón.; Eyzaguirre, F.C.; Asenjo, S.; Torrealba, I.; Cassorla, F. 2013: Metformin for the treatment of hyperandrogenism in adolescents with type 1 diabetes mellitus. Hormone Research in Paediatrics 80(5): 343-349
Nestler, J.E. 2008: Metformin for the treatment of the polycystic ovary syndrome. New England Journal of Medicine 358(1): 47-54
Wu, R.-R.; Jin, H.; Gao, K.; Twamley, E.W.; Ou, J.-J.; Shao, P.; Wang, J.; Guo, X.-F.; Davis, J.M.; Chan, P.K.; Zhao, J.-P. 2012: Metformin for treatment of antipsychotic-induced amenorrhea and weight gain in women with first-episode schizophrenia: a double-blind, randomized, placebo-controlled study. American Journal of Psychiatry 169(8): 813-821
Wang, M.; Tong, J.-h.; Zhu, G.; Liang, G.-m.; Yan, H.-f.; Wang, X.-z. 2012: Metformin for treatment of antipsychotic-induced weight gain: a randomized, placebo-controlled study. Schizophrenia Research 138(1): 54-57
Shin, L.; Bregman, H.; Breeze, J.L.; Noyes, N.; Frazier, J.A. 2009: Metformin for weight control in pediatric patients on atypical antipsychotic medication. Journal of Child and Adolescent Psychopharmacology 19(3): 275-279
Jarskog, L.F.; Hamer, R.M.; Catellier, D.J.; Stewart, D.D.; Lavange, L.; Ray, N.; Golden, L.H.; Lieberman, J.A.; Stroup, T.S.; Adler, L.; Burnie, G.; Barber, M.; Byerly, M.; Canive, J.M.; Glick, I.; Henderson, D.C.; Fredrik Jarskog, L.; Lamberti, J. S.; Khan, A.; McEvoy, J.P.; Meltzer, H.; Miller, A.; Miller, D.D.; Nasrallah, H.A.; Olson, S.; Patel, J.K.; Saltz, B.L. 2013: Metformin for weight loss and metabolic control in overweight outpatients with schizophrenia and schizoaffective disorder. American Journal of Psychiatry 170(9): 1032-1040
Tek, C.; Chwastiak, L. 2014: Metformin for weight loss in schizophrenia: safe but not a panacea. Evidence-Based Mental Health 17(2): 51-52
Björkhem-Bergman, L.; Asplund, A.B.; Lindh, J.D. 2011: Metformin for weight reduction in non-diabetic patients on antipsychotic drugs: a systematic review and meta-analysis. Journal of Psychopharmacology 25(3): 299-305
Łabuzek, K.; Liber, S.; Gabryel, B.że.; Okopień, B.ła. 2010: Metformin has adenosine-monophosphate activated protein kinase (AMPK)-independent effects on LPS-stimulated rat primary microglial cultures. Pharmacological Reports: Pr 62(5): 827-848
Fougner, K.J.; Vanky, E.; Carlsen, S.M. 2008: Metformin has no major effects on glucose homeostasis in pregnant women with PCOS: results of a randomized double-blind study. Scandinavian Journal of Clinical and Laboratory Investigation 68(8): 771-776
Brown, S. 2014: Metformin has wider implications than diabetes. Post Reproductive Health 20(3): 89
Wiwanitkit, V. 2011: Metformin high dosage and bleeding episode: a clinical case study. Indian Journal of Endocrinology and Metabolism 15(2): 132-133
Cai, X.; Shao, W.; Luan, Y.; Pang, J.; Li, F.; Li, Z. 2011: Metformin hydrochloride-loaded poly(vinyl alcohol) composites as drug delivery systems. Journal of Nanoscience and Nanotechnology 11(10): 8621-8627
Kumar, A.; Al-Sammarraie, N.; DiPette, D.J.; Singh, U.S. 2014: Metformin impairs Rho GTPase signaling to induce apoptosis in neuroblastoma cells and inhibits growth of tumors in the xenograft mouse model of neuroblastoma. Oncotarget 5(22): 11709-11722
Takahashi, A.; Kimura, F.; Yamanaka, A.; Takebayashi, A.; Kita, N.; Takahashi, K.; Murakami, T. 2014: Metformin impairs growth of endometrial cancer cells via cell cycle arrest and concomitant autophagy and apoptosis. Cancer Cell International 14: 53
Wessels, B.; Ciapaite, J.; van den Broek, N.M.A.; Nicolay, K.; Prompers, J.J. 2014: Metformin impairs mitochondrial function in skeletal muscle of both lean and diabetic rats in a dose-dependent manner. Plos one 9(6): E100525
Habib, A.; Karmali, V.; Polavarapu, R.; Akahori, H.; Nakano, M.; Yazdani, S.; Otsuka, F.; Pachura, K.; Davis, T.; Narula, J.; Kolodgie, F.D.; Virmani, R.; Finn, A.V. 2013: Metformin impairs vascular endothelial recovery after stent placement in the setting of locally eluted mammalian target of rapamycin inhibitors via S6 kinase-dependent inhibition of cell proliferation. Journal of the American College of Cardiology 61(9): 971-980
Wang, X.-F.; Zhang, J.-Y.; Li, L.; Zhao, X.-Y.; Tao, H.-L.; Zhang, L. 2011: Metformin improves cardiac function in rats via activation of AMP-activated protein kinase. Clinical and Experimental Pharmacology and Physiology 38(2): 94-101
Romualdi, D.; Costantini, B.; Selvaggi, L.; Giuliani, M.; Cristello, F.; Macrì, F.; Bompiani, A.; Lanzone, A.; Guido, M. 2008: Metformin improves endothelial function in normoinsulinemic PCOS patients: a new prospective. Human Reproduction 23(9): 2127-2133
Fang, X.; Xu, Q.-Y.; Jia, C.; Peng, Y.-F. 2012: Metformin improves epididymal sperm quality and antioxidant function of the testis in diet-induced obesity rats. Zhonghua Nan Ke Xue 18(2): 146-149
Pau, C.T.; Keefe, C.; Duran, J.; Welt, C.K. 2014: Metformin improves glucose effectiveness, not insulin sensitivity: predicting treatment response in women with polycystic ovary syndrome in an open-label, interventional study. Journal of Clinical Endocrinology and Metabolism 99(5): 1870-1878
Shivaswamy, V.; Bennett, R.G.; Clure, C.C.; Larsen, J.L.; Hamel, F.G. 2013: Metformin improves immunosuppressant induced hyperglycemia and exocrine apoptosis in rats. Transplantation 95(2): 280-284
Panserat, S.; Skiba-Cassy, S.; Seiliez, I.; Lansard, M.; Plagnes-Juan, E.; Vachot, C.; Aguirre, P.; Larroquet, L.; Chavernac, G.; Medale, F.; Corraze, G.; Kaushik, S.; Moon, T.W. 2009: Metformin improves postprandial glucose homeostasis in rainbow trout fed dietary carbohydrates: a link with the induction of hepatic lipogenic capacities?. American Journal of Physiology. Regulatory Integrative and Comparative Physiology 297(3): R707-R715
Morgante, G.; Tosti, C.; Orvieto, R.; Musacchio, M.C.; Piomboni, P.; De Leo, V. 2011: Metformin improves semen characteristics of oligo-terato-asthenozoospermic men with metabolic syndrome. Fertility and Sterility 95(6): 2150-2152
Taleb, S.; Moghaddas, P.; Rahimi Balaei, M.; Taleb, S.; Rahimpour, S.; Abbasi, A.; Ejtemaei-Mehr, S.; Dehpour, A.R. 2014: Metformin improves skin flap survival through nitric oxide system. Journal of Surgical Research 192(2): 686-691
Riksen, N.P.; Rongen, G.A.; Pickkers, P. 2013: Metformin improves survival in intensive care unit patients, but why?. Critical Care 17(6): 471
Wang, C-Chi.; Kao, J-Horng. 2010: Metformin improves sustained virologic response in difficult-to-cure hepatitis C: more questions than answers. Hepatology 51(3): 1082; Author Reply 1082-3
Ekeruo, I.A.; Solhpour, A.; Taegtmeyer, H. 2013: Metformin in Diabetic Patients with Heart Failure: Safe and Effective?. Current Cardiovascular Risk Reports 7(6): 417-422
Spaans, E.A.J.M.A.; Kleefstra, N.; van Hateren, K.J.J.H.; Aanstoot, H.-J.; Bilo, H.J.G.; Brand, P.L.P. 2011: Metformin in adolescents and adults with type 1 diabetes mellitus: not evidence-based. Nederlands Tijdschrift Voor Geneeskunde 155(39): A3166
Goodwin, P.J.; Ligibel, J.A.; Stambolic, V. 2009: Metformin in breast cancer: time for action. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 27(20): 3271-3273
Kasznicki, J.; Sliwinska, A.; Drzewoski, Józef. 2014: Metformin in cancer prevention and therapy. Annals of Translational Medicine 2(6): 57
Ben Sahra, I.; Le Marchand-Brustel, Y.; Tanti, J.-F.ço.; Bost, F.éd.ér. 2010: Metformin in cancer therapy: a new perspective for an old antidiabetic drug?. Molecular Cancer Therapeutics 9(5): 1092-1099
Morales, D.R.; Morris, A.D. 2015: Metformin in cancer treatment and prevention. Annual Review of Medicine 66: 17-29
Bojkova, B.; Orendas, P.; Garajova, M.; Kassayova, M.; Kutna, V.; Ahlersova, E.; Ahlers, I. 2009: Metformin in chemically-induced mammary carcinogenesis in rats. Neoplasma 56(3): 269-274
Rothermundt, C.; Hayoz, S.; Templeton, A.J.; Winterhalder, R.; Strebel, R.ät.T.; Bärtschi, D.; Pollak, M.; Lui, L.; Endt, K.; Schiess, R.; Rüschoff, J.H.; Cathomas, R.; Gillessen, S. 2014: Metformin in chemotherapy-naive castration-resistant prostate cancer: a multicenter phase 2 trial (SAKK 08/09). European Urology 66(3): 468-474
Geroldi, D.; Emanuele, E. 2010: Metformin in chronic hepatitis C virus hepatitis: caution needed with sex-based subgroup analysis. Hepatology 51(2): 719
Heaf, J. 2014: Metformin in chronic kidney disease: time for a rethink. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 34(4): 353-357
Clarson, C.L.; Mahmud, F.H.; Baker, J.E.; Clark, H.E.; McKay, W.M.; Schauteet, V.D.; Hill, D.J. 2009: Metformin in combination with structured lifestyle intervention improved body mass index in obese adolescents, but did not improve insulin resistance. Endocrine 36(1): 141-146
Durham, A.E. 2012: Metformin in equine metabolic syndrome: an enigma or a dead duck?. Veterinary Journal 191(1): 17-18
Inzucchi, S.E.; Masoudi, F.A.; McGuire, D.K. 2007: Metformin in heart failure. Diabetes Care 30(12): E129
Morgillo, F.; Sasso, F.C.; Della Corte, C.M.; Festino, L.; Manzo, A.; Martinelli, E.; Troiani, T.; Capuano, A.; Ciardiello, F. 2013: Metformin in lung cancer: rationale for a combination therapy. Expert Opinion on Investigational Drugs 22(11): 1401-1409
Li, Y.; Liu, L.; Wang, B.; Wang, J.; Chen, D. 2013: Metformin in non-alcoholic fatty liver disease: a systematic review and meta-analysis. Biomedical Reports 1(1): 57-64
Kazemi, R.; Aduli, M.; Sotoudeh, M.; Malekzadeh, R.; Seddighi, N.; Sepanlou, S.G.; Merat, S. 2012: Metformin in nonalcoholic steatohepatitis: a randomized controlled trial. Middle East Journal of Digestive Diseases 4(1): 16-22
Marcondes, Jé.A.M.; Yamashita, S.A.Y.; Maciel, G.A.R.; Baracat, E.C.; Halpern, A. 2007: Metformin in normal-weight hirsute women with polycystic ovary syndrome with normal insulin sensitivity. Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 23(5): 273-278
Anonymous 2014: Metformin in obesity. Archives of Disease in Childhood 99(3): 231
Berstein, L.M. 2012: Metformin in obesity, cancer and aging: addressing controversies. Aging 4(5): 320-329
Rocha, A.; Almeida, M.; Santos, J.; Carvalho, A.é 2013: Metformin in patients with chronic kidney disease: strengths and weaknesses. Journal of Nephrology 26(1): 55-60
Haukeland, J.Willy.; Konopski, Z.; Eggesbø, H.Beate.; von Volkmann, H.Løland.; Raschpichler, G.; Bjøro, K.; Haaland, T.; Løberg, E.Marit.; Birkeland, Kåre. 2009: Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial. Scandinavian Journal of Gastroenterology 44(7): 853-860
Al-Hwiesh, A.K.; Abdul-Rahman, I.S.; El-Deen, M.A.N.; Larbi, E.; Divino-Filho, J.C.; Al-Mohanna, F.A.-A.; Gupta, K.L. 2014: Metformin in peritoneal dialysis: a pilot experience. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 34(4): 368-375
Raskauskas, T.A. 2008: Metformin in polycystic ovary syndrome. New England Journal of Medicine 358(17): 1866-1867; Author Reply 1868
Diamanti-Kandarakis, E.; Economou, F.; Palimeri, S.; Christakou, C. 2010: Metformin in polycystic ovary syndrome. Annals of the new York Academy of Sciences 1205: 192-198
Bijok, J.; Bińkowska, M.łg.; Jakiel, G. 2014: Metformin in pregnancy. Ginekologia Polska 85(7): 527-531
Mani, M.K. 2009: Metformin in renal failure--weigh the evidence. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 24(7): 2287-2288
Sivalingam, V.N.; Myers, J.; Nicholas, S.; Balen, A.H.; Crosbie, E.J. 2014: Metformin in reproductive health, pregnancy and gynaecological cancer: established and emerging indications. Human Reproduction Update 20(6): 853-868
Frid, A.; Sterner, G.; Löndahl, M.; Vinge, E.; Cato, A.; Andersson, A. 2009: Metformin in serum. Results of a study as basis for preliminary therapeutic recommendations. Lakartidningen 106(7): 428-429
Milewicz, A.; Sieradzki, J.; Skałba, P.; Małecka-Tendera, E. 2008: Metformin in the clinical practice. Polish Society of Endocrinology consensus based on the European and American medical societies. Endokrynologia Polska 59(2): 174-179
Moreira, P.I. 2014: Metformin in the diabetic brain: friend or foe?. Annals of Translational Medicine 2(6): 54
Qublan, H.S.; Al-Khaderei, S.; Abu-Salem, A.N.; Al-Zpoon, A.; Al-Khateeb, M.; Al-Ibrahim, N.; Megdadi, M.; Al-Ahmad, N. 2009: Metformin in the treatment of clomiphene citrate-resistant women with polycystic ovary syndrome undergoing in vitro fertilisation treatment: a randomised controlled trial. Journal of Obstetrics and Gynaecology: the Journal of the Institute of Obstetrics and Gynaecology 29(7): 651-655
Nestler, J.E. 2008: Metformin in the treatment of infertility in polycystic ovarian syndrome: an alternative perspective. Fertility and Sterility 90(1): 14-16
Rouabhia, S.; Milic, N.; Abenavoli, L. 2014: Metformin in the treatment of non-alcoholic fatty liver disease: safety, efficacy and mechanism. Expert Review of Gastroenterology and Hepatology 8(4): 343-349
Kendall, D.L.; Amin, R.; Clayton, P.E. 2014: Metformin in the treatment of obese children and adolescents at risk of type 2 diabetes. Paediatric Drugs 16(1): 13-20
Schatz, H. 2010: Metformin in type 1 diabetes reduces insulin requirements without significantly improving glycaemic control. Diabetologia 53(10): 2264-2265
Rydén, M. 2011: Metformin in type 2 diabetes. An extensive observational study confirms the agent as first choice--so far. Lakartidningen 108(4): 136
Boussageon, R.ém. 2013: Metformin in type 2 diabetes: what if we get it wrong?. Presse Medicale 42(2): 132-133
Vignozzi, L.; Filippi, S.; Comeglio, P.; Cellai, I.; Morelli, A.; Rastrelli, G.; Maneschi, E.; Mannucci, E.; Maggi, M. 2014: Metformin in vitro and in vivo increases adenosine signaling in rabbit corpora cavernosa. Journal of Sexual Medicine 11(7): 1694-1708
Misso, M.L.; Teede, H.J. 2015: Metformin in women with PCOS, cons. Endocrine 48(2): 428-433
Pasquali, R.; Renato, P. 2015: Metformin in women with PCOS, pros. Endocrine 48(2): 422-426
Diehl, L.A.; Fabris, B.A.; Barbosa, D.éc.S.; De Faria, E.C.; Wiechmann, S.L.; Carrilho, A.J.F. 2008: Metformin increases HDL3-cholesterol and decreases subcutaneous truncal fat in nondiabetic patients with HIV-associated lipodystrophy. Aids Patient Care and Stds 22(10): 779-786
Tsilchorozidou, T.; Batterham, R.L.; Conway, G.S. 2008: Metformin increases fasting plasma peptide tyrosine tyrosine (PYY) in women with polycystic ovarian syndrome (PCOS). Clinical Endocrinology 69(6): 936-942
Vytla, V.S.; Ochs, R.S. 2013: Metformin increases mitochondrial energy formation in L6 muscle cell cultures. Journal of Biological Chemistry 288(28): 20369-20377
Labuzek, K.; Liber, S.; Gabryel, B.; Adamczyk, J.; Okopień, Bław. 2010: Metformin increases phagocytosis and acidifies lysosomal/endosomal compartments in AMPK-dependent manner in rat primary microglia. Naunyn-Schmiedeberg's Archives of Pharmacology 381(2): 171-186
Doogue, M.P.; Begg, E.J.; Moore, M.P.; Lunt, H.; Pemberton, C.J.; Zhang, M. 2009: Metformin increases plasma ghrelin in Type 2 diabetes. British Journal of Clinical Pharmacology 68(6): 875-882
García García, J.é A.; Lara Padilla, E.; Alvarez Hernández, E.; Ocharán Hernández, M.ía.E.; Gutiérrez Iglesias, G.; Melendro Lozano, E.I.; Amancio Chasin, O.; Sánchez Pedraza, V.ín.; Hernández Ruiz, J.ín.; López Alvarenga, J.C. 2014: Metformin increases serum concentration of high molecular weight (HMW-adiponectin) in nondiabetic obese subjects. Gaceta Medica de Mexico 150(4): 324-333
Tan, B.K.; Chen, J.; Adya, R.; Ramanjaneya, M.; Patel, V.; Randeva, H.S. 2013: Metformin increases the novel adipokine adipolin/CTRP12: role of the AMPK pathway. Journal of Endocrinology 219(2): 101-108
Tan, B.K.; Chen, J.; Hu, J.; Amar, O.; Mattu, H.S.; Adya, R.; Patel, V.; Ramanjaneya, M.; Lehnert, H.; Randeva, H.S. 2013: Metformin increases the novel adipokine cartonectin/CTRP3 in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 98(12): E1891-E1900
Alsubaie, S.; Almalki, M.H. 2013: Metformin induced acute pancreatitis. Dermato-Endocrinology 5(2): 317-318
Tsuei, A.-C.; Martinus, R.D. 2012: Metformin induced expression of Hsp60 in human THP-1 monocyte cells. Cell Stress and Chaperones 17(1): 23-28
Strugaru, A.-M.; Botnariu, G.; Agoroaei, L.; Grigoriu, I.-C.; Butnaru, E. 2013: Metformin induced lactic acidosis--particularities and course. Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 117(4): 1035-1042
Tsitsios, T.; Sotirakopoulos, N.; Armentzioiou, K.; Kalogiannidou, I.; Kolaggis, A.; Mavromatidis, K. 2010: Metformin induced severe hypophosphatemia in a patient on hemodialysis. Saudi Journal of Kidney Diseases and Transplantation: An Official Publication of the Saudi Center for Organ Transplantation Saudi Arabia 21(5): 923-926
Zhao, L.; Wen, Z.-H.; Jia, C.-H.; Li, M.; Luo, S.-Q.; Bai, X.-C. 2011: Metformin induces G1 cell cycle arrest and inhibits cell proliferation in nasopharyngeal carcinoma cells. Anatomical Record 294(8): 1337-1343
Aatsinki, S.-M.; Buler, M.; Salomäki, H.; Koulu, M.; Pavek, P.; Hakkola, J. 2014: Metformin induces PGC-1α expression and selectively affects hepatic PGC-1α functions. British Journal of Pharmacology 171(9): 2351-2363
Lee, J.O.; Lee, S.K.; Jung, J.H.; Kim, J.H.; You, G.Y.; Kim, S.J.; Park, S.H.; Uhm, K.-O.; Kim, H.S. 2011: Metformin induces Rab4 through AMPK and modulates GLUT4 translocation in skeletal muscle cells. Journal of Cellular Physiology 226(4): 974-981
Onken, B.; Driscoll, M. 2010: Metformin induces a dietary restriction-like state and the oxidative stress response to extend C. elegans Healthspan via AMPK, LKB1, and SKN-1. Plos one 5(1): E8758
Kurzthaler, D.; Hadziomerovic-Pekic, D.; Wildt, L.; Seeber, B.E. 2014: Metformin induces a prompt decrease in LH-stimulated testosterone response in women with PCOS independent of its insulin-sensitizing effects. Reproductive Biology and Endocrinology: Rb&e 12: 98
Williams, C.C.; Singleton, B.A.; Llopis, S.D.; Skripnikova, E.V. 2013: Metformin induces a senescence-associated gene signature in breast cancer cells. Journal of Health Care for the Poor and Underserved 24(1 Suppl): 93-103
Damelin, L.H.; Jivan, R.; Veale, R.B.; Rousseau, A.L.; Mavri-Damelin, D. 2014: Metformin induces an intracellular reductive state that protects oesophageal squamous cell carcinoma cells against cisplatin but not copper-bis(thiosemicarbazones). Bmc Cancer 14: 314
Queiroz, E.A.I.F.; Puukila, S.; Eichler, R.; Sampaio, S.C.; Forsyth, H.L.; Lees, S.J.; Barbosa, A.M.; Dekker, R.F.H.; Fortes, Z.B.; Khaper, N. 2014: Metformin induces apoptosis and cell cycle arrest mediated by oxidative stress, AMPK and FOXO3a in MCF-7 breast cancer cells. Plos one 9(5): E98207
Lin, F.; Yan, W.; Wen, T.; Wu, G.-y. 2013: Metformin induces apoptosis in hepatocellular carcinoma Huh-7 cells in vitro and its mechanism. Zhonghua Zhong Liu Za Zhi 35(10): 742-746
Wu, N.; Gu, C.; Gu, H.; Hu, H.; Han, Y.; Li, Q. 2011: Metformin induces apoptosis of lung cancer cells through activating JNK/p38 MAPK pathway and GADD153. Neoplasma 58(6): 482-490
Wang, L.-W.; Li, Z.-S.; Zou, D.-W.; Jin, Z.-D.; Gao, J.; Xu, G.-M. 2008: Metformin induces apoptosis of pancreatic cancer cells. World Journal of Gastroenterology 14(47): 7192-7198
Leclerc, G.M.; Leclerc, G.J.; Kuznetsov, J.N.; DeSalvo, J.; Barredo, J.C. 2013: Metformin induces apoptosis through AMPK-dependent inhibition of UPR signaling in ALL lymphoblasts. Plos one 8(8): E74420
Ko, J-Chung.; Huang, Y-Ching.; Chen, H-Jen.; Tseng, S-Chieh.; Chiu, H-Chun.; Wo, T-Yu.; Huang, Y-Jhen.; Weng, S-Hsing.; Chiou, R.Y.Y.; Lin, Y-Wei. 2013: Metformin induces cytotoxicity by down-regulating thymidine phosphorylase and excision repair cross-complementation 1 expression in non-small cell lung cancer cells. Basic and Clinical Pharmacology and Toxicology 113(1): 56-65
Huai, L.; Wang, C.; Zhang, C.; Li, Q.; Chen, Y.; Jia, Y.; Li, Y.; Xing, H.; Tian, Z.; Rao, Q.; Wang, M.; Wang, J. 2012: Metformin induces differentiation in acute promyelocytic leukemia by activating the MEK/ERK signaling pathway. Biochemical and Biophysical Research Communications 422(3): 398-404
Piel, S.; Ehinger, J.K.; Elmér, E.; Hansson, M.J. 2015: Metformin induces lactate production in peripheral blood mononuclear cells and platelets through specific mitochondrial complex i inhibition. Acta Physiologica 213(1): 171-180
Do, M.T.; Kim, H.G.; Choi, J.H.; Jeong, H.G. 2014: Metformin induces microRNA-34a to downregulate the Sirt1/Pgc-1α/Nrf2 pathway, leading to increased susceptibility of wild-type p53 cancer cells to oxidative stress and therapeutic agents. Free Radical Biology and Medicine 74: 21-34
Jang, W.G.; Kim, E.J.; Bae, I.-H.; Lee, K.-N.; Kim, Y.D.; Kim, D.-K.; Kim, S.-H.; Lee, C.-H.; Franceschi, R.T.; Choi, H.-S.; Koh, J.-T. 2011: Metformin induces osteoblast differentiation via orphan nuclear receptor SHP-mediated transactivation of Runx2. Bone 48(4): 885-893
Anedda, A.; Rial, E.; González-Barroso, M.M. 2008: Metformin induces oxidative stress in white adipocytes and raises uncoupling protein 2 levels. Journal of Endocrinology 199(1): 33-40
Leung, S.; Mattman, A.; Snyder, F.; Kassam, R.; Meneilly, G.; Nexo, E. 2010: Metformin induces reductions in plasma cobalamin and haptocorrin bound cobalamin levels in elderly diabetic patients. Clinical Biochemistry 43(9): 759-760
Zheng, S.; Liu, J.; Han, Q.; Huang, S.; Su, W.; Fu, J.; Jia, X.; Du, S.; Zhou, Y.; Zhang, X.; Guan, Y. 2014: Metformin induces renal medullary interstitial cell apoptosis in type 2 diabetic mice. Journal of Diabetes 6(2): 132-146
Piwkowska, A.; Rogacka, D.; Jankowski, M.; Dominiczak, M.H.; Stepiński, J.K.; Angielski, S. 2010: Metformin induces suppression of NAD(P)H oxidase activity in podocytes. Biochemical and Biophysical Research Communications 393(2): 268-273
Liu, B.; Fan, Z.; Edgerton, S.M.; Deng, X.-S.; Alimova, I.N.; Lind, S.E.; Thor, A.D. 2009: Metformin induces unique biological and molecular responses in triple negative breast cancer cells. Cell Cycle 8(13): 2031-2040
Carlsen, S.M.; Vanky, E. 2010: Metformin influence on hormone levels at birth, in PCOS mothers and their newborns. Human Reproduction 25(3): 786-790
Sinnett-Smith, J.; Kisfalvi, K.; Kui, R.; Rozengurt, E. 2013: Metformin inhibition of mTORC1 activation, DNA synthesis and proliferation in pancreatic cancer cells: dependence on glucose concentration and role of AMPK. Biochemical and Biophysical Research Communications 430(1): 352-357
Costa, D.; Gigoni, A.; Würth, R.; Cancedda, R.; Florio, T.; Pagano, A. 2014: Metformin inhibition of neuroblastoma cell proliferation is differently modulated by cell differentiation induced by retinoic acid or overexpression of NDM29 non-coding RNA. Cancer Cell International 14: 59
Tsoyi, K.; Jang, H.J.; Nizamutdinova, I.T.; Kim, Y.M.; Lee, Y.S.; Kim, H.J.; Seo, H.G.; Lee, J.H.; Chang, K.C. 2011: Metformin inhibits HMGB1 release in LPS-treated RAW 264.7 cells and increases survival rate of endotoxaemic mice. British Journal of Pharmacology 162(7): 1498-1508
Kim, H.G.; Hien, T.T.; Han, E.H.; Hwang, Y.P.; Choi, J.H.; Kang, K.W.; Kwon, K.-i.; Kim, B.-H.; Kim, S.K.; Song, G.Y.; Jeong, T.C.; Jeong, H.G. 2011: Metformin inhibits P-glycoprotein expression via the NF-κB pathway and CRE transcriptional activity through AMPK activation. British Journal of Pharmacology 162(5): 1096-1108
Xu, J.-N.; Zeng, C.; Zhou, Y.; Peng, C.; Zhou, Y.-F.; Xue, Q. 2014: Metformin inhibits StAR expression in human endometriotic stromal cells via AMPK-mediated disruption of CREB-CRTC2 complex formation. Journal of Clinical Endocrinology and Metabolism 99(8): 2795-2803
Huang, N.-L.; Chiang, S.-H.; Hsueh, C.-H.; Liang, Y.-J.; Chen, Y.-J.; Lai, L.-P. 2009: Metformin inhibits TNF-alpha-induced IkappaB kinase phosphorylation, IkappaB-alpha degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation. International Journal of Cardiology 134(2): 169-175
Malaguarnera, R.; Sacco, A.; Morcavallo, A.; Squatrito, S.; Migliaccio, A.; Morrione, A.; Maggiolini, M.; Belfiore, A. 2014: Metformin inhibits androgen-induced IGF-IR up-regulation in prostate cancer cells by disrupting membrane-initiated androgen signaling. Endocrinology 155(4): 1207-1221
Qu, H.; Yang, X. 2015: Metformin inhibits angiogenesis induced by interaction of hepatocellular carcinoma with hepatic stellate cells. Cell Biochemistry and Biophysics 71(2): 931-936
Bai, J.; Zhang, N.; Hua, Y.; Wang, B.; Ling, L.; Ferro, A.; Xu, B. 2013: Metformin inhibits angiotensin II-induced differentiation of cardiac fibroblasts into myofibroblasts. Plos one 8(9): E72120
Brown, K.A.; Hunger, N.I.; Docanto, M.; Simpson, E.R. 2010: Metformin inhibits aromatase expression in human breast adipose stromal cells via stimulation of AMP-activated protein kinase. Breast Cancer Research and Treatment 123(2): 591-596
Rice, S.; Pellatt, L.; Ramanathan, K.; Whitehead, S.A.; Mason, H.D. 2009: Metformin inhibits aromatase via an extracellular signal-regulated kinase-mediated pathway. Endocrinology 150(10): 4794-4801
Alimova, I.N.; Liu, B.; Fan, Z.; Edgerton, S.M.; Dillon, T.; Lind, S.E.; Thor, A.D. 2009: Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro. Cell Cycle 8(6): 909-915
Yang, F.-Q.; Wang, J.-J.; Yan, J.-S.; Huang, J.-H.; Li, W.; Che, J.-P.; Wang, G.-C.; Liu, M.; Zheng, J.-H. 2014: Metformin inhibits cell growth by upregulating microRNA-26a in renal cancer cells. International Journal of Clinical and Experimental Medicine 7(10): 3289-3296
Bao, B.; Wang, Z.; Ali, S.; Ahmad, A.; Azmi, A.S.; Sarkar, S.H.; Banerjee, S.; Kong, D.; Li, Y.; Thakur, S.; Sarkar, F.H. 2012: Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating mi RNAs in pancreatic cancer cells. Cancer Prevention Research 5(3): 355-364
Zhang, J.; Shen, C.; Wang, L.; Ma, Q.; Xia, P.; Qi, M.; Yang, M.; Han, B. 2014: Metformin inhibits epithelial-mesenchymal transition in prostate cancer cells: involvement of the tumor suppressor miR30a and its target gene SOX4. Biochemical and Biophysical Research Communications 452(3): 746-752
Xu, Y.; Lu, S. 2013: Metformin inhibits esophagus cancer proliferation through upregulation of USP7. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology Biochemistry and Pharmacology 32(5): 1178-1186
Yang, S.; Lv, Q.; Luo, T.; Liu, L.; Gao, R.; Chen, S.; Ye, P.; Cheng, Q.; Li, Q. 2013: Metformin inhibits expression and secretion of PEDF in adipocyte and hepatocyte via promoting AMPK phosphorylation. Mediators of Inflammation 2013: 429207
Duan, Y.; Zhang, R.; Zhang, M.; Sun, L.; Dong, S.; Wang, G.; Zhang, J.; Zhao, Z. 2013: Metformin inhibits food intake and neuropeptide y gene expression in the hypothalamus. Neural Regeneration Research 8(25): 2379-2388
Gao, L.-B.; Tian, S.; Gao, H.-H.; Xu, Y.-Y. 2013: Metformin inhibits glioma cell U251 invasion by downregulation of fibulin-3. Neuroreport 24(10): 504-508
Ampuero, J.; Ranchal, I.; Nuñez, D.; Díaz-Herrero, M.ía.d.M.; Maraver, M.; del Campo, J.é A.; Rojas, Án.; Camacho, I.és.; Figueruela, B.; Bautista, J.D.; Romero-Gómez, M. 2012: Metformin inhibits glutaminase activity and protects against hepatic encephalopathy. Plos one 7(11): E49279
Quattrini, I.; Conti, A.; Pazzaglia, L.; Novello, C.; Ferrari, S.; Picci, P.; Benassi, M.S. 2014: Metformin inhibits growth and sensitizes osteosarcoma cell lines to cisplatin through cell cycle modulation. Oncology Reports 31(1): 370-375
Xue, J.; Zhang, H.; Liu, W.; Liu, M.; Shi, M.; Wen, Z.; Li, C. 2013: Metformin inhibits growth of eutopic stromal cells from adenomyotic endometrium via AMPK activation and subsequent inhibition of AKT phosphorylation: a possible role in the treatment of adenomyosis. Reproduction 146(4): 397-406
Xiong, Y.; Lu, Q.-J.; Zhao, J.; Wu, G.-Y. 2012: Metformin inhibits growth of hepatocellular carcinoma cells by inducing apoptosis via mitochondrion-mediated pathway. Asian Pacific Journal of Cancer Prevention: Apjcp 13(7): 3275-3279
Foretz, M.; Hébrard, S.; Leclerc, J.; Zarrinpashneh, E.; Soty, M.; Mithieux, G.; Sakamoto, K.; Andreelli, F.; Viollet, B. 2010: Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state. Journal of Clinical Investigation 120(7): 2355-2369
Xun, Y.-H.; Zhang, Y.-J.; Pan, Q.-C.; Mao, R.-C.; Qin, Y.-L.; Liu, H.-Y.; Zhang, Y.-M.; Yu, Y.-S.; Tang, Z.-H.; Lu, M.-J.; Zang, G.-Q.; Zhang, J.-M. 2014: Metformin inhibits hepatitis B virus protein production and replication in human hepatoma cells. Journal of Viral Hepatitis 21(8): 597-603
Du, Y.; Zheng, H.; Wang, J.; Ren, Y.; Li, M.; Gong, C.; Xu, F.; Yang, C. 2014: Metformin inhibits histone H2B monoubiquitination and downstream gene transcription in human breast cancer cells. Oncology Letters 8(2): 809-812
Xavier, D.O.; Amaral, L.S.; Gomes, M.A.; Rocha, M.A.; Campos, P.R.; Cota, B.D.C.V.; Tafuri, L.S.A.; Paiva, A.M.R.; Silva, J.H.; Andrade, S.P.; Belo, A.V. 2010: Metformin inhibits inflammatory angiogenesis in a murine sponge model. Biomedicine and PharmacoTherapy 64(3): 220-225
Kim, S.A.; Choi, H.C. 2012: Metformin inhibits inflammatory response via AMPK-PTEN pathway in vascular smooth muscle cells. Biochemical and Biophysical Research Communications 425(4): 866-872
Alexandre, K.B.; Smit, A.M.; Gray, I.P.; Crowther, N.J. 2008: Metformin inhibits intracellular lipid accumulation in the murine pre-adipocyte cell line, 3T3-L1. Diabetes Obesity and Metabolism 10(8): 688-690
Ferla, R.; Haspinger, E.; Surmacz, E. 2012: Metformin inhibits leptin-induced growth and migration of glioblastoma cells. Oncology Letters 4(5): 1077-1081
Wang, Y.; Dai, W.; Chu, X.; Yang, B.; Zhao, M.; Sun, Y.'e. 2013: Metformin inhibits lung cancer cells proliferation through repressing microRNA-222. Biotechnology Letters 35(12): 2013-2019
Koren-Gluzer, M.; Aviram, M.; Hayek, T. 2013: Metformin inhibits macrophage cholesterol biosynthesis rate: possible role for metformin-induced oxidative stress. Biochemical and Biophysical Research Communications 439(3): 396-400
Wheaton, W.W.; Weinberg, S.E.; Hamanaka, R.B.; Soberanes, S.; Sullivan, L.B.; Anso, E.; Glasauer, A.; Dufour, E.; Mutlu, G.M.; Budigner, G.S.; Chandel, N.S. 2014: Metformin inhibits mitochondrial complex i of cancer cells to reduce tumorigenesis. Elife 3: E02242
Li, S.-N.; Wang, X.; Zeng, Q.-T.; Feng, Y.-B.; Cheng, X.; Mao, X.-B.; Wang, T.-H.; Deng, H.-P. 2009: Metformin inhibits nuclear factor kappaB activation and decreases serum high-sensitivity C-reactive protein level in experimental atherogenesis of rabbits. Heart and Vessels 24(6): 446-453
Gu, J.; Ye, S.; Wang, S.; Sun, W.; Hu, Y. 2014: Metformin inhibits nuclear factor-κB activation and inflammatory cytokines expression induced by high glucose via adenosine monophosphate-activated protein kinase activation in rat glomerular mesangial cells in vitro. Chinese Medical Journal 127(9): 1755-1760
Nair, V.; Pathi, S.; Jutooru, I.; Sreevalsan, S.; Basha, R.; Abdelrahim, M.; Samudio, I.; Safe, S. 2013: Metformin inhibits pancreatic cancer cell and tumor growth and downregulates Sp transcription factors. Carcinogenesis 34(12): 2870-2879
Ling, S.; Feng, T.; Ke, Q.; Fan, N.; Li, L.; Li, Z.; Dong, C.; Wang, C.; Xu, F.; Li, Y.; Wang, L. 2014: Metformin inhibits proliferation and enhances chemosensitivity of intrahepatic cholangiocarcinoma cell lines. Oncology Reports 31(6): 2611-2618
Chen, T.-w.; Liang, Y.-n.; Feng, D.; Tao, L.-y.; Qi, K.; Zhang, H.-y.; Wang, H.-x.; Lin, Q.-s.; Kong, H. 2013: Metformin inhibits proliferation and promotes apoptosis of HER2 positive breast cancer cells by downregulating HSP90. Journal of Buon: Official Journal of the Balkan Union of Oncology 18(1): 51-56
Li, W.; Ma, W.; Zhong, H.; Liu, W.; Sun, Q. 2014: Metformin inhibits proliferation of human keratinocytes through a mechanism associated with activation of the MAPK signaling pathway. Experimental and Therapeutic Medicine 7(2): 389-392
Checkley, L.A.; Rho, O.; Angel, J.M.; Cho, J.; Blando, J.; Beltran, L.; Hursting, S.D.; DiGiovanni, J. 2014: Metformin inhibits skin tumor promotion in overweight and obese mice. Cancer Prevention Research 7(1): 54-64
Zhao, Z.; Cheng, X.; Wang, Y.; Han, R.; Li, L.; Xiang, T.; He, L.; Long, H.; Zhu, B.; He, Y. 2014: Metformin inhibits the IL-6-induced epithelial-mesenchymal transition and lung adenocarcinoma growth and metastasis. Plos one 9(4): E95884
Wu, B.; Li, S.; Sheng, L.; Zhu, J.; Gu, L.; Shen, H.; La, D.; Hambly, B.D.; Bao, S.; Di, W. 2012: Metformin inhibits the development and metastasis of ovarian cancer. Oncology Reports 28(3): 903-908
Kisfalvi, K.; Moro, A.; Sinnett-Smith, J.; Eibl, G.; Rozengurt, E. 2013: Metformin inhibits the growth of human pancreatic cancer xenografts. Pancreas 42(5): 781-785
Li, H.; Chen, X.; Yu, Y.; Wang, Z.; Zuo, Y.; Li, S.; Yang, D.; Hu, S.; Xiang, M.; Xu, Z.; Yu, Z. 2014: Metformin inhibits the growth of nasopharyngeal carcinoma cells and sensitizes the cells to radiation via inhibition of the DNA damage repair pathway. Oncology Reports 32(6): 2596-2604
Hirsch, H.A.; Iliopoulos, D.; Struhl, K. 2013: Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth. Proceedings of the National Academy of Sciences of the United States of America 110(3): 972-977
Hsieh, S.-C.; Tsai, J.-P.; Yang, S.-F.; Tang, M.-J.; Hsieh, Y.-H. 2014: Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression. Amino Acids 46(12): 2809-2822
Wang, Y.; Lin, B.; Wu, J.; Zhang, H.; Wu, B. 2014: Metformin inhibits the proliferation of A549/CDDP cells by activating p38 mitogen-activated protein kinase. Oncology Letters 8(3): 1269-1274
Zhang, M.; Li, X.; Lu, X. 2014: Metformin inhibits the proliferation of hypopharyngeal carcinoma Fadu cells and enhances the chemotherapeutic sensitivity of cells. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 49(4): 317-322
Jang, S.Y.; Kim, A.; Kim, J.K.; Kim, C.; Cho, Y.-H.; Kim, J.-H.; Kim, C.H.; Lee, J.-Y. 2014: Metformin inhibits tumor cell migration via down-regulation of MMP9 in tamoxifen-resistant breast cancer cells. Anticancer Research 34(8): 4127-4134
Cao, X.; Li, H.; Tao, H.; Wu, N.; Yu, L.; Zhang, D.; Lu, X.; Zhu, J.; Lu, Z.; Zhu, Q. 2013: Metformin inhibits vascular calcification in female rat aortic smooth muscle cells via the AMPK-eNOS-NO pathway. Endocrinology 154(10): 3680-3689
Kumar, S.; Meuter, A.; Thapa, P.; Langstraat, C.; Giri, S.; Chien, J.; Rattan, R.; Cliby, W.; Shridhar, V. 2013: Metformin intake is associated with better survival in ovarian cancer: a case-control study. Cancer 119(3): 555-562
Zhang, Y.; Wang, Y.; Bao, C.; Xu, Y.; Shen, H.; Chen, J.; Yan, J.; Chen, Y. 2012: Metformin interacts with AMPK through binding to γ subunit. Molecular and Cellular Biochemistry 368(1-2): 69-76
Lien, F.; Berthier, A.; Bouchaert, E.; Gheeraert, C.él.; Alexandre, J.; Porez, G.; Prawitt, J.; Dehondt, H.él.èn.; Ploton, M.; Colin, S.; Lucas, A.; Patrice, A.; Pattou, F.ço.; Diemer, H.él.èn.; Van Dorsselaer, A.; Rachez, C.; Kamilic, J.; Groen, A.K.; Staels, B.; Lefebvre, P. 2014: Metformin interferes with bile acid homeostasis through AMPK-FXR crosstalk. Journal of Clinical Investigation 124(3): 1037-1051
Nguyen, H.-L.; Concepcion, L. 2011: Metformin intoxication requiring dialysis. Hemodialysis International. International Symposium on Home Hemodialysis 15(Suppl 1): S68-S71
Cantrell, L.A.; Zhou, C.; Mendivil, A.; Malloy, K.M.; Gehrig, P.A.; Bae-Jump, V.L. 2010: Metformin is a potent inhibitor of endometrial cancer cell proliferation--implications for a novel treatment strategy. Gynecologic Oncology 116(1): 92-98
Johnson, N. 2011: Metformin is a reasonable first-line treatment option for non-obese women with infertility related to anovulatory polycystic ovary syndrome--a meta-analysis of randomised trials. Australian and New Zealand Journal of Obstetrics and Gynaecology 51(2): 125-129
Dhar, G.C. 2009: Metformin is a unique drug. Canadian Family Physician Medecin de Famille Canadien 55(6): 589; Author Reply 589
Andersson, C.; Søgaard, P.; Hoffmann, S.ør.; Hansen, P.R.; Vaag, A.; Major-Pedersen, A.; Hansen, T.F.; Bech, J.; Køber, L.; Torp-Pedersen, C.; Gislason, G.H. 2010: Metformin is associated with improved left ventricular diastolic function measured by tissue Doppler imaging in patients with diabetes. European Journal of Endocrinology 163(4): 593-599
Ko, E.M.; Walter, P.; Jackson, A.; Clark, L.; Franasiak, J.; Bolac, C.; Havrilesky, L.J.; Secord, A.A.; Moore, D.T.; Gehrig, P.A.; Bae-Jump, V. 2014: Metformin is associated with improved survival in endometrial cancer. Gynecologic Oncology 132(2): 438-442
Wang, Z.; Lai, S.-T.; Xie, L.; Zhao, J.-D.; Ma, N.-Y.; Zhu, J.; Ren, Z.-G.; Jiang, G.-L. 2014: Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetes Research and Clinical Practice 106(1): 19-26
Yin, M.; Zhou, J.; Gorak, E.J.; Quddus, F. 2013: Metformin is associated with survival benefit in cancer patients with concurrent type 2 diabetes: a systematic review and meta-analysis. Oncologist 18(12): 1248-1255
Duseja, A.; Das, A.; Dhiman, R.K.; Chawla, Y.K.; Thumburu, K.T.; Bhadada, S.; Bhansali, A. 2007: Metformin is effective in achieving biochemical response in patients with nonalcoholic fatty liver disease (NAFLD) not responding to lifestyle interventions. Annals of Hepatology 6(4): 222-226
Taira, A.V.; Merrick, G.S.; Galbreath, R.W.; Morris, M.; Butler, W.M.; Adamovich, E. 2014: Metformin is not associated with improved biochemical free survival or cause-specific survival in men with prostate cancer treated with permanent interstitial brachytherapy. Journal of Contemporary BrachyTherapy 6(3): 254-261
Khurana, A.; Shridhar, V. 2012: Metformin is synthetically lethal with glucose withdrawal in cancer cells. Cell Cycle 11(15): 2779-2780
Jadhav, K.S.; Dungan, C.M.; Williamson, D.L. 2013: Metformin limits ceramide-induced senescence in C2C12 myoblasts. Mechanisms of Ageing and Development 134(11-12): 548-559
Tebbe, C.; Chhina, J.; Dar, S.A.; Sarigiannis, K.; Giri, S.; Munkarah, A.R.; Rattan, R. 2014: Metformin limits the adipocyte tumor-promoting effect on ovarian cancer. Oncotarget 5(13): 4746-4764
Sankhyan, A.; Pawar, P.K. 2013: Metformin loaded non-ionic surfactant vesicles: optimization of formulation, effect of process variables and characterization. Daru: Journal of Faculty of Pharmacy Tehran University of Medical Sciences 21(1): 7
Geerling, J.J.; Boon, M.ët.R.; van der Zon, G.C.; van den Berg, S.A.A.; van den Hoek, A.M.; Lombès, M.; Princen, H.M.G.; Havekes, L.M.; Rensen, P.C.N.; Guigas, B. 2014: Metformin lowers plasma triglycerides by promoting VLDL-triglyceride clearance by brown adipose tissue in mice. Diabetes 63(3): 880-891
Greibe, E.; Trolle, B.; Bor, M.V.; Lauszus, F.F.; Nexo, E. 2013: Metformin lowers serum cobalamin without changing other markers of cobalamin status: a study on women with polycystic ovary syndrome. Nutrients 5(7): 2475-2482
Cufí, S.íl.; Vazquez-Martin, A.; Oliveras-Ferraros, C.; Quirantes, R.; Segura-Carretero, A.; Micol, V.; Joven, J.; Bosch-Barrera, J.; Del Barco, S.; Martin-Castillo, B.ña.; Vellon, L.; Menendez, J.A. 2012: Metformin lowers the threshold for stress-induced senescence: a role for the microRNA-200 family and miR-205. Cell Cycle 11(6): 1235-1246
Sathyapalan, T.; Cho, L.W.; Kilpatrick, E.S.; Coady, A.-M.; Atkin, S.L. 2009: Metformin maintains the weight loss and metabolic benefits following rimonabant treatment in obese women with polycystic ovary syndrome (PCOS). Clinical Endocrinology 70(1): 124-128
Warren-Ulanch, J. 2008: Metformin may aid weight loss in overweight teenage girls. Journal of Pediatrics 153(5): 725-726
Steenkamp, D.W.; McDonnell, M.E.; Meibom, S. 2014: Metformin may be associated with false-negative cancer detection in the gastrointestinal tract on PET/CT. Endocrine Practice: Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20(10): 1079-1083
Bao, B.; Azmi, A.S.; Ali, S.; Zaiem, F.; Sarkar, F.H. 2014: Metformin may function as anti-cancer agent via targeting cancer stem cells: the potential biological significance of tumor-associated mi RNAs in breast and pancreatic cancers. Annals of Translational Medicine 2(6): 59
Dawson, A.J.; Mellor, D.D.; Sathyapalan, T.; Kilpatrick, E.S.; Atkin, S.L. 2011: Metformin may maintain weight loss in obese patients with dysglycaemia initially treated with rimonabant. Diabetic medicine: a journal of the British Diabetic Association 28(1): 124-125
Guo, M.; Mi, J.; Jiang, Q-Ming.; Xu, J-Mei.; Tang, Y-Ying.; Tian, G.; Wang, B. 2014: Metformin may produce antidepressant effects through improvement of cognitive function among depressed patients with diabetes mellitus. Clinical and Experimental Pharmacology and Physiology 41(9): 650-656
Tseng, C-Hsiao. 2014: Metformin may reduce bladder cancer risk in Taiwanese patients with type 2 diabetes. Acta Diabetologica 51(2): 295-303
Tseng, C-Hsiao. 2014: Metformin may reduce breast cancer risk in Taiwanese women with type 2 diabetes. Breast Cancer Research and Treatment 145(3): 785-790
Elmadhun, N.Y.; Sabe, A.A.; Lassaletta, A.D.; Chu, L.M.; Sellke, F.W. 2014: Metformin mitigates apoptosis in ischemic myocardium. Journal of Surgical Research 192(1): 50-58
Germeyer, A.; Jauckus, J.; Zorn, M.; Toth, B.; Capp, E.; Strowitzki, T. 2011: Metformin modulates IL-8, IL-1β, ICAM and IGFBP-1 expression in human endometrial stromal cells. Reproductive Biomedicine Online 22(4): 327-334
Ferreira, G.D.; Germeyer, A.; de Barros Machado, A.; do Nascimento, T.L.; Strowitzki, T.; Brum, I.S.; von Eye Corleta, H.; Capp, E. 2014: Metformin modulates PI3K and GLUT4 expression and Akt/PKB phosphorylation in human endometrial stromal cells after stimulation with androgen and insulin. European Journal of Obstetrics Gynecology and Reproductive Biology 175: 157-162
Arunachalam, G.; Samuel, S.M.; Marei, I.; Ding, H.; Triggle, C.R. 2014: Metformin modulates hyperglycaemia-induced endothelial senescence and apoptosis through SIRT1. British Journal of Pharmacology 171(2): 523-535
Biron, P. 1980: Metformin monitoring. Canadian Family Physician Medecin de Famille Canadien 26: 638-639
Thomas, C.C.; Bakris, G. 2014: Metformin nephrotoxicity insights: will they change clinical management?. Journal of Diabetes 6(2): 111-112
Matsumoto, T.; Noguchi, E.; Ishida, K.; Kobayashi, T.; Yamada, N.; Kamata, K. 2008: Metformin normalizes endothelial function by suppressing vasoconstrictor prostanoids in mesenteric arteries from OLETF rats, a model of type 2 diabetes. American Journal of Physiology. Heart and Circulatory Physiology 295(3): H1165-H1176
Hwang, I.K.; Kim, I.Y.; Joo, E.J.; Shin, J.H.; Choi, J.W.; Won, M.-H.; Yoon, Y.S.; Seong, J.K. 2010: Metformin normalizes type 2 diabetes-induced decrease in cell proliferation and neuroblast differentiation in the rat dentate gyrus. Neurochemical Research 35(4): 645-650
Caton, P.W.; Kieswich, J.; Yaqoob, M.M.; Holness, M.J.; Sugden, M.C. 2011: Metformin opposes impaired AMPK and SIRT1 function and deleterious changes in core clock protein expression in white adipose tissue of genetically-obese db/db mice. Diabetes Obesity and Metabolism 13(12): 1097-1104
Dell'Aglio, D.M.; Perino, L.J.; Todino, J.D.; Algren, D.A.; Morgan, B.W. 2010: Metformin overdose with a resultant serum pH of 6.59: survival without sequalae. Journal of Emergency Medicine 39(1): E77-E80
Al-Abri, S.A.; Hayashi, S.; Thoren, K.L.; Olson, K.R. 2013: Metformin overdose-induced hypoglycemia in the absence of other antidiabetic drugs. Clinical Toxicology 51(5): 444-447
Gong, L.; Goswami, S.; Giacomini, K.M.; Altman, R.B.; Klein, T.E. 2012: Metformin pathways: pharmacokinetics and pharmacodynamics. Pharmacogenetics and Genomics 22(11): 820-827
Wang, L.; Weinshilboum, R. 2014: Metformin pharmacogenomics: biomarkers to mechanisms. Diabetes 63(8): 2609-2610
Pawlyk, A.C.; Giacomini, K.M.; McKeon, C.; Shuldiner, A.R.; Florez, J.C. 2014: Metformin pharmacogenomics: current status and future directions. Diabetes 63(8): 2590-2599
Jiang, Y.; Huang, W.; Wang, J.; Xu, Z.; He, J.; Lin, X.; Zhou, Z.; Zhang, J. 2014: Metformin plays a dual role in MIN6 pancreatic β cell function through AMPK-dependent autophagy. International Journal of Biological Sciences 10(3): 268-277
Petrushev, B.; Tomuleasa, C.; Soritau, O.; Aldea, M.; Pop, T.; Susman, S.; Kacso, G.; Berindan, I.; Irimie, A.; Cristea, V. 2012: Metformin plus PIAF combination chemotherapy for hepatocellular carcinoma. Experimental Oncology 34(1): 17-24
Vaz-Leal, F.J. 2008: Metformin plus a lifestyle intervention was more effective than either alone for antipsychotic-induced weight gain. Acp Journal Club 149(2): 5
Bermúdez-Pirela, V.J.; Cano, C.ím.; Medina, M.T.; Souki, A.; Lemus, M.A.; Leal, E.M.; Seyfi, H.A.; Cano, R.; Ciscek, A.; Bermúdez-Arias, F.; Contreras, F.; Israili, Z.H.; Hernández-Hernández, R.; Valasco, M. 2007: Metformin plus low-dose glimeperide significantly improves Homeostasis Model Assessment for insulin resistance (HOMA(IR)) and beta-cell function (HOMA(beta-cell)) without hyperinsulinemia in patients with type 2 diabetes mellitus. American Journal of Therapeutics 14(2): 194-202
Kebapcilar, L.; Kebapcilar, A.Gul.; Bilgir, O.; Taner, C.Eftal.; Bozkaya, G.; Yildiz, Y.; Sari, I. 2011: Metformin plus oral contraceptive may decrease plasma sCD40 ligand in women with PCOS patients. Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 27(2): 91-95
Sturm, N.; Bronowicki, J.-P.; Maynard-Muet, M.; Tran, A.; Heluwaert, F.; Plages, A.; Zarski, J.-P. 2009: Metformin plus pentoxifylline versus prescriptive diet in non-alcoholic steatohepatitis (NASH): a randomized controlled pilot trial. Gastroenterologie Clinique et Biologique 33(10-11): 984-986
Aldea, M.D.; Petrushev, B.; Soritau, O.; Tomuleasa, C.I.; Berindan-Neagoe, I.; Filip, A.G.; Chereches, G.; Cenariu, M.; Craciun, L.; Tatomir, C.; Florian, I.-S.; Crivii, C.B.; Kacso, G. 2014: Metformin plus sorafenib highly impacts temozolomide resistant glioblastoma stem-like cells. Journal of Buon: Official Journal of the Balkan Union of Oncology 19(2): 502-511
Soritau, O.; Tomuleasa, C.; Aldea, M.; Petrushev, B.; Susman, S.; Gheban, D.; Ioani, H.; Cosis, A.; Brie, I.; Irimie, A.; Kacso, G.; Florian, I.S. 2011: Metformin plus temozolomide-based chemotherapy as adjuvant treatment for WHO grade IIi and IV malignant gliomas. Journal of Buon: Official Journal of the Balkan Union of Oncology 16(2): 282-289
Jagia, M.; Taqi, S.; Hanafi, M. 2011: Metformin poisoning: A complex presentation. Indian Journal of Anaesthesia 55(2): 190-192
Uehara, T.; Mitsuhashi, A.; Tsuruoka, N.; Shozu, M. 2015: Metformin potentiates the anticancer effects of cisplatin under normoxic conditions in vitro. Oncology Reports 33(2): 744-750
Derosa, G.; Romano, D.; Bianchi, L.; D'Angelo, A.; Maffioli, P. 2015: Metformin powder formulation compared to metformin tablets on glycemic control and on treatment satisfaction in subjects with type 2 diabetes mellitus. Journal of Clinical Pharmacology 55(4): 409-414
Sheng, B.; Liu, J.; Li, G.H. 2012: Metformin preconditioning protects Daphnia pulex from lethal hypoxic insult involving AMPK, HIF and mTOR signaling. Comparative Biochemistry and Physiology. Part B Biochemistry and Molecular Biology 163(1): 51-58
Qin, Z-Ying.; Zhang, M.; Dai, Y-mei.; Wang, Y-Mei.; Zhu, G-zhong.; Zhao, Y-Ping.; Ji, C-Bo.; Qiu, J.; Cao, X-Guo.; Guo, X-Rong. 2014: Metformin prevents LYRM1-induced insulin resistance in 3T3-L1 adipocytes via a mitochondrial-dependent mechanism. Experimental Biology and Medicine 239(12): 1567-1574
Kita, Y.; Takamura, T.; Misu, H.; Ota, T.; Kurita, S.; Takeshita, Y.; Uno, M.; Matsuzawa-Nagata, N.; Kato, K-Ichiro.; Ando, H.; Fujimura, A.; Hayashi, K.; Kimura, T.; Ni, Y.; Otoda, T.; Miyamoto, K-ichi.; Zen, Y.; Nakanuma, Y.; Kaneko, S. 2012: Metformin prevents and reverses inflammation in a non-diabetic mouse model of nonalcoholic steatohepatitis. Plos one 7(9): E43056
Jung, T.Woo.; Lee, M.Won.; Lee, Y.Jik.; Kim, S.Mee. 2012: Metformin prevents endoplasmic reticulum stress-induced apoptosis through AMPK-PI3K-c-Jun NH2 pathway. Biochemical and Biophysical Research Communications 417(1): 147-152
Liu, F.; Wang, C.; Zhang, L.; Xu, Y.; Jang, L.; Gu, Y.; Cao, X.; Zhao, X.; Ye, J.; Li, Q. 2014: Metformin prevents hepatic steatosis by regulating the expression of adipose differentiation-related protein. International Journal of Molecular Medicine 33(1): 51-58
Bhalla, K.; Hwang, B.Jang.; Dewi, R.E.; Twaddel, W.; Goloubeva, O.G.; Wong, K-Kin.; Saxena, N.K.; Biswal, S.; Girnun, G.D. 2012: Metformin prevents liver tumorigenesis by inhibiting pathways driving hepatic lipogenesis. Cancer Prevention Research 5(4): 544-552
Tajima, K.; Nakamura, A.; Shirakawa, J.; Togashi, Y.; Orime, K.; Sato, K.; Inoue, H.; Kaji, M.; Sakamoto, E.; Ito, Y.; Aoki, K.; Nagashima, Y.; Atsumi, T.; Terauchi, Y. 2013: Metformin prevents liver tumorigenesis induced by high-fat diet in C57Bl/6 mice. American Journal of Physiology. Endocrinology and Metabolism 305(8): E987-E998
Paiva, M.; Riksen, N.P.; Davidson, S.M.; Hausenloy, D.J.; Monteiro, P.; Gonçalves, L.; Providência, Lís.; Rongen, G.A.; Smits, P.; Mocanu, M.M.; Yellon, D.M. 2009: Metformin prevents myocardial reperfusion injury by activating the adenosine receptor. Journal of Cardiovascular Pharmacology 53(5): 373-378
Huang, Y.; Fu, J-fen.; Shi, H-bo.; Liu, L-rui. 2011: Metformin prevents non-alcoholic fatty liver disease in rats: role of phospholipase A2/lysophosphatidylcholine lipoapoptosis pathway in hepatocytes. Zhonghua Er Ke Za Zhi 49(2): 139-145
Sasaki, H.; Asanuma, H.; Fujita, M.; Takahama, H.; Wakeno, M.; Ito, S.; Ogai, A.; Asakura, M.; Kim, J.; Minamino, T.; Takashima, S.; Sanada, S.; Sugimachi, M.; Komamura, K.; Mochizuki, N.; Kitakaze, M. 2009: Metformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase. Circulation 119(19): 2568-2577
Vitale-Cross, L.; Molinolo, A.A.; Martin, D.; Younis, R.H.; Maruyama, T.; Patel, V.; Chen, W.; Schneider, A.; Gutkind, J.Silvio. 2012: Metformin prevents the development of oral squamous cell carcinomas from carcinogen-induced premalignant lesions. Cancer Prevention Research 5(4): 562-573
Memmott, R.M.; Mercado, J.R.; Maier, C.R.; Kawabata, S.; Fox, S.D.; Dennis, P.A. 2010: Metformin prevents tobacco carcinogen--induced lung tumorigenesis. Cancer Prevention Research 3(9): 1066-1076
Yoshida, T.; Okuno, A.; Tanaka, J.; Takahashi, K.; Nakashima, R.; Kanda, S.; Ogawa, J.; Hagisawa, Y.; Fujiwara, T. 2009: Metformin primarily decreases plasma glucose not by gluconeogenesis suppression but by activating glucose utilization in a non-obese type 2 diabetes Goto-Kakizaki rats. European Journal of Pharmacology 623(1-3): 141-147
Liu, Y.; Tang, G.; Zhang, Z.; Wang, Y.; Yang, G.-Y. 2014: Metformin promotes focal angiogenesis and neurogenesis in mice following middle cerebral artery occlusion. Neuroscience Letters 579: 46-51
Ohira, M.; Miyashita, Y.; Murano, T.; Watanabe, F.; Shirai, K. 2009: Metformin promotes induction of lipoprotein lipase in skeletal muscle through activation of adenosine monophosphate-activated protein kinase. Metabolism, Clinical and Experimental 58(10): 1408-1414
Li, D.-J.; Huang, F.; Lu, W.-J.; Jiang, G.-J.; Deng, Y.-P.; Shen, F.-M. 2015: Metformin promotes irisin release from murine skeletal muscle independently of AMP-activated protein kinase activation. Acta Physiologica 213(3): 711-721
De Haes, W.; Frooninckx, L.; Van Assche, R.; Smolders, A.; Depuydt, G.; Billen, J.; Braeckman, B.P.; Schoofs, L.; Temmerman, L. 2014: Metformin promotes lifespan through mitohormesis via the peroxiredoxin PRDX-2. Proceedings of the National Academy of Sciences of the United States of America 111(24): E2501-E2509
Xie, Y.; Wang, Y.-L.; Yu, L.; Hu, Q.; Ji, L.; Zhang, Y.; Liao, Q.-P. 2011: Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells. Journal of Steroid Biochemistry and Molecular Biology 126(3-5): 113-120
Oishi, N.; Kendall, A.; Schacht, J. 2014: Metformin protects against gentamicin-induced hair cell death in vitro but not ototoxicity in vivo. Neuroscience Letters 583: 65-69
Zhang, T.; Hu, X.; Cai, Y.; Yi, B.; Wen, Z. 2014: Metformin protects against hyperglycemia-induced cardiomyocytes injury by inhibiting the expressions of receptor for advanced glycation end products and high mobility group box 1 protein. Molecular Biology Reports 41(3): 1335-1340
Zhao, R.-R.; Xu, X.-C.; Xu, F.; Zhang, W.-L.; Zhang, W.-L.; Liu, L.-M.; Wang, W.-P. 2014: Metformin protects against seizures, learning and memory impairments and oxidative damage induced by pentylenetetrazole-induced kindling in mice. Biochemical and Biophysical Research Communications 448(4): 414-417
Xu, X.; Lu, Z.; Fassett, J.; Zhang, P.; Hu, X.; Liu, X.; Kwak, D.; Li, J.; Zhu, G.; Tao, Y.; Hou, M.; Wang, H.; Guo, H.; Viollet, B.; McFalls, E.O.; Bache, R.J.; Chen, Y. 2014: Metformin protects against systolic overload-induced heart failure independent of AMP-activated protein kinase α2. Hypertension 63(4): 723-728
Kobashigawa, L.C.; Xu, Y.C.; Padbury, J.F.; Tseng, Y.-T.; Yano, N. 2014: Metformin protects cardiomyocyte from doxorubicin induced cytotoxicity through an AMP-activated protein kinase dependent signaling pathway: an in vitro study. Plos one 9(8): E104888
Cheang, W.S.; Tian, X.Y.; Wong, W.T.; Lau, C.W.; Lee, S.S.-T.; Chen, Z.Y.; Yao, X.; Wang, N.; Huang, Y. 2014: Metformin protects endothelial function in diet-induced obese mice by inhibition of endoplasmic reticulum stress through 5' adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor δ pathway. Arteriosclerosis Thrombosis and Vascular Biology 34(4): 830-836
Woudenberg-Vrenken, T.E.; Conde de la Rosa, L.; Buist-Homan, M.; Faber, K.N.; Moshage, H. 2013: Metformin protects rat hepatocytes against bile acid-induced apoptosis. Plos one 8(8): E71773
Correia, S.ón.; Carvalho, C.; Santos, M.S.; Proença, T.; Nunes, E.; Duarte, A.I.; Monteiro, P.; Seiça, R.; Oliveira, C.R.; Moreira, P.I. 2008: Metformin protects the brain against the oxidative imbalance promoted by type 2 diabetes. Medicinal Chemistry 4(4): 358-364
Cai, H.; Zhang, G.; Chen, W.; Zhang, B.; Zhang, J.; Chang, J.; Tang, C.; Qi, Y.; Yin, X. 2014: Metformin protects the myocardium against isoproterenol-induced injury in rats through alleviating endoplasmic reticulum stress. Die Pharmazie 69(1): 64-69
Winsberg, B.; Yeager, C.; Hobbs, B.; Wei, R.; Elangovan, N. 2010: Metformin provides weight reduction for hospitalized patients receiving polypharmacy. Journal of Clinical Psychopharmacology 30(3): 345-346
Wiliński, B.; Wiliński, J.; Somogyi, E.; Piotrowska, J.; Opoka, W.ło. 2013: Metformin raises hydrogen sulfide tissue concentrations in various mouse organs. Pharmacological Reports: Pr 65(3): 737-742
Piwkowska, A.; Rogacka, D.; Jankowski, M.; Angielski, S. 2013: Metformin reduces NAD(P)H oxidase activity in mouse cultured podocytes through purinergic dependent mechanism by increasing extracellular ATP concentration. Acta Biochimica Polonica 60(4): 607-612
Park, I.-H.; Um, J.-Y.; Hong, S.-M.; Cho, J.-S.; Lee, S.H.; Lee, S.H.; Lee, H.-M. 2014: Metformin reduces TGF-β1-induced extracellular matrix production in nasal polyp-derived fibroblasts. Otolaryngology--Head and Neck Surgery: Official Journal of American Academy of Otolaryngology-Head and Neck Surgery 150(1): 148-153
Park, C.S.; Bang, B.-R.; Kwon, H.-S.; Moon, K.-A.; Kim, T.-B.; Lee, K.-Y.; Moon, H.-B.; Cho, Y.S. 2012: Metformin reduces airway inflammation and remodeling via activation of AMP-activated protein kinase. Biochemical Pharmacology 84(12): 1660-1670
Agarwal, N.; Rice, S.P.L.; Bolusani, H.; Luzio, S.D.; Dunseath, G.; Ludgate, M.; Rees, D.A. 2010: Metformin reduces arterial stiffness and improves endothelial function in young women with polycystic ovary syndrome: a randomized, placebo-controlled, crossover trial. Journal of Clinical Endocrinology and Metabolism 95(2): 722-730
Tsai, C-Min.; Kuo, H-Chang.; Hsu, C-Ning.; Huang, L-Tung.; Tain, Y-Lin. 2014: Metformin reduces asymmetric dimethylarginine and prevents hypertension in spontaneously hypertensive rats. Translational Research: the Journal of Laboratory and Clinical Medicine 164(6): 452-459
Matsui, Y.; Hirasawa, Y.; Sugiura, T.; Toyoshi, T.; Kyuki, K.; Ito, M. 2010: Metformin reduces body weight gain and improves glucose intolerance in high-fat diet-fed C57BL/6J mice. Biological and Pharmaceutical Bulletin 33(6): 963-970
Ohira, M.; Yamaguchi, T.; Saiki, A.; Ban, N.; Kawana, H.; Nagayama, D.; Nagumo, A.; Murano, T.; Shirai, K.; Tatsuno, I. 2014: Metformin reduces circulating malondialdehyde-modified low-density lipoprotein in type 2 diabetes mellitus. Clinical and Investigative Medicine. Medecine Clinique et Experimentale 37(4): E243-E251
Janjetovic, K.; Vucicevic, L.; Misirkic, M.; Vilimanovich, U.; Tovilovic, G.; Zogovic, N.; Nikolic, Z.; Jovanovic, S.; Bumbasirevic, V.; Trajkovic, V.; Harhaji-Trajkovic, L. 2011: Metformin reduces cisplatin-mediated apoptotic death of cancer cells through AMPK-independent activation of Akt. European Journal of Pharmacology 651(1-3): 41-50
Algire, C.; Moiseeva, O.; Deschênes-Simard, X.; Amrein, L.; Petruccelli, L.; Birman, E.; Viollet, B.; Ferbeyre, G.; Pollak, M.N. 2012: Metformin reduces endogenous reactive oxygen species and associated DNA damage. Cancer Prevention Research 5(4): 536-543
Buler, M.; Aatsinki, S.-M.; Izzi, V.; Hakkola, J. 2012: Metformin reduces hepatic expression of SIRT3, the mitochondrial deacetylase controlling energy metabolism. Plos one 7(11): E49863
Hou, X.; Song, J.; Li, X.-N.; Zhang, L.; Wang, X.; Chen, L.; Shen, Y.H. 2010: Metformin reduces intracellular reactive oxygen species levels by upregulating expression of the antioxidant thioredoxin via the AMPK-FOXO3 pathway. Biochemical and Biophysical Research Communications 396(2): 199-205
Song, J.; Ren, P.; Zhang, L.; Wang, X.L.; Chen, L.; Shen, Y.H. 2010: Metformin reduces lipid accumulation in macrophages by inhibiting FOXO1-mediated transcription of fatty acid-binding protein 4. Biochemical and Biophysical Research Communications 393(1): 89-94
Dafopoulos, K.; Vrekoussis, T.; Chalvatzas, N.; Messini, C.I.; Kalantaridou, S.N.; Georgoulias, P.; Messinis, I.E.; Makrigiannakis, A. 2013: Metformin reduces the expression of corticotropin-releasing hormone and urocortin in the endometrium of healthy women. Fertility and Sterility 100(5): 1405-1409
Fonseca, E.A.I.; de Oliveira, M.A.; Lobato, N.úb.d.S.; Akamine, E.H.; Colquhoun, A.; de Carvalho, M.H.C.; Zyngier, S.B.; Fortes, Z.B. 2011: Metformin reduces the stimulatory effect of obesity on in vivo Walker-256 tumor development and increases the area of tumor necrosis. Life Sciences 88(19-20): 846-852
Tseng, C.-H. 2014: Metformin reduces thyroid cancer risk in Taiwanese patients with type 2 diabetes. Plos one 9(10): E109852
Zhang, T.-X.; Xu, J.-X.; Peng, F.; Chai, D.-J.; Lin, J.-X. 2013: Metformin reduces vascular endothelial dysfunction caused by an acute glucose load in patients with hypertension. Blood Pressure 22(2): 106-113
Yilmaz, B.; Sucak, A.; Kilic, S.; Aksakal, O.; Aksoy, Y.; Lortlar, N.; Sut, N.; Gungor, T. 2010: Metformin regresses endometriotic implants in rats by improving implant levels of superoxide dismutase, vascular endothelial growth factor, tissue inhibitor of metalloproteinase-2, and matrix metalloproteinase-9. American Journal of Obstetrics and Gynecology 202(4): 368.E1-8
Vazquez-Martin, A.; Oliveras-Ferraros, C.; Cufí, S.; Del Barco, S.; Martin-Castillo, B.ña.; Menendez, J.A. 2010: Metformin regulates breast cancer stem cell ontogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status. Cell Cycle 9(18): 3807-3814
Lee, J.O.; Lee, S.K.; Kim, J.H.; Kim, N.; You, G.Y.; Moon, J.W.; Kim, S.J.; Park, S.H.; Kim, H.S. 2012: Metformin regulates glucose transporter 4 (GLUT4) translocation through AMP-activated protein kinase (AMPK)-mediated Cbl/CAP signaling in 3T3-L1 preadipocyte cells. Journal of Biological Chemistry 287(53): 44121-44129
Gao, Y.; Xue, J.; Li, X.; Jia, Y.; Hu, J. 2008: Metformin regulates osteoblast and adipocyte differentiation of rat mesenchymal stem cells. Journal of Pharmacy and Pharmacology 60(12): 1695-1700
Kim, D.-S.; Jeong, S.-K.; Kim, H.-R.; Kim, D.-S.; Chae, S.-W.; Chae, H.-J. 2010: Metformin regulates palmitate-induced apoptosis and ER stress response in HepG2 liver cells. Immunopharmacology and Immunotoxicology 32(2): 251-257
Maida, A.; Lamont, B.J.; Cao, X.; Drucker, D.J. 2011: Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-α in mice. Diabetologia 54(2): 339-349
Gritti, M.; Würth, R.; Angelini, M.; Barbieri, F.; Peretti, M.; Pizzi, E.; Pattarozzi, A.; Carra, E.; Sirito, R.; Daga, A.; Curmi, P.M.G.; Mazzanti, M.; Florio, T. 2014: Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion current. Oncotarget 5(22): 11252-11268
Yang, H.; Garzel, B.; Heyward, S.; Moeller, T.; Shapiro, P.; Wang, H. 2014: Metformin represses drug-induced expression of CYP2B6 by modulating the constitutive androstane receptor signaling. Molecular Pharmacology 85(2): 249-260
Jung, J.-W.; Park, S.-B.; Lee, S.-J.; Seo, M.-S.; Trosko, J.E.; Kang, K.-S. 2011: Metformin represses self-renewal of the human breast carcinoma stem cells via inhibition of estrogen receptor-mediated OCT4 expression. Plos one 6(11): E28068
Oliveras-Ferraros, C.; Cufí, S.íl.; Vazquez-Martin, A.; Menendez, O.J.; Bosch-Barrera, J.; Martin-Castillo, B.ña.; Joven, J.; Menendez, J.A. 2012: Metformin rescues cell surface major histocompatibility complex class i (MHC-I) deficiency caused by oncogenic transformation. Cell Cycle 11(5): 865-870
Shao, X.; Cao, X.; Song, G.; Zhao, Y.; Shi, B. 2014: Metformin rescues the MG63 osteoblasts against the effect of high glucose on proliferation. Journal of Diabetes Research 2014: 453940
Ashour, A.E.; Sayed-Ahmed, M.M.; Abd-Allah, A.R.; Korashy, H.M.; Maayah, Z.H.; Alkhalidi, H.; Mubarak, M.; Alhaider, A. 2012: Metformin rescues the myocardium from doxorubicin-induced energy starvation and mitochondrial damage in rats. Oxidative Medicine and Cellular Longevity 2012: 434195
Schweighofer, N.; Lerchbaum, E.; Trummer, O.; Schwetz, V.; Pieber, T.; Obermayer-Pietsch, B. 2014: Metformin resistance alleles in polycystic ovary syndrome: pattern and association with glucose metabolism. Pharmacogenomics 15(3): 305-317
Sena, C.M.; Matafome, P.; Louro, T.; Nunes, E.; Fernandes, R.; Seiça, R.M. 2011: Metformin restores endothelial function in aorta of diabetic rats. British Journal of Pharmacology 163(2): 424-437
Matsuki, K.; Tamasawa, N.; Yamashita, M.; Tanabe, J.; Murakami, H.; Matsui, J.; Imaizumi, T.; Satoh, K.; Suda, T. 2009: Metformin restores impaired HDL-mediated cholesterol efflux due to glycation. Atherosclerosis 206(2): 434-438
Nakhjavani, M.; Morteza, A.; Asgarani, F.; Mokhtari, A.; Esteghamati, A.; Khalilzadeh, O.; Rahbari, G. 2011: Metformin restores the correlation between serum-oxidized LDL and leptin levels in type 2 diabetic patients. Redox Report: Communications in Free Radical Research 16(5): 193-200
Cabreiro, F.; Au, C.; Leung, K-Yi.; Vergara-Irigaray, N.; Cochemé, H.M.; Noori, T.; Weinkove, D.; Schuster, E.; Greene, N.D.E.; Gems, D. 2013: Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism. Cell 153(1): 228-239
Da Silva, D.; Zancan, P.; Coelho, W.S.; Gomez, L.S.; Sola-Penna, M. 2010: Metformin reverses hexokinase and 6-phosphofructo-1-kinase inhibition in skeletal muscle, liver and adipose tissues from streptozotocin-induced diabetic mouse. Archives of Biochemistry and Biophysics 496(1): 53-60
Qu, C.; Zhang, W.; Zheng, G.; Zhang, Z.; Yin, J.; He, Z. 2014: Metformin reverses multidrug resistance and epithelial-mesenchymal transition (EMT) via activating AMP-activated protein kinase (AMPK) in human breast cancer cells. Molecular and Cellular Biochemistry 386(1-2): 63-71
Ling, S.; Tian, Y.; Zhang, H.; Jia, K.; Feng, T.; Sun, D.; Gao, Z.; Xu, F.; Hou, Z.; Li, Y.; Wang, L. 2014: Metformin reverses multidrug resistance in human hepatocellular carcinoma Bel‑7402/5‑fluorouracil cells. Molecular Medicine Reports 10(6): 2891-2897
Zhang, Z.; Dong, L.; Sui, L.; Yang, Y.; Liu, X.; Yu, Y.; Zhu, Y.; Feng, Y. 2011: Metformin reverses progestin resistance in endometrial cancer cells by downregulating Gloi expression. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 21(2): 213-221
Zhen, D.; Chen, Y.; Tang, X. 2010: Metformin reverses the deleterious effects of high glucose on osteoblast function. Journal of Diabetes and its Complications 24(5): 334-344
Spada, A.; Philippe, J. 2008: Metformin role in the treatment of type 2 diabetes in 2008. Revue Medicale Suisse 4(160): 1392-1394; 1396-1397
Marques, P.; Carvalho, M.R.; Pinto, L.ís.; Guerra, S.íl. 2014: Metformin safety in the management of gestational diabetes. Endocrine Practice: Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20(10): 1022-1031
Würth, R.; Pattarozzi, A.; Gatti, M.; Bajetto, A.; Corsaro, A.; Parodi, A.; Sirito, R.; Massollo, M.; Marini, C.; Zona, G.; Fenoglio, D.; Sambuceti, G.; Filaci, G.; Daga, A.; Barbieri, F.; Florio, T. 2013: Metformin selectively affects human glioblastoma tumor-initiating cell viability: a role for metformin-induced inhibition of Akt. Cell Cycle 12(1): 145-156
Kane, D.A.; Anderson, E.J.; Price, J.W.; Woodlief, T.L.; Lin, C.-T.; Bikman, B.T.; Cortright, R.N.; Neufer, P.D. 2010: Metformin selectively attenuates mitochondrial H2O2 emission without affecting respiratory capacity in skeletal muscle of obese rats. Free Radical Biology and Medicine 49(6): 1082-1087
Hirsch, H.A.; Iliopoulos, D.; Tsichlis, P.N.; Struhl, K. 2009: Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission. Cancer Research 69(19): 7507-7511
Zhu, P.; Davis, M.; Blackwelder, A.J.; Bachman, N.; Liu, B.; Edgerton, S.; Williams, L.L.; Thor, A.D.; Yang, X. 2014: Metformin selectively targets tumor-initiating cells in ErbB2-overexpressing breast cancer models. Cancer Prevention Research 7(2): 199-210
Li, L.; Han, R.; Xiao, H.; Lin, C.; Wang, Y.; Liu, H.; Li, K.; Chen, H.; Sun, F.; Yang, Z.; Jiang, J.; He, Y. 2014: Metformin sensitizes EGFR-TKI-resistant human lung cancer cells in vitro and in vivo through inhibition of IL-6 signaling and EMT reversal. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 20(10): 2714-2726
Lin, Y.-C.; Wu, M.-H.; Wei, T.-T.; Lin, Y.-C.; Huang, W.-C.; Huang, L.-Y.; Lin, Y.-T.; Chen, C.-C. 2014: Metformin sensitizes anticancer effect of dasatinib in head and neck squamous cell carcinoma cells through AMPK-dependent ER stress. Oncotarget 5(1): 298-308
Honjo, S.; Ajani, J.A.; Scott, A.W.; Chen, Q.; Skinner, H.D.; Stroehlein, J.; Johnson, R.L.; Song, S. 2014: Metformin sensitizes chemotherapy by targeting cancer stem cells and the mTOR pathway in esophageal cancer. International Journal of Oncology 45(2): 567-574
Zhang, T.; Wang, X.; He, D.; Jin, X.; Guo, P. 2014: Metformin sensitizes human bladder cancer cells to TRAIL-induced apoptosis through mTOR/S6K1-mediated downregulation of c-FLIP. Anti-Cancer Drugs 25(8): 887-897
Lee, S.K.; Lee, J.O.; Kim, J.H.; Kim, S.J.; You, G.Y.; Moon, J.W.; Jung, J.H.; Park, S.H.; Uhm, K.-O.; Park, J.M.; Suh, P.-G.; Kim, H.S. 2011: Metformin sensitizes insulin signaling through AMPK-mediated PTEN down-regulation in preadipocyte 3T3-L1 cells. Journal of Cellular Biochemistry 112(5): 1259-1267
Zhang, T.; Zhang, L.; Zhang, T.; Fan, J.; Wu, K.; Guan, Z.; Wang, X.; Li, L.; Hsieh, J.-T.; He, D.; Guo, P. 2014: Metformin sensitizes prostate cancer cells to radiation through EGFR/p-DNA-PKCS in vitro and in vivo. Radiation Research 181(6): 641-649
Ijäs, H.; Vääräsmäki, M.; Morin-Papunen, L.; Keravuo, R.; Ebeling, T.; Saarela, T.; Raudaskoski, T. 2011: Metformin should be considered in the treatment of gestational diabetes: a prospective randomised study. Bjog: An International Journal of Obstetrics and Gynaecology 118(7): 880-885
Gudmundsdottir, H.; Brørs, O.; Os, I. 2008: Metformin should not be used by patients with reduced renal function. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 128(8): 936-937
Tseng, C.-H. 2014: Metformin significantly reduces incident prostate cancer risk in Taiwanese men with type 2 diabetes mellitus. European Journal of Cancer 50(16): 2831-2837
Zamek-Gliszczynski, M.J.; Bao, J.Q.; Day, J.S.; Higgins, J.W. 2013: Metformin sinusoidal efflux from the liver is consistent with negligible biliary excretion and absence of enterohepatic cycling. Drug Metabolism and Disposition: the Biological Fate of Chemicals 41(11): 1967-1971
Anisimov, V.N.; Berstein, L.M.; Egormin, P.A.; Piskunova, T.S.; Popovich, I.G.; Zabezhinski, M.A.; Tyndyk, M.L.; Yurova, M.V.; Kovalenko, I.G.; Poroshina, T.E.; Semenchenko, A.V. 2008: Metformin slows down aging and extends life span of female SHR mice. Cell Cycle 7(17): 2769-2773
Takahashi, N.; Shibata, R.; Ouchi, N.; Sugimoto, M.; Murohara, T.; Komori, K. 2015: Metformin stimulates ischemia-induced revascularization through an eNOS dependent pathway in the ischemic hindlimb mice model. Journal of Vascular Surgery 61(2): 489-496
Mai, Q.-G.; Zhang, Z.-M.; Xu, S.; Lu, M.; Zhou, R.-P.; Zhao, L.; Jia, C.-H.; Wen, Z.-H.; Jin, D.-D.; Bai, X.-C. 2011: Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats. Journal of Cellular Biochemistry 112(10): 2902-2909
Pelletier, A.L.; Butler, A.M.; Gillies, R.A.; May, J.R. 2010: Metformin stinks, literally. Annals of Internal Medicine 152(4): 267-268
Resuli, B.; Demiraj, V.; Babameto, A.; Sema, K.; Malaj, V. 2012: Metformin superior to low‑fat diet for the treatment of patients with nonalcoholic fatty liver disease and/or steatohepatitis. Polskie Archiwum Medycyny Wewnetrznej 122(Suppl 1): 68-71
Smith, D.L.; Elam, C.F.; Mattison, J.A.; Lane, M.A.; Roth, G.S.; Ingram, D.K.; Allison, D.B. 2010: Metformin supplementation and life span in Fischer-344 rats. Journals of Gerontology. Series A Biological Sciences and Medical Sciences 65(5): 468-474
Neschen, S.; Scheerer, M.; Seelig, A.; Huypens, P.; Schultheiss, J.ür.; Wu, M.; Wurst, W.; Rathkolb, B.; Suhre, K.; Wolf, E.; Beckers, J.; Hrabé de Angelis, M. 2015: Metformin supports the antidiabetic effect of a sodium glucose cotransporter 2 inhibitor by suppressing endogenous glucose production in diabetic mice. Diabetes 64(1): 284-290
Do, M.Truong.; Kim, H.Gyun.; Tran, T.Thu.Phuong.; Khanal, T.; Choi, J.Ho.; Chung, Y.Chul.; Jeong, T.Cheon.; Jeong, H.Gwang. 2014: Metformin suppresses CYP1A1 and CYP1B1 expression in breast cancer cells by down-regulating aryl hydrocarbon receptor expression. Toxicology and Applied Pharmacology 280(1): 138-148
Hosono, K.; Endo, H.; Takahashi, H.; Sugiyama, M.; Uchiyama, T.; Suzuki, K.; Nozaki, Y.; Yoneda, K.; Fujita, K.; Yoneda, M.; Inamori, M.; Tomatsu, A.; Chihara, T.; Shimpo, K.; Nakagama, H.; Nakajima, A. 2010: Metformin suppresses azoxymethane-induced colorectal aberrant crypt foci by activating AMP-activated protein kinase. Molecular Carcinogenesis 49(7): 662-671
Hosono, K.; Endo, H.; Takahashi, H.; Sugiyama, M.; Sakai, E.; Uchiyama, T.; Suzuki, K.; Iida, H.; Sakamoto, Y.; Yoneda, K.; Koide, T.; Tokoro, C.; Abe, Y.; Inamori, M.; Nakagama, H.; Nakajima, A. 2010: Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial. Cancer Prevention Research 3(9): 1077-1083
Takayama, H.; Misu, H.; Iwama, H.; Chikamoto, K.; Saito, Y.; Murao, K.; Teraguchi, A.; Lan, F.; Kikuchi, A.; Saito, R.; Tajima, N.; Shirasaki, T.; Matsugo, S.; Miyamoto, K.-i.; Kaneko, S.; Takamura, T. 2014: Metformin suppresses expression of the selenoprotein P gene via an AMP-activated kinase (AMPK)/FoxO3a pathway in H4IIEC3 hepatocytes. Journal of Biological Chemistry 289(1): 335-345
Ota, S.; Horigome, K.; Ishii, T.; Nakai, M.; Hayashi, K.; Kawamura, T.; Kishino, A.; Taiji, M.; Kimura, T. 2009: Metformin suppresses glucose-6-phosphatase expression by a complex i inhibition and AMPK activation-independent mechanism. Biochemical and Biophysical Research Communications 388(2): 311-316
Sikka, A.; Kaur, M.; Agarwal, C.; Deep, G.; Agarwal, R. 2012: Metformin suppresses growth of human head and neck squamous cell carcinoma via global inhibition of protein translation. Cell Cycle 11(7): 1374-1382
Fujita, Y.; Hosokawa, M.; Fujimoto, S.; Mukai, E.; Abudukadier, A.; Obara, A.; Ogura, M.; Nakamura, Y.; Toyoda, K.; Nagashima, K.; Seino, Y.; Inagaki, N. 2010: Metformin suppresses hepatic gluconeogenesis and lowers fasting blood glucose levels through reactive nitrogen species in mice. Diabetologia 53(7): 1472-1481
Caton, P.W.; Nayuni, N.K.; Kieswich, J.; Khan, N.Q.; Yaqoob, M.M.; Corder, R. 2010: Metformin suppresses hepatic gluconeogenesis through induction of SIRT1 and GCN5. Journal of Endocrinology 205(1): 97-106
Cai, X.; Hu, X.; Cai, B.; Wang, Q.; Li, Y.; Tan, X.; Hu, H.; Chen, X.; Huang, J.; Cheng, J.; Jing, X. 2013: Metformin suppresses hepatocellular carcinoma cell growth through induction of cell cycle G1/G0 phase arrest and p21CIP and p27KIP expression and downregulation of cyclin D1 in vitro and in vivo. Oncology Reports 30(5): 2449-2457
Mahrouf-Yorgov, M.; Marie, N.; Borderie, D.; Djelidi, R.; Bonnefont-Rousselot, D.; Legrand, A.; Beaudeux, J-Louis.; Peynet, J. 2009: Metformin suppresses high glucose-induced poly(adenosine diphosphate-ribose) polymerase overactivation in aortic endothelial cells. Metabolism, Clinical and Experimental 58(4): 525-533
Takemura, Y.; Osuga, Y.; Yoshino, O.; Hasegawa, A.; Hirata, T.; Hirota, Y.; Nose, E.; Morimoto, C.; Harada, M.; Koga, K.; Tajima, T.; Yano, T.; Taketani, Y. 2007: Metformin suppresses interleukin (IL)-1beta-induced IL-8 production, aromatase activation, and proliferation of endometriotic stromal cells. Journal of Clinical Endocrinology and Metabolism 92(8): 3213-3218
Tomimoto, A.; Endo, H.; Sugiyama, M.; Fujisawa, T.; Hosono, K.; Takahashi, H.; Nakajima, N.; Nagashima, Y.; Wada, K.; Nakagama, H.; Nakajima, A. 2008: Metformin suppresses intestinal polyp growth in ApcMin/+ mice. Cancer Science 99(11): 2136-2141
Wang, C.; Liu, F.; Yuan, Y.; Wu, J.; Wang, H.; Zhang, L.; Hu, P.; Li, Z.; Li, Q.; Ye, J. 2014: Metformin suppresses lipid accumulation in skeletal muscle by promoting fatty acid oxidation. Clinical Laboratory 60(6): 887-896
Kim, J.; Kwak, H.J.; Cha, J.-Y.; Jeong, Y.-S.; Rhee, S.D.; Kim, K.R.; Cheon, H.G. 2014: Metformin suppresses lipopolysaccharide (LPS)-induced inflammatory response in murine macrophages via activating transcription factor-3 (ATF-3) induction. Journal of Biological Chemistry 289(33): 23246-23255
Rattan, R.; Graham, R.P.; Maguire, J.L.; Giri, S.; Shridhar, V. 2011: Metformin suppresses ovarian cancer growth and metastasis with enhancement of cisplatin cytotoxicity in vivo. Neoplasia 13(5): 483-491
Krausova, L.; Stejskalova, L.; Wang, H.; Vrzal, R.; Dvorak, Z.; Mani, S.; Pavek, P. 2011: Metformin suppresses pregnane X receptor (PXR)-regulated transactivation of CYP3A4 gene. Biochemical Pharmacology 82(11): 1771-1780
Nakamura, M.; Ogo, A.; Yamura, M.; Yamaguchi, Y.; Nakashima, H. 2014: Metformin suppresses sonic hedgehog expression in pancreatic cancer cells. Anticancer Research 34(4): 1765-1769
Teixeira, S.F.; Guimarães, I.d.S.; Madeira, K.P.; Daltoé, R.D.; Silva, I.V.; Rangel, L.B.A. 2013: Metformin synergistically enhances antiproliferative effects of cisplatin and etoposide in NCI-H460 human lung cancer cells. Jornal Brasileiro de Pneumologia: Publicacao Oficial da Sociedade Brasileira de Pneumologia e Tisilogia 39(6): 644-649
Duo, J.; Ma, Y.; Wang, G.; Han, X.; Zhang, C. 2013: Metformin synergistically enhances antitumor activity of histone deacetylase inhibitor trichostatin a against osteosarcoma cell line. Dna and Cell Biology 32(4): 156-164
Deng, X.-S.; Wang, S.; Deng, A.; Liu, B.; Edgerton, S.M.; Lind, S.E.; Wahdan-Alaswad, R.; Thor, A.D. 2012: Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancers. Cell Cycle 11(2): 367-376
Akinyeke, T.; Matsumura, S.; Wang, X.; Wu, Y.; Schalfer, E.D.; Saxena, A.; Yan, W.; Logan, S.K.; Li, X. 2013: Metformin targets c-MYC oncogene to prevent prostate cancer. Carcinogenesis 34(12): 2823-2832
Lonardo, E.; Cioffi, M.; Sancho, P.; Sanchez-Ripoll, Y.; Trabulo, S.M.; Dorado, J.; Balic, A.; Hidalgo, M.; Heeschen, C. 2013: Metformin targets the metabolic achilles heel of human pancreatic cancer stem cells. Plos one 8(10): E76518
Scarpello, J.H.B.; Howlett, H.C.S. 2008: Metformin therapy and clinical uses. Diabetes and Vascular Disease Research 5(3): 157-167
Kapoor, S. 2013: Metformin therapy and its anti-neoplastic role in systemic malignancies besides hepatocellular carcinomas. Scandinavian Journal of Gastroenterology 48(5): 636-637
Kajbaf, F.; Arnouts, P.; de Broe, M.; Lalau, J-Daniel. 2013: Metformin therapy and kidney disease: a review of guidelines and proposals for metformin withdrawal around the world. Pharmacoepidemiology and Drug Safety 22(10): 1027-1035
Shah, D.D.; Fonarow, G.C.; Horwich, T.B. 2010: Metformin therapy and outcomes in patients with advanced systolic heart failure and diabetes. Journal of Cardiac Failure 16(3): 200-206
Franciosi, M.; Lucisano, G.; Lapice, E.; Strippoli, G.F.M.; Pellegrini, F.; Nicolucci, A. 2013: Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review. Plos one 8(8): E71583
Farimani Sanoee, M.; Neghab, N.; Rabiee, S.; Amiri, I. 2011: Metformin therapy decreases hyperandrogenism and ovarian volume in women with polycystic ovary syndrome. Iranian Journal of Medical Sciences 36(2): 90-95
Feig, D.S.; Moses, R.G. 2011: Metformin therapy during pregnancy: good for the goose and good for the gosling too?. Diabetes Care 34(10): 2329-2330
Nazari, T.; Bayat, R.; Hamedi, M. 2007: Metformin therapy in girls with polycystic ovary syndrome: a self-controlled clinical trial. Archives of Iranian Medicine 10(2): 176-181
Inzucchi, S.E.; Masoudi, F.A.; McGuire, D.K. 2007: Metformin therapy in patients with type 2 diabetes complicated by heart failure. American Heart Journal 154(6): E45
Jakimiuk, A.J. 2008: Metformin therapy in polycystic ovary syndrome. Ginekologia Polska 79(1): 8-11
Casteels, K.; Fieuws, S.; van Helvoirt, M.; Verpoorten, C.; Goemans, N.; Coudyzer, W.; Loeckx, D.; de Zegher, F. 2010: Metformin therapy to reduce weight gain and visceral adiposity in children and adolescents with neurogenic or myogenic motor deficit. Pediatric Diabetes 11(1): 61-69
Margel, D. 2014: Metformin to prevent prostate cancer: a call to unite. European Urology 66(6): 1021-1022
Lheureux, P.E.; Lheureux, O.F.; Penaloza-Baeza, A. 2009: Metformin toxicity. European Journal of Emergency Medicine: Official Journal of the European Society for Emergency Medicine 16(6): 348-349
Shadnia, S.; Barzi, F.; Askari, A.; Hassanian-Moghaddam, H.; Zamani, N.; Ebrahimian, K. 2013: Metformin toxicity: a report of 204 cases from Iran. Current Drug Safety 8(4): 278-281
DiTacchio, K.A.; Heinemann, S.F.; Dziewczapolski, G. 2015: Metformin treatment alters memory function in a mouse model of Alzheimer's disease. Journal of Alzheimer's Disease: Jad 44(1): 43-48
Pérez-López, F.R. 2014: Metformin treatment and evolution of endometrial cancer. Climacteric: the Journal of the International Menopause Society 17(2): 207-209
Tso, L.O.; Costello, M.F.; Albuquerque, L.E.T.; Andriolo, R.ég.B.; Macedo, C.R. 2014: Metformin treatment before and during IVF or ICSi in women with polycystic ovary syndrome. Cochrane Database of Systematic Reviews 11: Cd006105
Gamst, J.; Hansen, L.K.; Rasmussen, B.S. 2010: Metformin treatment causes persisting lactic acidosis after cardiac arrest. Ugeskrift for Laeger 172(49): 3418-3419
Tan, B.K.; Adya, R.; Chen, J.; Lehnert, H.; Sant Cassia, L.J.; Randeva, H.S. 2011: Metformin treatment exerts antiinvasive and antimetastatic effects in human endometrial carcinoma cells. Journal of Clinical Endocrinology and Metabolism 96(3): 808-816
Simmons, D. 2010: Metformin treatment for Type 2 diabetes in pregnancy?. Best Practice and Research. Clinical Endocrinology and Metabolism 24(4): 625-634
Park, M.H.; Kinra, S. 2010: Metformin treatment for adolescent obesity has limited long-term benefits. Journal of Pediatrics 157(1): 172
Rezzónico, J.; Rezzónico, M.; Pusiol, E.; Pitoia, F.; Niepomniszcze, H. 2011: Metformin treatment for small benign thyroid nodules in patients with insulin resistance. Metabolic Syndrome and Related Disorders 9(1): 69-75
Kaneb, H.M.; Sharp, P.S.; Rahmani-Kondori, N.; Wells, D.J. 2011: Metformin treatment has no beneficial effect in a dose-response survival study in the SOD1(G93A) mouse model of ALS and is harmful in female mice. Plos one 6(9): E24189
Labazi, H.; Wynne, B.M.; Tostes, R.; Webb, R.C. 2013: Metformin treatment improves erectile function in an angiotensin Ii model of erectile dysfunction. Journal of Sexual Medicine 10(9): 2154-2164
Luong, D.Q.; Oster, R.; Ashraf, A.P. 2015: Metformin treatment improves weight and dyslipidemia in children with metabolic syndrome. Journal of Pediatric Endocrinology and Metabolism: Jpem 28(5-6): 649-655
Eurich, D.T.; Tsuyuki, R.T.; Majumdar, S.R.; McAlister, F.A.; Lewanczuk, R.; Shibata, M.C.; Johnson, J.A. 2009: Metformin treatment in diabetes and heart failure: when academic equipoise meets clinical reality. Trials 10: 12
Hosseini, M.A.; Alleyassin, A.; Sarvi, F.; Safdarian, L.; Kokab, A.; Fanisalek, M. 2013: Metformin treatment in different phenotypes of polycystic ovary syndrome. Archives of Gynecology and Obstetrics 288(5): 1131-1136
Panahi, Y.; Mojtahedzadeh, M.; Zekeri, N.; Beiraghdar, F.; Khajavi, M.-R.; Ahmadi, A. 2011: Metformin treatment in hyperglycemic critically ill patients: another challenge on the control of adverse outcomes. Iranian Journal of Pharmaceutical Research: Ijpr 10(4): 913-919
Andersson, C.; Olesen, J.B.; Hansen, P.R.; Weeke, P.; Norgaard, M.L.; Jørgensen, C.H.; Lange, T.; Abildstrøm, S.Z.; Schramm, T.K.; Vaag, A.; Køber, L.; Torp-Pedersen, C.; Gislason, G.H. 2010: Metformin treatment is associated with a low risk of mortality in diabetic patients with heart failure: a retrospective nationwide cohort study. Diabetologia 53(12): 2546-2553
Rosiak, M.; Postula, M.; Kaplon-Cieslicka, A.; Trzepla, E.; Czlonkowski, A.; Filipiak, K.J.; Opolski, G. 2013: Metformin treatment may be associated with decreased levels of NT-proBNP in patients with type 2 diabetes. Advances in Medical Sciences 58(2): 362-368
Tan, B.K.; Adya, R.; Farhatullah, S.; Chen, J.; Lehnert, H.; Randeva, H.S. 2010: Metformin treatment may increase omentin-1 levels in women with polycystic ovary syndrome. Diabetes 59(12): 3023-3031
Kongsuphol, P.; Cassidy, D.; Romeiras, F.; Schreiber, R.; Mehta, A.; Kunzelmann, K. 2010: Metformin treatment of diabetes mellitus increases the risk for pancreatitis in patients bearing the CFTR-mutation S573C. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology Biochemistry and Pharmacology 25(4-5): 389-396
Díaz, M.; Bassols, J.; López-Bermejo, A.; de Zegher, F.; Ibáñez, L. 2015: Metformin treatment to reduce central adiposity after prenatal growth restraint: a placebo-controlled pilot study in prepubertal children. Pediatric Diabetes 16(7): 538-545
Petrányi, G.; Zaoura-Petrányi, M.ár. 2011: Metformin treatment with or without life style changes in patients with polycystic ovary syndrome. Orvosi Hetilap 152(16): 628-632
Huang, W.; Castelino, R.L.; Peterson, G.M. 2014: Metformin usage in type 2 diabetes mellitus: are safety guidelines adhered to?. Internal Medicine Journal 44(3): 266-272
Kittisupamongkol, W. 2009: Metformin usages in women with heart failure. American Journal of Obstetrics and Gynecology 201(1): E18; Author Reply E18-9
Walker, E.J.; Ko, A.H.; Holly, E.A.; Bracci, P.M. 2015: Metformin use among type 2 diabetics and risk of pancreatic cancer in a clinic-based case-control study. International Journal of Cancer 136(6): E646-E653
Margel, D.; Urbach, D.R.; Lipscombe, L.L.; Bell, C.M.; Kulkarni, G.; Austin, P.C.; Fleshner, N. 2013: Metformin use and all-cause and prostate cancer-specific mortality among men with diabetes. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 31(25): 3069-3075
Nevadunsky, N.S.; Van Arsdale, A.; Strickler, H.D.; Moadel, A.; Kaur, G.; Frimer, M.; Conroy, E.; Goldberg, G.L.; Einstein, M.H. 2014: Metformin use and endometrial cancer survival. Gynecologic Oncology 132(1): 236-240
Carr, A.J.; Sharma, A.P.; Ross, M.L.; Welvaert, M.; Slater, G.J.; Burke, L.M. 2018: Chronic Ketogenic Low Carbohydrate High Fat Diet Has Minimal Effects on Acid-Base Status in Elite Athletes. Nutrients 10(2)
Hemmelder, M.H.; van Balen, J.; Scherpbier, N.; Schenk, P.W.; Tuut, M.K.; Gansevoort, R.T. 2018: Chronic kidney damage guidelines revision. Nederlands Tijdschrift Voor Geneeskunde 162
Roussel, R.; Travert, F.; Pasquet, B.; Wilson, P.W.F.; Smith, S.C.; Goto, S.; Ravaud, P.; Marre, M.; Porath, A.; Bhatt, D.L.; Steg, P.G.; Bhatt, D.L.; Steg, G.; Ohman, E.M.; Röther, J.; Wilson, P.W.F.; Alberts, M.J.; Bhatt, D.L.; D'Agostino, R.; Eagle, K.; Goto, S.; Hirsch, A.T.; Liau, C.-S.; Mas, J.-L.; Ohman, E.M.; Röther, J.; Smith, S.C.; Steg, G.; Wilson, P.W.F. 2010: Metformin use and mortality among patients with diabetes and atherothrombosis. Archives of Internal Medicine 170(21): 1892-1899
Aguilar, D.; Chan, W.; Bozkurt, B.; Ramasubbu, K.; Deswal, A. 2011: Metformin use and mortality in ambulatory patients with diabetes and heart failure. CIRCULATION. Heart Failure 4(1): 53-58
Wright, J.L.; Stanford, J.L. 2009: Metformin use and prostate cancer in Caucasian men: results from a population-based case-control study. Cancer Causes and Control: Ccc 20(9): 1617-1622
Preston, M.A.; Riis, A.H.; Ehrenstein, V.; Breau, R.H.; Batista, J.L.; Olumi, A.F.; Mucci, L.A.; Adami, H.-O.; Sørensen, H.T. 2014: Metformin use and prostate cancer risk. European Urology 66(6): 1012-1020
Wijnen, J.C.F.; van de Riet, I.R.; Lijfering, W.M.; van der Meer, F.J.M. 2014: Metformin use decreases the anticoagulant effect of phenprocoumon. Journal of Thrombosis and Haemostasis: Jth 12(6): 887-890
Gray, L.; Lee, J.H.; Nashelsky, J. 2013: Metformin use in adolescents. American Family Physician 87(8): Od4
Nagai, T.; Imamura, M.; Mori, M. 2003: Metformin use in an obese diabetic patient from weeks 1 to 21 of pregnancy. Journal of Medicine 34(1-6): 163-168
Mauras, N.; DelGiorno, C.; Hossain, J.; Bird, K.; Killen, K.; Merinbaum, D.; Weltman, A.; Damaso, L.; Balagopal, P. 2012: Metformin use in children with obesity and normal glucose tolerance--effects on cardiovascular markers and intrahepatic fat. Journal of Pediatric Endocrinology and Metabolism: Jpem 25(1-2): 33-40
Herrington, W.G.; Nye, H.J.; Aung, T. 2013: Metformin use in chronic kidney disease: new evidence to guide dosing. Qjm: Monthly Journal of the Association of Physicians 106(11): 1059-1061
Boyd, A.; Nawarskas, J. 2008: Metformin use in decompensated heart failure. Cardiology in Review 16(5): 269-272
Gupta, Y.; Singla, R.; Kalra, S. 2014: Metformin use in gestational diabetes mellitus. Diabetes Research and Clinical Practice 105(1): E1-E2
Giamouzis, G.; Triposkiadis, F.; Butler, J. 2010: Metformin use in patients with diabetes mellitus and heart failure: friend or foe?. Journal of Cardiac Failure 16(3): 207-210
Goodarzi, M.O.; Azziz, R. 2008: Metformin use in polycystic ovary syndrome: metabolic benefits and diabetes prevention. American Journal of Medicine 121(8): E9; Author Reply E11
Philbrick, A.M.; Ernst, M.E.; McDanel, D.L.; Ross, M.B.; Moores, K.G. 2009: Metformin use in renal dysfunction: is a serum creatinine threshold appropriate?. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 66(22): 2017-2023
Johnson, N.P. 2014: Metformin use in women with polycystic ovary syndrome. Annals of Translational Medicine 2(6): 56
Sadeghi, N.; Abbruzzese, J.L.; Yeung, S.-C.J.; Hassan, M.; Li, D. 2012: Metformin use is associated with better survival of diabetic patients with pancreatic cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 18(10): 2905-2912
Hanjalic-Beck, A.; Gabriel, B.; Schaefer, W.; Zahradnik, H.-P.; Schories, M.; Tempfer, C.; Keck, C.; Denschlag, D. 2010: Metformin versus acarbose therapy in patients with polycystic ovary syndrome (PCOS): a prospective randomised double-blind study. Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 26(9): 690-697
Amooee, S.; Parsanezhad, M.E.; Ravanbod Shirazi, M.; Alborzi, S.; Samsami, A. 2013: Metformin versus chromium picolinate in clomiphene citrate-resistant patients with PCOs: a double-blind randomized clinical trial. Iranian Journal of Reproductive Medicine 11(8): 611-618
Hamed, H.O.; Hasan, A.F.; Ahmed, O.G.; Ahmed, M.A. 2010: Metformin versus laparoscopic ovarian drilling in clomiphene- and insulin-resistant women with polycystic ovary syndrome. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 108(2): 143-147
Curi, D.D.G.; Fonseca, A.M.; Marcondes, J.é A.ôn.M.; Almeida, J.é A.M.; Bagnoli, V.R.; Soares, J.é M.; Baracat, E.C. 2012: Metformin versus lifestyle changes in treating women with polycystic ovary syndrome. Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 28(3): 182-185
Liao, L.; Tian, Y.-J.; Zhao, J.-J.; Xin, Y.; Xing, H.-Y.; Dong, J.-J. 2011: Metformin versus metformin plus rosiglitazone in women with polycystic ovary syndrome. Chinese Medical Journal 124(5): 714-718
Vanky, E.; Stridsklev, S.; Heimstad, R.; Romundstad, P.ål.; Skogøy, K.; Kleggetveit, O.; Hjelle, S.; von Brandis, P.; Eikeland, T.; Flo, K.; Berg, K.F.; Bunford, G.; Lund, A.; Bjerke, C.; Almås, I.; Berg, A.H.; Danielson, A.; Lahmami, G.; Carlsen, S.M. 2010: Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study. Journal of Clinical Endocrinology and Metabolism 95(12): E448-E455
Gui, J.; Liu, Q.; Feng, L. 2013: Metformin vs insulin in the management of gestational diabetes: a meta-analysis. Plos one 8(5): E64585
Su, D.F.; Wang, X.Y. 2014: Metformin vs insulin in the management of gestational diabetes: a systematic review and meta-analysis. Diabetes Research and Clinical Practice 104(3): 353-357
Li, X.-J.; Yu, Y.-X.; Liu, C.-Q.; Zhang, W.; Zhang, H.-J.; Yan, B.; Wang, L.-Y.; Yang, S.-Y.; Zhang, S.-H. 2011: Metformin vs thiazolidinediones for treatment of clinical, hormonal and metabolic characteristics of polycystic ovary syndrome: a meta-analysis. Clinical Endocrinology 74(3): 332-339
Malin, S.K.; Stephens, B.R.; Sharoff, C.G.; Hagobian, T.A.; Chipkin, S.R.; Braun, B. 2010: Metformin's effect on exercise and postexercise substrate oxidation. International Journal of Sport Nutrition and Exercise Metabolism 20(1): 63-71
Sant'Anna, J.R.; Yajima, J.P.R.S.; Rosada, L.úc.J.; Franco, C.éi.C.S.; Prioli, A.J.; Della-Rosa, V.A.; Mathias, P.C.F.; Castro-Prado, M.A.A. 2013: Metformin's performance in in vitro and in vivo genetic toxicology studies. Experimental Biology and Medicine 238(7): 803-810
Pollak, M. 2013: Metformin's potential in oncology. Clinical Advances in Hematology and Oncology: H&o 11(9): 594-595
Garcia, A.; Tisman, G. 2010: Metformin, B(12), and enhanced breast cancer response to chemotherapy. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 28(2): e19; author reply e20
Musarrat, K.; Kalathil, D.; Varughese, G.I. 2008: Metformin, B12 and homocysteine levels: the plausible cause or effect?. Journal of the Formosan Medical Association 107(6): 505-6; Author Reply 507
Saito, T.; Chiba, T.; Yuki, K.; Zen, Y.; Oshima, M.; Koide, S.; Motoyama, T.; Ogasawara, S.; Suzuki, E.; Ooka, Y.; Tawada, A.; Tada, M.; Kanai, F.; Takiguchi, Y.; Iwama, A.; Yokosuka, O. 2013: Metformin, a diabetes drug, eliminates tumor-initiating hepatocellular carcinoma cells. Plos one 8(7): E70010
Moiseeva, O.; Deschênes-Simard, X.; Pollak, M.; Ferbeyre, G. 2013: Metformin, aging and cancer. Aging 5(5): 330-331
Arai, M.; Uchiba, M.; Komura, H.; Mizuochi, Y.; Harada, N.; Okajima, K. 2010: Metformin, an antidiabetic agent, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitro. Journal of Pharmacology and Experimental Therapeutics 334(1): 206-213
Beck, E.; Scheen, A.J. 2013: Metformin, an antidiabetic molecule with anti-cancer properties. Revue Medicale de Liege 68(9): 444-449
Machado, H.A.; Vieira, M.; Cunha, M.R.; Correia, M.R.S.; Fukui, R.T.; Santos, R.F.d.; Rocha, D.M.; Wajchenberg, B.L.; Lage, S.G.; Silva, M.E.R.d. 2012: Metformin, but not glimepiride, improves carotid artery diameter and blood flow in patients with type 2 diabetes mellitus. Clinics 67(7): 711-717
Kusaka, I.; Nagasaka, S.; Horie, H.; Ishibashi, S. 2008: Metformin, but not pioglitazone, decreases postchallenge plasma ghrelin levels in type 2 diabetic patients: a possible role in weight stability?. Diabetes Obesity and Metabolism 10(11): 1039-1046
Skov, V.; Cangemi, C.; Gram, J.; Christensen, M.M.; Grodum, E.; Sørensen, D.; Argraves, W.S.; Henriksen, J.E.; Rasmussen, L.M. 2014: Metformin, but not rosiglitazone, attenuates the increasing plasma levels of a new cardiovascular marker, fibulin-1, in patients with type 2 diabetes. Diabetes Care 37(3): 760-766
Salani, B.; Del Rio, A.; Marini, C.; Sambuceti, G.; Cordera, R.; Maggi, D. 2014: Metformin, cancer and glucose metabolism. Endocrine-Related Cancer 21(6): R461-R471
Duncan, B.B.; Schmidt, M.I. 2009: Metformin, cancer, alphabet soup, and the role of epidemiology in etiologic research. Diabetes Care 32(9): 1748-1750
Muti, P.; Berrino, F.; Krogh, V.; Villarini, A.; Barba, M.; Strano, S.; Blandino, G. 2009: Metformin, diet and breast cancer: an avenue for chemoprevention. Cell Cycle 8(16): 2661
Guercio, G.; Di Palma, M.I.; Pepe, C.; Saraco, N.I.; Prieto, M.; Saure, C.; Mazza, C.; Rivarola, M.A.; Belgorosky, A. 2009: Metformin, estrogen replacement therapy and gonadotropin inhibition fail to improve insulin sensitivity in a girl with aromatase deficiency. Hormone Research 72(6): 370-376
Lefèbvre, P. 2007: Metformin, fifty years since the arrival of this molecule!. Journees Annuelles de Diabetologie de l'Hotel-Dieu 2007: 1-3
Yilmaz, Y.; Yonal, O.; Imeryuz, N. 2009: Metformin, hepatitis C, and insulin resistance: sufficient evidence?. Hepatology 50(6): 2054-5; Author Reply 2055
Ben Sahra, I.; Regazzetti, C.; Robert, G.; Laurent, K.; Le Marchand-Brustel, Y.; Auberger, P.; Tanti, J-François.; Giorgetti-Peraldi, S.; Bost, Fédéric. 2011: Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1. Cancer Research 71(13): 4366-4372
Kalender, A.; Selvaraj, A.; Kim, S.Y.; Gulati, P.; Brûlé, S.; Viollet, B.; Kemp, B.E.; Bardeesy, N.; Dennis, P.; Schlager, J.J.; Marette, A.é; Kozma, S.C.; Thomas, G. 2010: Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner. Cell Metabolism 11(5): 390-401
Berstein, L.M. 2009: Metformin, insulin, breast cancer and more.. Future Oncology 5(3): 309-312
Sugden, M.C.; Holness, M.J. 2012: Metformin, metabolic stress, and mitochondria. Focus on "A novel inverse relationship between metformin-triggered AMPK-SIRT1 signaling and p53 protein abundance in high glucose-exposed HepG2 cells". American Journal of Physiology. Cell Physiology 303(1): C1-C3
Hadžiomerović-Pekić, D.; Wildt, L.; Weiss, J.ür.M.; Moeller, K.; Mattle, V.; Seeber, B.E. 2010: Metformin, naltrexone, or the combination of prednisolone and antiandrogenic oral contraceptives as first-line therapy in hyperinsulinemic women with polycystic ovary syndrome. Fertility and Sterility 94(6): 2385-2388
Palomba, S.; Materazzo, C.; Falbo, A.; Orio, F.; La Sala, G.B.; Sultan, C. 2014: Metformin, oral contraceptives or both to manage oligo-amenorrhea in adolescents with polycystic ovary syndrome? a clinical review. Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 30(5): 335-340
Mitrov-Winkelmolen, L.; Oude Engberink, R.D.; Roelofs, R.; Ponjee, G.A.E.; Vleming, L.J.; Wilms, E.B.; Geelhoed-Duijvestijn, N.H.L.M. 2014: Metformin, renal function and lactate: the MetClear Study. Nederlands Tijdschrift Voor Geneeskunde 158(5): A6266
Bodmer, M.; Meier, C.; Krähenbühl, S.; Jick, S.S.; Meier, C.R. 2008: Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: a nested case-control analysis. Diabetes Care 31(11): 2086-2091
Rai, L.; Meenakshi, D.; Kamath, A. 2009: Metformin--a convenient alternative to insulin for Indian women with diabetes in pregnancy. Indian Journal of Medical Sciences 63(11): 491-497
Habibollahi, P.; van den Berg, N.S.; Kuruppu, D.; Loda, M.; Mahmood, U. 2013: Metformin--an adjunct antineoplastic therapy--divergently modulates tumor metabolism and proliferation, interfering with early response prediction by 18F-FDG PET imaging. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 54(2): 252-258
Bujak-Gizycka, B.; Suski, M.; Olszanecki, R.ł; Madej, J.óz.; Korbut, R. 2009: Metformin--an inhibitor of early stages of protein glycation. Folia Medica Cracoviensia 50(3-4): 21-33
Bosi, E. 2009: Metformin--the gold standard in type 2 diabetes: what does the evidence tell us?. Diabetes Obesity and Metabolism 11(Suppl 2): 3-8
Yılmaz, S.; Ozhan, M.; Sager, S.; Yörük Atik, D.; Halac, M.; Sönmezoğlu, K. 2011: Metformin-Induced Intense Bowel Uptake Observed on Restaging FDG PET/CT Study in a Patient with Gastric Lymphoma. Molecular Imaging and Radionuclide Therapy 20(3): 114-116
Arroyo, D.; Melero, R.; Panizo, N.; Goicoechea, M.; Rodríguez-Benítez, P.; Vinuesa, S.G.ía.; Verde, E.; Tejedor, A.; Luño, J.é 2011: Metformin-associated acute kidney injury and lactic acidosis. International Journal of Nephrology 2011: 749653
Olivera-González, S.; de Escalante-Yangüela, B.; Velilla-Soriano, C.; Amores-Arriaga, B.; Martín-Fortea, P.; Navarro-Aguilar, M.E. 2010: Metformin-associated hepatotoxicity. Medicina Intensiva 34(7): 483-487
Briggs, D. 2014: Metformin-associated lactic acidosis. Emergency Nurse: the Journal of the Rcn Accident and Emergency Nursing Association 22(5): 20-25
Kopec, K.T.; Kowalski, M.J. 2013: Metformin-associated lactic acidosis (MALA): case files of the Einstein Medical Center medical toxicology fellowship. Journal of medical toxicology: official journal of the American College of Medical Toxicology 9(1): 61-66
Hofkens, P.J.; De Winter, S.; Vanbrabant, P. 2011: Metformin-associated lactic acidosis (MALA): case report. Acta Clinica Belgica 66(5): 390-392
Biradar, V.; Moran, J.L.; Peake, S.L.; Peter, J.V. 2010: Metformin-associated lactic acidosis (MALA): clinical profile and outcomes in patients admitted to the intensive care unit. Critical Care and Resuscitation: Journal of the Australasian Academy of Critical Care Medicine 12(3): 191-195
Esteve, V.; Saurina, A.; Fontseré, N.; de las Cuevas, X. 2007: Metformin-associated lactic acidosis and acute renal failure secondary to cardiac catheterism. Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 27(3): 385-386
Korvenius Jørgensen, H.; Nielsen, J.S.; Gilsaa, T. 2012: Metformin-associated lactic acidosis can be treated with continuous renal replacement therapy. Ugeskrift for Laeger 174(23): 1602-1603
Jain, V.; Sharma, D.; Prabhakar, H.; Dash, H.H. 2008: Metformin-associated lactic acidosis following contrast media-induced nephrotoxicity. European Journal of Anaesthesiology 25(2): 166-167
Yeung, C.W.; Chung, H.Y.; Fong, B.M.W.; Tsai, N.W.; Chan, W.M.; Siu, T.S.; Tam, S.; Tsui, S.H. 2011: Metformin-associated lactic acidosis in Chinese patients with type Ii diabetes. Pharmacology 88(5-6): 260-265
Hong, Y.-C.; O'Boyle, C.P.; Chen, I.-C.; Hsiao, C.-T.; Kuan, J.-T. 2008: Metformin-associated lactic acidosis in a pregnant patient. Gynecologic and Obstetric Investigation 66(2): 138-141
Peters, N.; Jay, N.; Barraud, D.; Cravoisy, A.él.; Nace, L.; Bollaert, P.-E.; Gibot, S.éb. 2008: Metformin-associated lactic acidosis in an intensive care unit. Critical Care 12(6): R149
Kwok, W.C.; Chan, T.C.; Luk, J.; Chan, F. 2013: Metformin-associated lactic acidosis in an older adult after colonoscopy: an uncommon trigger for a rare complication. Journal of the American Geriatrics Society 61(12): 2257-2258
Runge, S.; Mayerle, J.; Warnke, C.; Robinson, D.; Roser, M.; Felix, S.B.; Friesecke, S. 2008: Metformin-associated lactic acidosis in patients with renal impairment solely due to drug accumulation?. Diabetes Obesity and Metabolism 10(1): 91-93
Tébar, M.T.; de Luis, N.; Sánchez, I.; Aguilera, L. 2014: Metformin-associated lactic acidosis in the Intensive Care Unit. Revista Espanola de Anestesiologia y Reanimacion 61(8): 466-467
Correia, C.S.; Bronander, K.A. 2012: Metformin-associated lactic acidosis masquerading as ischemic bowel. American Journal of Medicine 125(5): E9
El-Hennawy, A.S.; Jacob, S.; Mahmood, A.K. 2007: Metformin-associated lactic acidosis precipitated by diarrhea. American Journal of Therapeutics 14(4): 403-405
Ncomanzi, D.; Sicat, R.Mae.R.; Sundararajan, K. 2014: Metformin-associated lactic acidosis presenting as an ischemic gut in a patient who then survived a cardiac arrest: a case report. Journal of Medical Case Reports 8: 159
Renda, F.; Mura, P.; Finco, G.; Ferrazin, F.; Pani, L.; Landoni, G. 2013: Metformin-associated lactic acidosis requiring hospitalization. A national 10 year survey and a systematic literature review. European Review for Medical and Pharmacological Sciences 17 Suppl. 1: 45-49
Akoglu, H.; Akan, B.; Piskinpasa, S.; Karaca, O.; Dede, F.; Erdem, D.; Albayrak, M.D.; Odabas, A.R. 2011: Metformin-associated lactic acidosis treated with prolonged hemodialysis. American Journal of Emergency Medicine 29(5): 575.E3
Seidowsky, A.; Nseir, S.; Houdret, N.; Fourrier, F.ço. 2009: Metformin-associated lactic acidosis: a prognostic and therapeutic study. Critical Care Medicine 37(7): 2191-2196
Vives, M.; Romano, J.; Stoll, E.; Lafuente, A.; Nagore, D.; Monedero, P. 2012: Metformin-associated lactic acidosis: incidence, diagnosis, prognostic factors and treatment. Revista Espanola de Anestesiologia y Reanimacion 59(5): 276-279
Lemyze, M.; Mallat, J.; Thevenin, D. 2011: Metformin-associated lactic acidosis: is it really just an association?. American Journal of Emergency Medicine 29(3): 349-350
He, H.; Zhao, Z.; Chen, J.; Ni, Y.; Zhong, J.; Yan, Z.; Li, Y.; Liu, D.; Pletcher, M.J.; Zhu, Z. 2012: Metformin-based treatment for obesity-related hypertension: a randomized, double-blind, placebo-controlled trial. Journal of Hypertension 30(7): 1430-1439
Ayaz, A.; Alwan, Y.; Farooq, M.U. 2013: Metformin-clomiphene citrate vs. clomiphene citrate alone: Polycystic ovarian syndrome. Journal of Human Reproductive Sciences 6(1): 15-18
Wahlqvist, M.L.; Lee, M.-S.; Hsu, C.-C.; Chuang, S.-Y.; Lee, J.-T.; Tsai, H.-N. 2012: Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort. Parkinsonism and Related Disorders 18(6): 753-758
Cheng, Y.-Y.; Leu, H.-B.; Chen, T.-J.; Chen, C.-L.; Kuo, C.-H.; Lee, S.-D.; Kao, C.-L. 2014: Metformin-inclusive therapy reduces the risk of stroke in patients with diabetes: a 4-year follow-up study. Journal of Stroke and Cerebrovascular Diseases: the Official Journal of National Stroke Association 23(2): E99-105
Sánchez-Rubio Ferrández, J.; Manteiga Riestra, E.; Martínez González, O. 2007: Metformin-induced acute lactic acidosis. Farmacia Hospitalaria: Organo Oficial de Expresion Cientifica de la Sociedad Espanola de Farmacia Hospitalaria 31(1): 71-72
Biyyani, R.S.R.S.; Battula, S.; Erhardt, C.A.; Korkor, K. 2009: Metformin-induced cholangiohepatitis. BMJ Case Reports
Jung, E.Y.; Cho, H.S.; Seo, J.W.; Kim, D.W.; Kim, H.-J.; Chang, S.-H.; Park, D.J. 2009: Metformin-induced encephalopathy without lactic acidosis in a patient with contraindication for metformin. Hemodialysis International. International Symposium on Home Hemodialysis 13(2): 172-175
Kirkiz, S.; Yarali, N.; Arman Bilir, O.; Tunc, B. 2014: Metformin-induced hemolytic anemia. Medical Principles and Practice: International Journal of the Kuwait University Health Science Centre 23(2): 183-185
Miralles-Linares, F.; Puerta-Fernandez, S.; Bernal-Lopez, M.R.; Tinahones, F.J.; Andrade, R.J.; Gomez-Huelgas, R. 2012: Metformin-induced hepatotoxicity. Diabetes Care 35(3): E21
Kim, K.H.; Jeong, Y.T.; Kim, S.H.; Jung, H.S.; Park, K.S.; Lee, H.-Y.; Lee, M.-S. 2013: Metformin-induced inhibition of the mitochondrial respiratory chain increases FGF21 expression via ATF4 activation. Biochemical and Biophysical Research Communications 440(1): 76-81
Wahdan-Alaswad, R.S.; Cochrane, D.R.; Spoelstra, N.S.; Howe, E.N.; Edgerton, S.M.; Anderson, S.M.; Thor, A.D.; Richer, J.K. 2014: Metformin-induced killing of triple-negative breast cancer cells is mediated by reduction in fatty acid synthase via miRNA-193b. Hormones and Cancer 5(6): 374-389
Audia, P.; Feinfeld, D.A.; Dubrow, A.; Winchester, J.F. 2008: Metformin-induced lactic acidosis and acute pancreatitis precipitated by diuretic, celecoxib, and candesartan-associated acute kidney dysfunction. Clinical Toxicology 46(2): 164-166
Bolleku, E.; Idrizi, A.; Barbullushi, M.; Bajrami, V.; Likaj, E.; Thereska, N.; Ohri, I.; Nunci, L. 2013: Metformin-induced lactic acidosis associated with multiorganic failure. Medical Archives 67(5): 381-382
Macías-Robles, M.D.; Maciá-Bobes, C.; Yano-Escudero, R.; Fernández-Diéguez, O.; Alvarez-Lecue, O. 2011: Metformin-induced lactic acidosis due to acute renal failure. Anales del Sistema Sanitario de Navarra 34(1): 115-118
Di Grande, A.; Vancheri, F.; Giustolisi, V.; Giuffrida, C.; Narbone, G.; Licata, M.; Le Moli, C.; Riccobene, S.; Burgio, A.; Bartolotta, S.; Nigro, F.; Cannone, V. 2008: Metformin-induced lactic acidosis in a type 2 diabetic patient with acute renal failure. La Clinica Terapeutica 159(2): 87-89
Silvestre, J.; Carvalho, S.; Mendes, V.; Coelho, L.; Tapadinhas, C.; Ferreira, P.; Povoa, P.; Ceia, F. 2007: Metformin-induced lactic acidosis: a case series. Journal of Medical Case Reports 1: 126
Vecchio, S.; Protti, A. 2011: Metformin-induced lactic acidosis: no one left behind. Critical Care 15(1): 107
Martin Gómez, M.A.; Sánchez Martos, M.D.; García Marcos, S.A.; Serrano Carrillo de Albornoz, J.L. 2011: Metformin-induced lactic acidosis: usefulness of measuring levels and therapy with high-flux haemodialysis. Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 31(5): 610-611
Czarnowicki, T.; Ramot, Y.; Ingber, A.; Maly, A.; Horev, L. 2012: Metformin-induced leukocytoclastic vasculitis: a case report. American Journal of Clinical Dermatology 13(1): 61-63
Cioce, M.; Valerio, M.; Casadei, L.; Pulito, C.; Sacconi, A.; Mori, F.; Biagioni, F.; Manetti, C.; Muti, P.; Strano, S.; Blandino, G. 2014: Metformin-induced metabolic reprogramming of chemoresistant ALDHbright breast cancer cells. Oncotarget 5(12): 4129-4143
Saadi, T.; Waterman, M.; Yassin, H.; Baruch, Y. 2013: Metformin-induced mixed hepatocellular and cholestatic hepatic injury: case report and literature review. International Journal of General Medicine 6: 703-706
Koc, F.; Yerdelen, D. 2008: Metformin-induced paroxysmal dystonia. Neurosciences 13(2): 194-195
Cufi, S.; Corominas-Faja, B.; Vazquez-Martin, A.; Oliveras-Ferraros, C.; Dorca, J.; Bosch-Barrera, J.; Martin-Castillo, B.ña.; Menendez, J.A. 2012: Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts. Oncotarget 3(4): 395-398
Lenfestey, A.; Friedmann, D.; Burke, W.A. 2012: Metformin-induced pseudoporphyria. Journal of Drugs in Dermatology: Jdd 11(11): 1272
Sakar, Y.; Meddah, B.; Faouzi, M.A.; Cherrah, Y.; Bado, A.; Ducroc, R. 2010: Metformin-induced regulation of the intestinal D-glucose transporters. Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 61(3): 301-307
Cappelli, C.; Rotondi, M.; Pirola, I.; Agosti, B.; Formenti, A.M.; De Cata, P.; Salvetti, M.; Chiovato, L.; Castellano, M. 2014: Metformin-induced thyrotropin suppression is not associated with cardiac effects. Hormones 13(2): 252-258
Bell, D.S.H. 2010: Metformin-induced vitamin B12 deficiency presenting as a peripheral neuropathy. Southern Medical Journal 103(3): 265-267
Davar, R.; Javedani, M.; Fallahzadeh, M.H. 2011: Metformin-letrozole in comparison with Metformin-clomiphene citrate in clomiphene-resistance PCOS patients undergoing IUi. Iranian Journal of Reproductive Medicine 9(1): 31-36
Jose, P.; Sundar, K.; Anjali, C.H.; Ravindran, A. 2015: Metformin-loaded BSA nanoparticles in cancer therapy: a new perspective for an old antidiabetic drug. Cell Biochemistry and Biophysics 71(2): 627-636
Subramaniam, N.; Sherman, M.H.; Rao, R.; Wilson, C.; Coulter, S.; Atkins, A.R.; Evans, R.M.; Liddle, C.; Downes, M. 2012: Metformin-mediated Bambi expression in hepatic stellate cells induces prosurvival Wnt/β-catenin signaling. Cancer Prevention Research 5(4): 553-561
Tseng, S-Chieh.; Huang, Y-Ching.; Chen, H-Jen.; Chiu, H-Chun.; Huang, Y-Jhen.; Wo, T-Yu.; Weng, S-Hsing.; Lin, Y-Wei. 2013: Metformin-mediated downregulation of p38 mitogen-activated protein kinase-dependent excision repair cross-complementing 1 decreases DNA repair capacity and sensitizes human lung cancer cells to paclitaxel. Biochemical Pharmacology 85(4): 583-594
Van der Linden, C.M.J.; Knol, W.; van Marum, R.J.; Jansen, P.A.F. 2007: Metformin-related lactic acidosis in an 85-year-old woman. Nederlands Tijdschrift Voor Geneeskunde 151(17): 977-980
Devetzis, V.; Passadakis, P.; Panagoutsos, S.; Theodoridis, M.; Thodis, E.; Georgoulidou, A.; Vargemezis, V. 2011: Metformin-related lactic acidosis in patients with acute kidney injury. International Urology and Nephrology 43(4): 1243-1248
Mapas-Dimaya, A.Celeste.; Agdere, L.; Bahtiyar, G.; Mejia, J.O.; Sacerdote, A.S. 2008: Metformin-responsive classic salt-losing congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a case report. Endocrine Practice: Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 14(7): 889-891
Jian, M.-Y.; Alexeyev, M.F.; Wolkowicz, P.E.; Zmijewski, J.W.; Creighton, J.R. 2013: Metformin-stimulated AMPK-α1 promotes microvascular repair in acute lung injury. American Journal of Physiology. Lung Cellular and Molecular Physiology 305(11): L844-L855
Schmitt-Hönl, B. 2008: Metformin. Contraindications in heart failure reconsidered. Medizinische Monatsschrift für Pharmazeuten 31(4): 148-149
Anonymous 2009: Metformin/Repaglinide (PrandiMet) for type 2 diabetes. Medical Letter on Drugs and Therapeutics 51(1313): 41-43
Zuccarini, G.; Bocchino, M.; Assante, L.Rosario.; Rea, G.; Sanduzzi, A. 2014: Metformin/glibenclamide-related interstitial lung disease: a case report. Sarcoidosis Vasculitis and Diffuse Lung Diseases: Official Journal of Wasog 31(2): 170-173
Smiley, D.; Umpierrez, G. 2007: Metformin/rosiglitazone combination pill (Avandamet) for the treatment of patients with Type 2 diabetes. Expert Opinion on PharmacoTherapy 8(9): 1353-1364
Nasri, H.; Rafieian-Kopaei, M. 2014: Metformin: Current knowledge. Journal of Research in Medical Sciences: the Official Journal of Isfahan University of Medical Sciences 19(7): 658-664
De Souza, A.L. 2008: Metformin: from medieval age to new therapeutic targets. International Journal of Diabetes in Developing Countries 28(1): 31
Kalra, S.; Dhamija, P.; Das, A.K. 2012: Metformin: Midlife maturity, maiden charm. Indian Journal of Endocrinology and Metabolism 16(6): 1015-1018
Pulito, C.; Sanli, T.; Rana, P.; Muti, P.; Blandino, G.; Strano, S. 2013: Metformin: On Ongoing Journey across Diabetes, Cancer Therapy and Prevention. Metabolites 3(4): 1051-1075
Martin, M.; Marais, R. 2012: Metformin: a diabetes drug for cancer, or a cancer drug for diabetics?. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 30(21): 2698-2700
Cheong, B. 2013: Metformin: a differential diagnosis for weight loss, altered bowel habits and B12 deficiency anemia in an elderly diabetic. Medical Journal of Malaysia 68(5): 441-442
Rosilio, C.él.; Ben-Sahra, I.; Bost, F.éd.ér.; Peyron, J.-F.ço. 2014: Metformin: a metabolic disruptor and anti-diabetic drug to target human leukemia. Cancer Letters 346(2): 188-196